| Q80798874 | 'Warm-up' phenomenon in diabetic patients with stable angina treated with diet or sulfonylureas |
| Q64996247 | 1-Deoxynojirimycin in Mulberry (Morus indica L.) Leaves Ameliorates Stable Angina Pectoris in Patients With Coronary Heart Disease by Improving Antioxidant and Anti-inflammatory Capacities. |
| Q98153328 | 18F-NaF PET uptake characteristics of coronary artery culprit lesions in a cohort of patients of acute coronary syndrome with ST-elevation myocardial infarction and chronic stable angina: A hybrid fluoride PET/CTCA study |
| Q58972877 | 2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina |
| Q34722286 | 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to |
| Q90266580 | 3D-speckle tracking echocardiography for assessment of coronary artery disease severity in stable angina pectoris |
| Q64058363 | 72-Year-old woman with effort angina >3 <12 months after acute myocardial infarction |
| Q72886967 | 99mTc-pyrophosphate myocardial scintigraphy in patients with chronic stable angina pectoris (author's transl) |
| Q68331608 | A Comparison of Epanolol and Nifedipine in Stable Angina Patients: Results of a Multicentre Trial |
| Q39555763 | A Destabilized Case of Stable Effort Angina Pectoris Induced by Low-dose Adenosine Triphosphate |
| Q37131815 | A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of STA-2 (Green Tea Polyphenols) in Patients with Chronic Stable Angina |
| Q33737301 | A Systematic Review on the Short-term Efficacy and Safety of Nicorandil for Stable Angina Pectoris in Comparison with Those of β-Blockers, Nitrates and Calcium Antagonists |
| Q84131987 | A brave new world? Measuring trends in percutaneous coronary intervention for stable angina after COURAGE |
| Q89642880 | A case of effort angina complicated with cerebrotendinous xanthomatosis involving severe coronary artery calcification and the detection of a calcified nodule on optical coherence tomography |
| Q73415745 | A case of effort angina pectoris with total obstruction of the left main coronary artery and extracardiac anastomose detected by angiography |
| Q76090945 | A case report of vascular spasm and angina of effort with treatment |
| Q78918104 | A clinical trial of Persantin and Crodimyl in the treatment of angina of effort |
| Q33599175 | A clinical trial of penta-erythritol tetranitrate, a khellin derivative (recordil), and iproniazid in angina of effort |
| Q79645756 | A clinical trial of prenylamine lactate (synadrin) in the treatment of angina of effort |
| Q43999841 | A comparative study of carteolol and propranolol on exercise performance in patients with chronic stable angina pectoris |
| Q68324551 | A comparative study of celiprolol and nicardipine in stable angina of effort |
| Q77355910 | A comparative study of eccentric and concentric coronary stenosis vasomotion in patients with Prinzmental's variant angina and patients with stable angina pectoris |
| Q77504100 | A comparative study of once-daily amlodipine versus twice-daily diltiazem controlled release (CR) in the treatment of stable angina pectoris. Amlodipine Study Group |
| Q70240431 | A comparison of carteolol and nadolol in the treatment of stable angina pectoris |
| Q44641638 | A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study |
| Q71195267 | A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina |
| Q42219545 | A comparison of nine calcium ion antagonists and propranolol: exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris |
| Q67833877 | A comparison of sustained release verapamil versus atenolol for 24 h protection from exercise-induced angina pectoris |
| Q77997669 | A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study Group |
| Q28255857 | A dose-dependent improvement in exercise tolerance in patients with stable angina treated with mildronate: a clinical trial "MILSS I" |
| Q69900533 | A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects |
| Q34118098 | A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris |
| Q70689310 | A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris |
| Q72921045 | A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris |
| Q67899859 | A double-blind dose-response study of amlodipine in patients with stable angina pectoris |
| Q73350315 | A double-blind evaluation of amlodipine in patients with chronic, stable angina: sustained efficacy and lack of "withdrawal phenomenon" upon abrupt discontinuation |
| Q70245841 | A double-blind randomized trial of propranolol and verapamil in the treatment of effort angina |
| Q38046358 | A meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with medical therapy in stable angina pectoris |
| Q80740225 | A method for the evaluation of the effects of drugs on cardiac pain in patients with angina of effort; a study of khellin (visammin) |
| Q44743851 | A multicenter trial of transdermal nitroglycerin in exercise-induced angina: individual antianginal response after repeated administration |
| Q47447825 | A multicenter, randomized, double-blind clinical study on Wufuxinnaoqing Soft Capsule () in treatment of chronic stable angina patients with blood stasis syndrome |
| Q54113068 | A multicentre open comparison of isosorbide-5-mononitrate and nifedipine given prophylactically to general practice patients with chronic stable angina pectoris. |
| Q67907231 | A new anti-ischemic drug for the treatment of stable effort angina pectoris: nicorandil. Comparison with placebo and isosorbide-5-mononitrate |
| Q46133345 | A new combination therapy in stable angina pectoris |
| Q39387142 | A new isosorbide dinitrate extended-release formulation: pharmacokinetic and clinical parameters in patients with stable angina pectoris |
| Q79799200 | A new method to quantify coronary calcification by intravascular ultrasound - the different patterns of calcification of acute myocardial infarction, unstable angina pectoris and stable angina pectoris |
| Q47820514 | A persistent increase in C-reactive protein is a risk factor for restenosis in patients with stable angina who are not receiving statins |
| Q44432240 | A pilot double-blind randomized placebo-controlled study of molsidomine 16�mg once-a-day in patients suffering from stable angina pectoris: correlation between efficacy and over time plasma concentrations |
| Q68512749 | A placebo-controlled, double-blind study of eicosapentaenoic acid-rich fish oil in patients with stable angina pectoris |
| Q44162757 | A possibility to interchange heart rate-slowing therapy with ivabradine and atenolol in patients with stable angina pectoris |
| Q40845422 | A potassium channel opener as monotherapy in chronic stable angina pectoris: comparison with placebo |
| Q35618271 | A protocol of histone modification-based mechanistic study of acupuncture in patients with stable angina pectoris. |
| Q69225500 | A randomised double-blind crossover study of isosorbide mononitrate and nifedipine retard in chronic stable angina |
| Q70226968 | A randomized double-blind comparison of diltiazem and nifedipine in stable angina |
| Q38801662 | A randomized double-blind placebo-controlled crossover trial of sodium nitrate in patients with stable angina INAS. |
| Q70400501 | A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris |
| Q44141471 | A randomized, double-blind comparison of 10 and 20 mg lercanidipine in patients with stable effort angina: effects on myocardial ischemia and heart rate variability |
| Q45150211 | A randomized, double-blind comparison of lercanidipine 10 and 20 mg in patients with stable effort angina: clinical evaluation of cardiac function by ambulatory ventricular scintigraphic monitoring |
| Q35927515 | A randomized, double-blind, placebo-controlled, crossover, dose-ranging multicenter study to determine the effect of sublingual nitroglycerin spray on exercise capacity in patients with chronic stable angina |
| Q89136867 | A randomized, triple-blind trial of cardiac shock-wave therapy on exercise tolerance and symptoms in patients with stable angina pectoris |
| Q39654927 | A rare, life-threatening effort angina and anomalous origin of the left circumflex coronary artery: CT and SPECT findings. |
| Q39841174 | A review of nitrate therapy in stable angina, variant angina, unstable angina and myocardial infarction |
| Q90513779 | A review of the mechanism of action of Dantonic® for the treatment of chronic stable angina |
| Q40523316 | A surgical view of stable angina pectoris |
| Q50577364 | A sustained effect of coronary bypass surgery in stable angina pectoris. |
| Q35253322 | A system review of randomized controlled trials on treating chronic stable angina by rhodiola |
| Q35748011 | A systematic review of psychoeducational intervention trials for the management of chronic stable angina |
| Q92151400 | A systematic review of the effectiveness and safety of Chinese herbal medicine formula Gualou Xiebai Banxia (GLXBBX) decoction for the treatment of stable angina pectoris |
| Q53547975 | A three-vessel virtual histology intravascular ultrasound analysis of frequency and distribution of thin-cap fibroatheromas in patients with acute coronary syndrome or stable angina pectoris. |
| Q33813134 | ABC of antithrombotic therapy: Antithrombotic therapy in myocardial infarction and stable angina |
| Q77853784 | ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stab |
| Q77822706 | ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on M |
| Q79355503 | ACTION results of nifedipine in stable angina due next year |
| Q86498118 | ASCERTing the value of coronary artery bypass graft in stable angina patients: the challenges and potential of observational research to improve care |
| Q106576321 | ATHEROSCLEROTIC LESIONS’ FORMATION IN STABLE ANGINA IS AFFECTED BY INFLAMMATION OF PERICORONARY ADIPOSE TISSUE, BUT ONLY AMONG OVERWEIGHT PATIENTS |
| Q50970032 | Abnormalities of T waves in effort angina pectoris patients at rest evaluated by spatial velocity electrocardiogram. |
| Q68775012 | Abnormalities of left ventricular shape in patients with stable angina |
| Q40694543 | Abolition of pacing induced akinesia after aorto-coronary bypass grafting in patients with stable angina (author's transl) |
| Q28378873 | Abrupt cessation of short-term continuous treatment with isosorbide dinitrate may cause a rebound increase in silent myocardial ischaemia in patients with stable angina pectoris |
| Q70042049 | Abrupt change from propranolol to verapamil. Safety and feasibility in stable angina pectoris |
| Q62819506 | Abrupt withdrawal of isosorbide 5-mononitrate (Imdur) after long term treatment in stable angina pectoris. A preliminary report |
| Q42209334 | Abrupt withdrawal of isosorbide-5-mononitrate in Durules (Imdur) after long term treatment in patients with stable angina pectoris |
| Q70642085 | Accelerated secretion of atrial natriuretic peptide during exercise in effort angina |
| Q43681326 | Accuracy and safety of technetium-99m hexakis 2-methoxy-2-isobutyl isonitrile (Sestamibi) myocardial scintigraphy with high dose dipyridamole test in patients with effort angina pectoris: a multicenter study. Italian Group of Nuclear Cardiology. |
| Q50972535 | Acetyl salicylic acid resistance in patients with chronic stable angina and the correlation with coronary risk factors. |
| Q38438010 | AchievemenT of target resting HEart rate on beta-blockers in patients with stable angiNA and hypertension (ATHENA) in routine clinical practice in Russia. |
| Q44187977 | Achievement of goal resting heart rate in patients with stable angina and hypertension at the background of therapy with -adrenoblockers in real clinical practice |
| Q34176592 | Acupoint application in patients with chronic stable angina pectoris: study protocol of a randomized, double-blind, controlled trial. |
| Q104608307 | Acupuncture and related therapies for stable angina pectoris: A protocol for network meta-analysis |
| Q104608275 | Acupuncture and related therapies for treating stable angina pectoris: A protocol of an overview of systematic reviews and meta-analysis |
| Q92247447 | Acupuncture as Adjunctive Therapy for Chronic Stable Angina: A Randomized Clinical Trial |
| Q91550028 | Acupuncture as an adjunctive therapy for stable angina |
| Q101408989 | Acupuncture for chronic stable angina pectoris based on the theory of Meridian-Viscera Association: study protocol for a multicenter randomized controlled trial |
| Q37580127 | Acupuncture for chronic, stable angina pectoris and an investigation of the characteristics of acupoint specificity: study protocol for a multicenter randomized controlled trial. |
| Q91342043 | Acupuncture for stable angina pectoris: A few noteworthy additions |
| Q53278652 | Acupuncture for stable angina pectoris: a systematic review protocol. |
| Q98210459 | Acupuncture for treating chronic stable angina pectoris-associated anxiety and depression: A protocol for systematic review and meta-analysis |
| Q54436344 | Acupuncture in severe, stable angina pectoris: a randomized trial. |
| Q91321230 | Acupuncture therapy for the treatment of stable angina pectoris: An updated meta-analysis of randomized controlled trials |
| Q92274935 | Acupuncture to Improve Symptoms for Stable Angina: Protocol for a Randomized Controlled Trial |
| Q71833874 | Acute and Chronic Effect of Molsidomine Extended Release on Exercise Capacity in Patients with Stable Angina, a Double-Blind Cross-Over Clinical Trial Versus Placebo |
| Q70380128 | Acute and chronic efficacy of 10 mg of nitroglycerin patch in stable angina pectoris |
| Q43643287 | Acute and chronic efficacy of low-dose nitroglycerin patches in stable angina pectoris. |
| Q36739679 | Acute and long-term effect of percutaneous coronary intervention on serially-measured oxidative, inflammatory, and coagulation biomarkers in patients with stable angina |
| Q69633290 | Acute and sustained effects of isosorbide 5-mononitrate in stable angina pectoris |
| Q71727551 | Acute effects of chewable nifedipine on hemodynamic responses to upright exercise in patients with prior myocardial infarction and effort angina |
| Q70623804 | Acute effects of nifedipine, diltiazem and their combination in patients with chronic stable angina: a double-blind, randomized, cross-over, placebo-controlled study |
| Q67668944 | Acute effects of nisoldipine, propranolol, and their combination in patients with chronic stable angina: a double-blind, randomized, cross-over, placebo-controlled study |
| Q67875201 | Acute effects of transdermal administration of nitroglycerin on effort tolerance and myocardial perfusion, evaluated by Tl-201 scintigraphy, in patients with stable effort angina |
| Q70284206 | Acute effects of trimetazidine on ergometric parameters in effort angina |
| Q28335239 | Acute effects on exercise tolerance of felodipine and diltiazem, alone and in combination, in stable effort angina |
| Q54504988 | Acute haemodynamic effects of endralazine in patients with coronary artery disease and stable angina pectoris. |
| Q36832309 | Acute heavy alcohol intake increases silent myocardial ischaemia in patients with stable angina pectoris |
| Q81357509 | Adding ACE inhibitor doesn't improve outcomes in stable angina and normal LVEF |
| Q74787363 | Additional antianginal and anti-ischemic efficacy of mibefradil in patients concomitantly treated with long-acting nitrates for chronic stable angina pectoris |
| Q73256682 | Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris |
| Q73853541 | Adenosine deaminase activity in blood of patients with stable angina pectoris |
| Q90848469 | Adherence to the Healthy Nordic Food Index and the incidence of acute myocardial infarction and mortality among patients with stable angina pectoris |
| Q45713195 | Administration of various dosages of retard isosorbide-5-mononitrate in patients with stable angina pectoris on combined therapy |
| Q34664322 | Advances in the management of stable angina |
| Q72751077 | Adverse effects of acebutolol in chronic stable angina: drug-induced positive antinuclear antibody |
| Q51011550 | Age and gender differences in left ventricular function among patients with stable angina and a matched control group. A report from the Angina Prognosis Study in Stockholm. |
| Q70236900 | Alinidine in chronic stable angina: the effect on diastolic perfusion time |
| Q43027847 | Allopurinol for chronic stable angina: old drug, new tricks? |
| Q49024885 | Alprazolam as an adjunct to propranolol in anxious outpatients with stable angina pectoris. |
| Q69746062 | Alterations in myocardial metabolism and function at rest in stable angina pectoris: relations with the amount of exercise-induced thallium-201 perfusion defect |
| Q44588750 | Altered global myocardial substrate preference at rest and during pacing in coronary artery disease with stable angina pectoris |
| Q49475771 | Altered heart rate variability depend on the characteristics of coronary lesions in stable angina pectoris |
| Q52840282 | Alternative complement pathway activation during invasive coronary procedures in acute myocardial infarction and stable angina pectoris. |
| Q73335137 | Alternative therapies for patients with persistent chronic stable angina |
| Q69008779 | Ambulatory heart rate and ST-segment depression during painful and silent myocardial ischemia in chronic stable angina pectoris |
| Q42281054 | Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial |
| Q74425953 | Amlodipine in patients with stable angina pectoris treated with beta-blockers. Double-blind comparison with placebo |
| Q50532817 | Amlodipine in patients with stable angina pectoris treated with nitrates and beta-blockers. The influence on exercise tolerance, systolic and diastolic functions of the left ventricle. |
| Q72878197 | Amlodipine monotherapy in chronic stable angina |
| Q42288505 | Amlodipine once a day in stable angina: double-blind crossover comparison with placebo |
| Q93526502 | Amlodipine versus nadolol in patients with stable angina pectoris |
| Q43605098 | Amlodipine versus nifedipine retard. A randomized double-blind comparative study on long-term efficacy and safety of amlodipine and nifedipine retard in the monotherapy of chronic stable angina pectoris |
| Q89995938 | Ample evidence for statins preloading before PCI on periprocedural myocardial infarction among stable angina pectoris patients undergoing percutaneous coronary intervention |
| Q54135522 | An acute double-blind placebo-controlled study of transdermal glyceryl trinitrate with 12 months' follow-up in patients with stable angina pectoris. |
| Q54141366 | An evaluation of the effects of isosorbide 5-mononitrate in patients with angina on effort using dynamic electrocardiography and echocardiography. |
| Q71270570 | An impaired carotid sinus distensibility and baroreceptor sensitivity alter autonomic activity in patients with effort angina associated with significant coronary artery disease |
| Q71618726 | An objective comparison of verapamil and placebo in chronic stable angina |
| Q70232778 | An objective evaluation of once-daily sustained-release verapamil (480 mg) in chronic stable angina |
| Q78478320 | Anaerobic threshold and maximal oxygen uptake in patients with coronary artery disease and stable angina before and after percutaneous transluminal coronary angioplasty |
| Q73691632 | Analysis of phasic flow velocity dynamics in the left anterior descending coronary artery before and after angioplasty using transthoracic echocardiography in patients with stable angina pectoris |
| Q91230846 | Anatomical and functional assessment of coronary artery disease in patients with stable angina: Which is the gold standard? |
| Q91682329 | Anatomically and functionally relevant coronary stenoses in patients with normal single-photon emission computed tomography but persistent stable angina |
| Q92291673 | Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina |
| Q64058359 | Angina and left ventricular dysfunction: can we 'reduce' it? |
| Q93906446 | Angina of Effort: A Clinical Study |
| Q79462982 | Angina of effort in pregnancy; report of a case |
| Q41440911 | Angina of effort with a variable threshold: a unique entity due to different mechanisms? |
| Q73501172 | Angina of effort: use of heparin for its control |
| Q75703599 | Angina of effort; its treatment with crystalline khellin |
| Q46045436 | Angina: Ivabradine for treatment of stable angina pectoris |
| Q40586433 | Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris |
| Q95796133 | Angiogenic gene therapy appears safe to treat stable angina |
| Q77295565 | Angiographic characteristics of infarct-related and non-infarct-related stenoses in patients in whom stable angina progressed to acute myocardial infarction |
| Q74267523 | Angioscopy in stable angina: the emperor has no clothes |
| Q36811049 | Angiotensin converting enzyme inhibition in chronic stable angina: effects on myocardial ischaemia and comparison with nifedipine |
| Q72015429 | Anipamil prevents ST depression in patients with stable angina pectoris |
| Q70558745 | Anomalous origin of the left anterior descending coronary artery from the right sinus of Valsalva associated with effort angina pectoris |
| Q58784311 | Anti-Anginal Effectiveness and Tolerability of Trimetazidine Modified Release 80 Mg Once Daily in Stable Angina Patients in Real-World Practice |
| Q38394310 | Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study |
| Q45279545 | Anti-anginal and anti-ischemic effects of the selective beta-blocker talinolol in patients with stable angina pectoris. |
| Q44200627 | Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study |
| Q70261235 | Anti-ischaemic and anti-anginal activity of atenolol, nifedipine and their combination in stable, chronic effort angina |
| Q72119319 | Anti-ischaemic and haemodynamic effects of elgodipine, a potent new generation calcium antagonist, in chronic stable angina |
| Q44872599 | Anti-ischaemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: when does cross-tolerance occur? |
| Q53942024 | Anti-ischemic and anti-anginal effects of controlled-release and conventional isosorbide-5-mononitrate in stable angina pectoris. |
| Q41643739 | Anti-ischemic effects of amlodipine in patients with stable angina pectoris and myocardial ischemia during daily life. Amlodipine Study Group |
| Q42190601 | Anti-ischemic effects of celiprolol in patients with exercise-induced angina pectoris |
| Q46643129 | Anti-ischemic efficacy of combination of trimetazidine with enalapril in patients with stable effort angina and metabolic syndrome |
| Q41809602 | Antianginal Efficacy and Tolerability of Ranolazine as an Add-on Drug to Concomitant Medications Primarily Metoprolol in Chronic Stable Angina Patients: A Prospective, Open-Label Study |
| Q73673622 | Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris |
| Q72679868 | Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectoris |
| Q73083809 | Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial |
| Q44319414 | Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial |
| Q70789822 | Antianginal and antiischemic efficacy of monotherapy extended-release nisoldipine (Coat Core) in chronic stable angina |
| Q71586932 | Antianginal drugs for stable angina pectoris |
| Q71378038 | Antianginal effect of conventional and controlled release diltiazem in stable angina pectoris |
| Q69721334 | Antianginal effect of isosorbide dinitrate spray in patients with exercise-induced stable angina |
| Q39476307 | Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study. |
| Q69422542 | Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris |
| Q28366052 | Antianginal effects of hydroxyfasudil, a Rho-kinase inhibitor, in a canine model of effort angina |
| Q70368730 | Antianginal effects of nitroglycerin during exercise-induced angina: hemodynamic and left ventricular function changes related to indexes of myocardial oxygen consumption |
| Q44731705 | Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris |
| Q28291239 | Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial |
| Q42741517 | Antianginal efficacy and tolerability of ivabradine in the therapy of patients with stable angina: results of the CONTROL study |
| Q39450562 | Antianginal efficacy over 24 hours and exercise hemodynamic effects of once daily sustained-release 300 mg diltiazem and 240 mg verapamil in stable angina pectoris |
| Q54319505 | Antianginal, hemodynamic and coronary vascular effects of captopril in stable angina pectoris |
| Q28291783 | Antiarrhythmic effects of prajmaline (Neo-Gilurythmal) in stable angina pectoris in light of Holter electrocardiographic monitoring |
| Q43422473 | Antibodies against Chlamydia pneumoniae in stable angina and interleukin-6 levels |
| Q67924043 | Antiischemic and metabolic effects of glutamate during pacing in patients with stable angina pectoris secondary to either coronary artery disease or syndrome X |
| Q44257661 | Antiischemic efficacy of trimetazidine in patients with ischemic heart disease, stable angina pectoris and disturbances of carbohydrate metabolism |
| Q72074792 | Antiplatelet Effects of Nitroglycerin in Healthy Subjects and in Patients with Stable Angina Pectoris |
| Q38535999 | Antiplatelet Therapy During PCI for Patients with Stable Angina and Atrial Fibrillation |
| Q70234108 | Antithrombin III and protein C in stable angina pectoris--influence of dietary supplementation with polyunsaturated fatty acids |
| Q72485164 | Antithrombotic properties of transdermal nitroglycerin in stable angina pectoris |
| Q70229865 | Aortocoronary bypass in stable angina pectoris |
| Q95266036 | Apnea Hypopnea Index is an Independent Predictor of Coronary Microcirculatory Dysfunction in Stable Angina Pectoris Patients with a Single Borderline Lesion |
| Q74265010 | Approaches to improving outcome in stable angina |
| Q49618788 | Approaches to the choice of antianginal therapy of elderly patients with stable angina pectoris depending on psycho-emotional status |
| Q34696317 | Appropriate revascularization in stable angina: lessons from the BARI 2D trial |
| Q34602258 | Appropriateness of coronary revascularization for patients with chronic stable angina or following an acute myocardial infarction: multinational versus Dutch criteria |
| Q70226713 | Are all anti anginal agents the same? Comparative evaluation of seven calcium channel blockers with placebo and propranolol in patients with chronic stable angina |
| Q68699146 | Are all anti-anginal agents the same? Comparative evaluation of seven calcium channel blockers with placebo and propranolol in patients with chronic stable angina |
| Q73967948 | Are patients suffering from stable angina receiving optimal medical treatment? |
| Q40360487 | Arterial remodeling correlates positively with serological evidence of inflammation in patients with chronic stable angina pectoris |
| Q72605073 | Arteriographic morphology and intracoronary thrombus in patients with unstable angina, non-Q wave myocardial infarction and stable angina pectoris |
| Q41496123 | Articles to Read in Other Journals: Long-term Results of Prospective Randomised Study of Coronary Artery Bypass Surgery in Stable Angina Pectoris |
| Q89456326 | Ascending Aortic Strain Analysis Using 2-Dimensional Speckle Tracking Echocardiography Improves the Diagnostics for Coronary Artery Stenosis in Patients With Suspected Stable Angina Pectoris |
| Q34290387 | Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study |
| Q57620890 | Assessment of coronary artery disease: chronic stable angina |
| Q92802790 | Assessment of the relationship between C-reactive protein-to-albumin ratio and slow coronary flow in patients with stable angina pectoris |
| Q35966113 | Association between Body Mass Index, Asymmetric Dimethylarginine and Risk of Cardiovascular Events and Mortality in Norwegian Patients with Suspected Stable Angina Pectoris |
| Q73580828 | Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting |
| Q79436666 | Association between Toll-like receptors and the extent and severity of coronary artery disease in patients with stable angina |
| Q40331368 | Association between bariatric surgery and rate of hospitalisations for stable angina pectoris in obese adults. |
| Q47899630 | Association between echocardiographic epicardial fat thickness and circulating endothelial progenitor cell level in patients with stable angina pectoris. |
| Q80133481 | Association between inflammation, lipid and hemostatic factors in patients with stable angina |
| Q85226978 | Association between insulin like growth factor-1 and lipoprotein metabolism in stable angina patients on statin therapy: a pilot study |
| Q88066095 | Association between plasma apelin levels and coronary collateral development in patients with stable angina pectoris |
| Q37680325 | Association between platelet to lymphocyte ratio and saphenous vein graft disease in patients with stable angina pectoris |
| Q91053896 | Association between serum adropin levels and isolated coronary artery ectasia in patients with stable angina pectoris |
| Q40815630 | Association of Intravascular Ultrasound- and Optical Coherence Tomography-Assessed Coronary Plaque Morphology With Periprocedural Myocardial Injury in Patients With Stable Angina Pectoris |
| Q36766123 | Association of Low Levels of Vitamin D with Chronic Stable Angina: A Prospective Case-Control Study |
| Q91041073 | Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina |
| Q90768584 | Association of Vitamin D Deficiency with Chronic Stable Angina: A Case Control Study |
| Q86218756 | Association of blood pressure and coronary collateralization in type 2 diabetic and nondiabetic patients with stable angina and chronic total occlusion |
| Q33655700 | Association of body mass index with risk of acute myocardial infarction and mortality in Norwegian male and female patients with suspected stable angina pectoris: a prospective cohort study |
| Q80969172 | Association of chronic stable angina pectoris with MCP-1-2518 A/G single nucleotide polymorphism in the Slovak population |
| Q34478974 | Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion |
| Q53280246 | Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris. |
| Q59275989 | Association of plasma B-6 vitamers with systemic markers of inflammation before and after pyridoxine treatment in patients with stable angina pectoris |
| Q88779694 | Association of plasma pentraxin-3 levels with coronary risk factors and the lipid profile: a cross-sectional study in Japanese patients with stable angina pectoris |
| Q91134668 | Association of serum uric acid levels with SYNTAX score II and long term mortality in the patients with stable angina pectoris who undergo percutaneous coronary interventions due to multivessel and/or unprotected left main disease |
| Q39071200 | Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris |
| Q44028451 | Asymptomatic myocardial ischemia as a predictor of cardiac events after coronary artery bypass grafting for stable angina pectoris |
| Q69913111 | Atenolol and celiprolol for stable angina pectoris |
| Q67980366 | Atenolol and/or nifedipine in effort angina: which is the treatment of choice for exercise coronary protection? |
| Q44257503 | Atenolol induced bradycardia in patients with stable angina: effects on exercise tolerance, myocardial perfusion and left ventricular contractility |
| Q72875263 | Atenolol or nicardipine alone is as efficacious in stable angina as their combination: a double blind randomised trial |
| Q72659220 | Atenolol versus the fixed combination of atenolol and nifedipine in stable angina pectoris |
| Q44409743 | Atorvastatin in stable angina patients lowers CCL2 and ICAM1 expression: pleiotropic evidence from plasma mRNA analyses |
| Q87209613 | Atorvastatin treatment increases plasma bilirubin but not HMOX1 expression in stable angina patients |
| Q53934531 | Attenuation of anti-ischemic efficacy during chronic therapy with nicorandil in patients with stable angina pectoris. |
| Q70767909 | Attenuation of exercise-induced R wave increase after diltiazem in effort angina pectoris |
| Q77579166 | Attenuation of myocardial ischemia with repeated exercise in subjects with chronic stable angina: relation to myocardial contractility, intensity of exercise and the adenosine triphosphate-sensitive potassium channel |
| Q87861040 | Atypical chest pain in diabetic patients with suspected stable angina: impact on diagnosis and coronary outcomes |
| Q53261289 | Atypical exercise stress myocardial perfusion SPECT imaging in a patient with effort angina pectoris. |
| Q60169468 | Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications |
| Q55059550 | B vitamin treatments modify the risk of myocardial infarction associated with a MTHFD1 polymorphism in patients with stable angina pectoris. |
| Q40353088 | B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study |
| Q48704032 | B-type natriuretic peptide levels in patients in the emergency department with possible heart failure and previous stable angina pectoris and/or healed myocardial infarction |
| Q74485374 | Basic fibroblast growth factor changes in response to coronary angioplasty in patients with stable angina |
| Q72209485 | Behavior of some hemodynamic parameters during the effect of cigarette smoking, in conditions of rest and after muscular exercise, in smoking and non-smoking subjects with angina of effort |
| Q44243126 | Beneficial clinical effects of perhexiline in patients with stable angina pectoris and acute coronary syndromes are associated with potentiation of platelet responsiveness to nitric oxide. |
| Q71499095 | Beneficial effect of treatment with transdermal estradiol-17-beta on exercise-induced angina and ST segment depression in syndrome X |
| Q54252021 | Beneficial effects of atrial natriuretic peptide on exercise-induced myocardial ischemia in patients with stable effort angina pectoris. |
| Q41308437 | Beneficial effects of diltiazem and propranolol, alone and in combination, in patients with stable angina pectoris |
| Q35582952 | Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina: results from the Lescol intervention prevention study (LIPS). |
| Q69861918 | Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study |
| Q47384123 | Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris. A double-blind, randomized, placebo-controlled trial |
| Q35066470 | Benefits from new ADP antagonists as compared with clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials |
| Q70312270 | Bepridil for chronic stable angina pectoris: results of a prospective multicenter, placebo-controlled, dose-ranging study in 77 patients |
| Q43465465 | Bepridil hydrochloride compared with placebo in patients with stable angina pectoris |
| Q41774883 | Bepridil in stable angina of effort: a double-blind comparison with verapamil |
| Q35868598 | Bepridil treatment of chronic stable angina: a review of comparative studies versus placebo, nifedipine, and diltiazem |
| Q69208797 | Bepridil versus verapamil in stable angina pectoris--a controlled clinical trial |
| Q34534497 | Bepridil. A review of its pharmacological properties and therapeutic use in stable angina pectoris |
| Q24203833 | Beta blockers for stable angina |
| Q24242158 | Beta blockers for stable angina |
| Q92292882 | Beta blockers, calcium channel blockers, and long-acting nitrates for patients with stable angina and low blood pressure levels: should this recommendation be reconsidered? |
| Q58645702 | Beta-Blocker Dose Up-Titration or Addition of Ivabradine in Stable Angina: More is Not Necessarily Better |
| Q38378877 | Beta-adrenoceptor antagonists plus nifedipine in the treatment of chronic stable angina pectoris |
| Q72532042 | Beta-blocker therapy evaluated by radionuclide angiography: a study in chronic stable angina |
| Q43747066 | Beta-blockers in effort angina |
| Q72428588 | Betaxolol in the treatment of stable angina pectoris |
| Q44063717 | Biochemical detection of minor myocardial injury after elective, uncomplicated, successful percutaneous coronary intervention in patients with stable angina: clinical outcome |
| Q73637391 | Biphasic relaxation-frequency relations in patients with effort angina pectoris: a new marker of myocardial demand ischemia |
| Q46611986 | Bisoprolol improved endothelial function and myocardium survival of hypertension with stable angina: a randomized double-blinded trial |
| Q54099925 | Bisoprolol in the treatment of chronic stable angina pectoris. |
| Q38413119 | Bivalirudin in stable angina and acute coronary syndromes |
| Q61455259 | Blood pressure reduction in stable angina by nifedipine was related to stroke and heart failure reduction but not to coronary interventions |
| Q54441455 | Body surface distributions of ST segment changes after exercise in effort angina pectoris without myocardial infarction. |
| Q69375150 | Bopindolol and atenolol in patients with stable angina pectoris. Double-blind randomized comparative trial |
| Q68168217 | Bopindolol for the treatment of chronic stable angina pectoris--a clinical study of the relationship between dose and effect |
| Q34358796 | Bopindolol in chronic stable angina pectoris: duration and extent of antianginal action |
| Q90524902 | Brachial pulse pressure is associated with the presence and extent of coronary artery disease in stable angina patients: a cross-sectional study |
| Q37713339 | Bypass surgery for chronic stable angina: predictors of survival benefit and strategy for patient selection |
| Q74137663 | Bypass surgery versus stenting for the treatment of multivessel disease in patients with unstable angina compared with stable angina |
| Q30321094 | C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris |
| Q74316336 | C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men |
| Q73179613 | C-reactive protein in stable angina patients without peripheral vascular disease |
| Q55075663 | CABG and Preoperative use of Beta-Blockers in Patients with Stable Angina are Associated with Better Cardiovascular Survival. |
| Q53584118 | CABG in chronic stable angina pectoris patients: indications and outcomes (SECOR/SBU). Swedish Societies for Cardiology, Thoracic Radiology and Thoracic surgery/Swedish Council for Technology Assessment in Health Care. |
| Q33885236 | CD4(+)CD25(high)CD127(low) regulatory T cells in patients with stable angina and their dynamics after intracoronary sirolimus-eluting stent implantation. |
| Q89210427 | CORRIGENDUM to Management of Stable Angina: A commentary of the European Society of Cardiology Guidelines |
| Q41324671 | CPMP note for guidance: clinical investigation of anti-anginal drugs in stable angina pectoris. |
| Q35672631 | CT attenuation features of individual calcified coronary plaque: differences among asymptomatic, stable angina pectoris, and acute coronary syndrome groups |
| Q88983850 | CT-based total vessel plaque analyses improves prediction of hemodynamic significance lesions as assessed by fractional flow reserve in patients with stable angina pectoris |
| Q53395313 | Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death. |
| Q39666735 | Calcium antagonist drugs in the treatment of coronary spasm, effort angina and hypertension |
| Q39461557 | Calcium antagonists for chronic stable angina pectoris |
| Q72538648 | Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol |
| Q72533905 | Calcium-channel blockers and beta blockers: Advantages and disadvantages of combination therapy in chronic stable angina pectoris |
| Q83461454 | Can metabolic syndrome predict the vulnerable plaque in patients with stable angina pectoris? Virtual histology-intravascular ultrasound analysis |
| Q48433217 | Can we predict the severity of coronary artery disease in patients with stable angina using NT-ProBNP? |
| Q79782653 | Canadian Cardiovascular Society classification of effort angina: an angiographic correlation |
| Q43186428 | Capecitabine cardiac toxicity presenting as effort angina: a case report |
| Q93748209 | Carbon Monoxide Effect on Exercise-Induced Angina Pectoris |
| Q89355312 | Cardiac Troponin T Concentrations, Reversible Myocardial Ischemia, and Indices of Left Ventricular Remodeling in Patients with Suspected Stable Angina Pectoris: a DOPPLER-CIP Substudy |
| Q71352118 | Cardiac function improvement 24 hours after isradipine SRO in patients with chronic stable angina: a double-blind randomized study |
| Q67293233 | Cardiac prostaglandin synthesis in spontaneous and in effort angina |
| Q41048214 | Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris |
| Q43866032 | Cardiac venous blood flow in atrial pacing versus exercise-induced angina pectoris |
| Q33713979 | Cardiology 7. Stable angina pectoris: treatment and referral options. |
| Q61650982 | Cardiorespiratory and symptomatic variables during maximal and submaximal exercise in men with stable effort angina: a comparison of atenolol and celiprolol |
| Q28201480 | Cardioselective beta-adrenoblockers in patients with stable angina pectoris. Comparison of efficacy and safety |
| Q91622941 | Cardiovascular MRI versus FFR in stable angina |
| Q48545941 | Cardiovascular devices; reclassification of external counter-pulsating devices for treatment of chronic stable angina; effective date of requirement for premarket approval for external counter-pulsating devices for other specified intended uses. Fin |
| Q61684253 | Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis Study in Stockholm (APSIS) |
| Q44006623 | Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction |
| Q73396423 | Carvedilol versus verapamil in chronic stable angina: a multicentre trial |
| Q57223930 | Celiprolol in the treatment of chronic stable angina |
| Q58434029 | Cervicothoracic Angina Identified by Case History and Palpation Findings in Patients with Stable Angina Pectoris |
| Q69054744 | Changes in blood rheology in patients with stable angina pectoris as a result of coronary artery disease |
| Q51742064 | Changes in coronary plaque morphology in patients with acute coronary syndrome versus stable angina pectoris after initiation of statin therapy. |
| Q67895911 | Changes in lymphocyte subsets and polymorphonuclear phagocytes activity after a work test in patients with stable angina pectoris |
| Q52877334 | Changes in myocardial ischaemia during isosorbide dinitrate or indoramin therapy in patients with stable angina using relations between the ST segment and heart rate. |
| Q71869533 | Changes in myocardial lactate metabolism during ramp exercise in patients with effort angina and microvascular angina |
| Q69485943 | Changes in myocardial metabolism during therapy in patients with chronic stable angina: a comparison of long-term dosing with propranolol and nicardipine |
| Q70027003 | Changes in myoglobin, creatine kinase and creatine kinase-MB after percutaneous transluminal coronary angioplasty for stable angina pectoris |
| Q47293759 | Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain |
| Q43721590 | Changes in serum malondialdehyde-modified low-density lipoprotein in patients with acute myocardial infarction and stable angina pectoris treated by coronary angioplasty |
| Q104105049 | Changes in serum serotonin levels in patients with acute coronary syndrome and stable angina undergoing percutaneous coronary intervention |
| Q78106216 | Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina |
| Q92843360 | Characteristics and significance of healed plaques in patients with acute coronary syndrome and stable angina: an in vivo OCT and IVUS study |
| Q85639325 | Characterization of culprit lesions in acute coronary syndromes compared with stable angina pectoris by dual-source computed tomography |
| Q34499433 | Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris |
| Q99551717 | Chinese Herbal Formula Xuefu Zhuyu for Stable Angina (CheruSA): Study Protocol for a Multicenter Randomized Controlled Trial |
| Q42841271 | Chronic administration of N-acetylcysteine fails to prevent nitrate tolerance in patients with stable angina pectoris |
| Q69319283 | Chronic effects of nicorandil on exercise tolerance in patients with stable effort angina pectoris |
| Q69243567 | Chronic effects of transdermal nitroglycerin in stable angina pectoris: a within-patient, placebo-controlled study |
| Q70284211 | Chronic effects of trimetazidine on ergometric parameters in effort angina |
| Q92369426 | Chronic spontaneous coronary artery dissection in association with antiphospholipid syndrome presenting as stable angina |
| Q73265789 | Chronic stable angina and its treatment; why Cinderella never gets to the ball? |
| Q33631727 | Chronic stable angina is associated with lower health-related quality of life: evidence from Chinese patients |
| Q69485199 | Chronic stable angina monotherapy. Nifedipine versus propranolol |
| Q37251320 | Chronic stable angina pectoris |
| Q49967987 | Chronic stable angina pectoris |
| Q44905476 | Chronic stable angina pectoris. Risk stratification and treatment |
| Q40383185 | Chronic stable angina pectoris. Strategies for effective drug therapy |
| Q53123444 | Chronic stable angina: Addressing the needs of patients through risk reduction, education and support. |
| Q71453971 | Chronic stable angina: comparison of verapamil and propranolol |
| Q83254746 | Chronic stable angina: pathophysiology and innovations in treatment |
| Q37885049 | Chronic stable angina: percutaneous coronary intervention or medication? |
| Q33815136 | Chronic stable angina: treatment options |
| Q83492542 | Chronic total coronary occlusions in patients with stable angina pectoris: impact on therapy and outcome in present day clinical practice |
| Q40793764 | Circadian patterns of heart rate variability in normals, chronic stable angina and diabetes mellitus |
| Q74526822 | Circadian variation in ischemic threshold in patients with stable angina: relation to plasma endothelin-1 |
| Q44122535 | Circadian variation in occurrence of transient overt and silent myocardial ischemia in chronic stable angina and comparison with Prinzmetal angina in men. |
| Q72664115 | Circadian variation of ischaemic events in patients with chronic stable angina: pathophysiological and therapeutical considerations |
| Q68095864 | Circadian variation of ischemic threshold in patients with chronic stable angina |
| Q84564442 | Circulating CD14+CD16+ monocyte subsets as biomarkers of the severity of coronary artery disease in patients with stable angina pectoris |
| Q84563291 | Circulating CD34+/133+ progenitor cells in patients with stable angina pectoris undergoing percutaneous coronary intervention |
| Q83777764 | Circulating CD34⁺ progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris |
| Q35904860 | Circulating Microparticles and Coronary Plaque Components Assessed by Virtual Histology Intravascular Ultrasound of the Target Lesion in Patients with Stable Angina |
| Q42374545 | Circulating adipocyte fatty acid-binding protein is a predictor of cardiovascular events in patients with stable angina undergoing percutaneous coronary intervention |
| Q104735165 | Circulating hepassocin level in patients with stable angina is associated with fatty liver and renal function |
| Q73562649 | Circulating interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction |
| Q73572621 | Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina |
| Q55357833 | Clinical Acceptability Of Trimetazidine Modified-Release 80 mg Once Daily Versus Trimetazidine Modified-Release 35 mg Twice Daily In Stable Angina Pectoris. |
| Q92423291 | Clinical Impact of High-Sensitivity Cardiac Troponin T on the Chronic Phase of Stable Angina after a Successful Initial Percutaneous Coronary Intervention |
| Q47387483 | Clinical Impact of Subsequent Depression in Patients With a New Diagnosis of Stable Angina: A Population-Based Study |
| Q58763151 | Clinical Implications of Moderate Coronary Stenosis on Coronary Computed Tomography Angiography in Patients with Stable Angina |
| Q57192257 | Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris |
| Q37076603 | Clinical and angiographic features associated with coronary collateralization in stable angina patients with chronic total occlusion |
| Q47424400 | Clinical characteristics, in-hospital and long-term outcomes of stable angina treatment in patients below and over 40 years of age (from the PRESAGE registry). |
| Q30744920 | Clinical course of disease and prognosis in patients with ischemic heart disease with stable angina pectoris, caused by stenosing coronary atherosclerosis (data from a a 20-year study |
| Q36847030 | Clinical course of isolated stable angina due to coronary heart disease |
| Q41859672 | Clinical diagnosis of stable angina pectoris |
| Q39694193 | Clinical effect of diltiazem on angina of effort in relation to dosage of nitroglycerin |
| Q104571027 | Clinical effectiveness and safety of salvia miltiorrhiza depside salt combined with aspirin in patients with stable angina pectoris: A multicenter, pragmatic, randomized controlled trial |
| Q71755319 | Clinical efficacy and safety of once-daily diltiazem in patients with stable angina pectoris switched from twice-daily diltiazem |
| Q44129943 | Clinical efficacy of perhexiline maleate in stable angina pectoris (author's transl) |
| Q70815400 | Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris |
| Q28338088 | Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report |
| Q39410851 | Clinical evaluation of nitrates in exercise-induced angina |
| Q46625681 | Clinical evaluation of pentaerythritol tetranitrate in two doses in patients with stable angina pectoris |
| Q87187484 | Clinical implications of increased Nogo-B levels in patients with acute coronary syndromes and stable angina pectoris |
| Q57298286 | Clinical metabolomics analysis of therapeutic mechanism of Tongmai Yangxin Pill on stable angina |
| Q34470280 | Clinical presentation and diagnosis of coronary artery disease: stable angina |
| Q71450736 | Clinical relevance of verapamil plasma levels in stable angina pectoris |
| Q70060468 | Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris |
| Q93526451 | Clinical safety and efficacy of once-daily amlodipine for chronic stable angina pectoris |
| Q71291007 | Clinical significance of decreased myocardial uptake of 123I-BMIPP in patients with stable effort angina pectoris |
| Q41639122 | Clinical significance of symptom-limited exercise test to evaluate the coronary narrowing in patients with effort angina pectoris |
| Q69703743 | Clinical significance of symptomatic and silent myocardial ischemia during exercise test in patients with effort angina pectoris--investigation of hemodynamic responses during supine ergometer exercise test |
| Q34119077 | Clinical trials of coronary revascularization for chronic stable angina: medical treatment versus coronary revascularization |
| Q26859111 | Clinical usefulness of novel serum and imaging biomarkers in risk stratification of patients with stable angina |
| Q41341044 | Clinically stable angina pectoris is not necessarily associated with histologically stable atherosclerotic plaques |
| Q82966670 | Clopidogrel loading dose (300 versus 600 mg) strategies for patients with stable angina pectoris subjected to percutaneous coronary intervention |
| Q36724610 | Clopidogrel pre-treatment in stable angina: for all patients > 6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8. |
| Q84355525 | Clopidogrel trial in patients with elective percutaneous coronary intervention for stable angina and old myocardial infarction (CLEAN) |
| Q89823214 | Closure of an acquired aortocoronary venous fistula after coronary artery bypass grafting causing heart failure and stable angina: A case report |
| Q77909594 | Coagulation indicators in chronic stable effort angina and unstable angina: relationship with acute phase reactants and clinical outcome |
| Q42208664 | Collateral circulation during exercise-induced angina: evaluation by coronary angiography |
| Q83076466 | Colon specific chitosan microspheres for chronotherapy of chronic stable angina |
| Q42332061 | Combination and triple therapy in patients with stable angina pectoris not adequately controlled by optimal β-blocker therapy |
| Q36053263 | Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardio |
| Q77956590 | Combination of calcium channel blockers and beta-blockers for patients with exercise-induced angina pectoris: beneficial effect of calcium channel blockers largely determined by their effect on heart rate |
| Q67005380 | Combination of nifedipine with isosorbitol dinitrate and with propranolol. Verification of their effectiveness in angina of effort |
| Q70284216 | Combination of trimetazidine with nifedipine in effort angina |
| Q44879186 | Combination propranolol and bepridil therapy in stable angina pectoris |
| Q39346358 | Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris |
| Q44436330 | Combination therapy with diltiazem and nifedipine in patients with effort angina pectoris |
| Q53369391 | Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study. |
| Q43811969 | Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand |
| Q42161142 | Combination treatment with trimetazidine and diltiazem in stable angina pectoris |
| Q47817531 | Combined effects of fibrinogen genetic variability on atherosclerosis in patients with or without stable angina pectoris: focus on the coagulation cascade and endothelial function. |
| Q42249049 | Combined therapy with Ca-antagonists and beta-adrenergic receptor blocking agents in chronic stable angina |
| Q70264766 | Combined therapy with verapamil and propranolol in chronic stable angina |
| Q40551499 | Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions |
| Q34622364 | Comparative clinical efficacy of bepridil, propranolol and placebo in patients with chronic stable angina |
| Q80415599 | Comparative clinical study of the efficacy and safety of a S-metoprolol ER tablet versus a racemate metoprolol ER tablet in patients with chronic stable angina |
| Q69939420 | Comparative costs versus symptomatic and employment benefits of medical and surgical treatment of stable angina pectoris |
| Q68317882 | Comparative effect of anti-anginal drugs on myocardial ischemia in patient with effort angina: evaluation by ambulatory electrocardiographic monitoring |
| Q34507881 | Comparative effectiveness of Di'ao Xin Xue Kang capsule and Compound Danshen tablet in patients with symptomatic chronic stable angina |
| Q69897589 | Comparative effects of calcium entry-blocking drugs, beta-blocking drugs, and their combination in patients with chronic stable angina |
| Q69985717 | Comparative effects of metoprolol and celiprolol on cardiac hemodynamics and left ventricular volume at rest and during exercise-induced angina |
| Q41733849 | Comparative effects of nifedipine, verapamil, isosorbide dinitrate and propranolol on exercise-induced angina pectoris |
| Q58537055 | Comparative effects of nifedipine, verapamil, isosorbide dinitrate and propranolol on exercise-induced angina pectoris |
| Q41963045 | Comparative effects of prolonged therapy with four calcium ion antagonists (diltiazem, nicardipine, tiapamil and verapamil) in patients with chronic stable angina pectoris |
| Q69801182 | Comparative effects of theophylline and isosorbide dinitrate on exercise capacity in stable angina pectoris, and their mechanisms of action |
| Q46414247 | Comparative efficacy and safety of bepridil and diltiazem in chronic stable angina pectoris refractory to diltiazem. The Bepridil Collaborative Study Group |
| Q69939918 | Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris |
| Q70014258 | Comparative efficacy of high-dose versus low-dose nicorandil therapy for chronic stable angina pectoris |
| Q70672850 | Comparative efficacy of nicardipine, a new calcium antagonist, versus nifedipine in effort stable angina |
| Q70735854 | Comparative efficacy of nicardipine, a new calcium antagonist, versus nifedipine in stable effort angina |
| Q72215084 | Comparative efficacy of nifedipine gastrointestinal therapeutic system versus diltiazem when added to beta blockers in stable angina pectoris |
| Q42212628 | Comparative evaluation of 3 calcium antagonist drugs in patients with stable angina of effort. Double-blind placebo-controlled randomized study |
| Q44386404 | Comparative multicentre study of the tolerability and efficacy of epanolol versus metoprolol in patients with stable angina pectoris |
| Q48949660 | Comparative multicentre study of the tolerability and efficacy of epanolol versus nifedipine in patients with stable angina pectoris. |
| Q43479168 | Comparative study of effects of diltiazem, nifedipine and their combination on exercise stable angina |
| Q39368727 | Comparative study of left ventricular function in patients with unstable angina, non-Q wave myocardial infarction and stable angina pectoris: assessment with atrial pacing and digital ventriculography |
| Q54508221 | Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina |
| Q67783948 | Comparative study of the effect of drug therapy and its combination with hyperbaric oxygenation and hemosorption on stable angina pectoris |
| Q42199219 | Comparative study of the effect of nifedipine versus diltiazem on exercise performance, serum propranolol levels, and ST-segment abnormalities in patients with chronic stable angina taking propranolol |
| Q72567168 | Comparative study of the effectiveness of inderal and anaprilin in effort angina |
| Q79810335 | Comparing systems for costing hospital treatments. The case of stable angina pectoris |
| Q92329365 | Comparing the Diagnostic Value of the C-Reactive Protein to Albumin Ratio With Other Inflammatory Markers in Patients With Stable Angina Pectoris |
| Q26747599 | Comparison between National Institute for Health and Care Excellence (NICE) and European Society of Cardiology (ESC) guidelines for the diagnosis and management of stable angina: implications for clinical practice |
| Q53535065 | Comparison of 50-mg and 100-mg sustained-release isosorbide mononitrate in the treatment of stable angina pectoris: effects on quality-of-life indices. Dutch Mononitrate Quality of Life (DUMQOL) Study Group. |
| Q94461534 | Comparison of Archival Angiographic Findings in Patients Later Developing Acute Coronary Syndrome or Stable Angina |
| Q40647004 | Comparison of C-reactive protein and terminal complement complex in patients with unstable angina pectoris versus stable angina pectoris |
| Q30447937 | Comparison of Coronary Plaque Components between Non-Culprit Lesions in Patients with Acute Coronary Syndrome and Target Lesions in Patients with Stable Angina: Virtual Histology-Intravascular Ultrasound Analysis |
| Q61651556 | Comparison of Diltiazem Standard Formulation and Diltiazem Controlled Release in Patients with Stable Angina Pectoris |
| Q58775630 | Comparison of International Guidelines for Assessment of Suspected Stable Angina: Insights From the PROMISE and SCOT-HEART |
| Q73179074 | Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris |
| Q67577491 | Comparison of acute and steady-state conditions of gallopamil therapy in stable angina pectoris |
| Q28340657 | Comparison of antianginal efficacies and exercise hemodynamic effects of nifedipine and diltiazem in stable angina pectoris |
| Q93564573 | Comparison of antianginal efficacy of nifedipine and isosorbide dinitrate in chronic stable angina: a long-term, randomized, double-blind, crossover study |
| Q36784618 | Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris |
| Q69515518 | Comparison of atenolol and nifedipine in chronic stable angina pectoris |
| Q91936231 | Comparison of automated quantification and semiquantitative visual analysis findings of IQ SPECT MPI with conventional coronary angiography in patients with stable angina |
| Q69919020 | Comparison of bevantolol and atenolol in chronic stable angina |
| Q68086310 | Comparison of bopindolol and atenolol in chronic stable angina pectoris |
| Q69971465 | Comparison of buccal nitroglycerin and oral isosorbide dinitrate for nitrate tolerance in stable angina pectoris |
| Q81123154 | Comparison of carotid intima-media thickness in patients with stable angina pectoris versus patients with acute coronary syndrome |
| Q30406330 | Comparison of carotid plaque tissue characteristics in patients with acute coronary syndrome or stable angina pectoris: assessment by iPlaque, transcutaneous carotid ultrasonography with integrated backscatter analysis. |
| Q32102233 | Comparison of carvedilol and atenolol efficacy in patients with stable effort angina |
| Q53399986 | Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group. |
| Q60154846 | Comparison of chest pain, electrocardiographic changes and thallium-201 scintigraphy during varying exercise intensities in men with stable angina pectoris |
| Q74572556 | Comparison of circulating endothelin-1 and big endothelin-1 levels in unstable versus stable angina pectoris |
| Q61808651 | Comparison of clinical outcomes following percutaneous coronary intervention versus optimal medical therapy based on gray-zone fractional flow reserve in stable angina patients with intermediate coronary artery stenosis (COMFORTABLE prospective study |
| Q46767426 | Comparison of combination nifedipine-propranolol and diltiazem-propranolol with high dose diltiazem monotherapy for stable angina pectoris |
| Q74598283 | Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris |
| Q71906107 | Comparison of coronary angiographic narrowing in stable angina pectoris, unstable angina pectoris, and in acute myocardial infarction |
| Q51032402 | Comparison of coronary artery specific leukocyte-platelet conjugate formation in unstable versus stable angina pectoris. |
| Q74190828 | Comparison of coronary calcium in stable angina pectoris and in first acute myocardial infarction utilizing double helical computerized tomography |
| Q58911468 | Comparison of coronary lesions obtained by directional coronary atherectomy in unstable angina, stable angina, and restenosis after either atherectomy or angioplasty |
| Q53635947 | Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. |
| Q36411725 | Comparison of cytokine expressions in acute myocardial infarction and stable angina stages of coronary artery disease |
| Q53417128 | Comparison of differential expression of P2Y₁₂ receptor in culprit coronary plaques in patients with acute myocardial infarction versus stable angina pectoris. |
| Q70379042 | Comparison of diltiazem at two dose levels with propranolol for treatment of stable angina pectoris |
| Q54308671 | Comparison of diltiazem, nitrendipine, and their combination for systemic hypertension and stable angina pectoris |
| Q57243546 | Comparison of direct coronary stenting with and without balloon predilatation in patients with stable angina pectoris |
| Q43991547 | Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia |
| Q77371797 | Comparison of effects of ascorbic acid on endothelium-dependent vasodilation in patients with chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy versus patients with effort angina pectoris secondary to coronary artery di |
| Q44301231 | Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris |
| Q70124060 | Comparison of epicardial coronary artery tone and reactivity in Prinzmetal's variant angina and chronic stable angina pectoris |
| Q47354027 | Comparison of frequency of interferon-gamma-positive CD4+ T cells before and after percutaneous coronary intervention and the effect of statin therapy in patients with stable angina pectoris |
| Q104494052 | Comparison of functional exercise capacity, quality of life and respiratory and peripheral muscle strength between patients with stable angina and healthy controls |
| Q72323439 | Comparison of histopathologic coronary lesions obtained from directional atherectomy in stable angina versus acute coronary syndromes |
| Q51560244 | Comparison of insulin response to intravenous glucose in healed myocardial infarction, in "cooled-off" unstable and stable angina pectoris, and in healthy subjects. |
| Q70046857 | Comparison of isradipine and nifedipine in chronic stable angina |
| Q82404817 | Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris |
| Q45936019 | Comparison of long-term mortality after percutaneous coronary intervention in patients treated for acute ST-elevation myocardial infarction versus those with unstable and stable angina pectoris. |
| Q73456963 | Comparison of men versus women in cross-sectional area luminal narrowing, quantity of plaque, presence of calcium in plaque, and lumen location in coronary arteries by intravascular ultrasound in patients with stable angina pectoris |
| Q100737699 | Comparison of mitral annular displacement and global longitudinal strain imaging for predicting significant coronary atherosclerotic disease in patients of chronic stable angina pectoris |
| Q69940823 | Comparison of mortality and myocardial infarction rates in stable angina pectoris with and without ischemic episodes during daily activities |
| Q53589350 | Comparison of multiple-dose and once-daily nitrate therapy in 1212 patients with stable angina pectoris: effects on quality of life indices. Dutch Mononitrate Quality of Life (DUMQOL) Study Group. |
| Q71566564 | Comparison of nadolol, a new long-acting beta-receptor blocking agent, and placebo in the treatment of stable angina pectoris |
| Q68857991 | Comparison of nicardipine and propranolol for chronic stable angina pectoris |
| Q68134043 | Comparison of nicardipine and verapamil in the management of chronic stable angina |
| Q44382530 | Comparison of nicorandil and atenolol in stable angina pectoris |
| Q70287409 | Comparison of nifedipine alone with propranolol alone for stable angina pectoris including hemodynamics at rest and during exercise |
| Q69186220 | Comparison of nifedipine and isosorbide dinitrate when added to maximal propranolol therapy in stable angina pectoris |
| Q72701576 | Comparison of nifedipine gastrointestinal therapeutic system and atenolol on antianginal efficacies and exercise hemodynamic responses in stable angina pectoris |
| Q69375350 | Comparison of once and twice daily oral dosing schedules of bevantolol, a new beta-adrenoceptor antagonist with alpha-adrenoceptor partial antagonist activity in patients with angina of effort |
| Q70336552 | Comparison of once and twice daily sotalol in exercise-induced angina pectoris |
| Q44972893 | Comparison of once daily versus twice daily oral nitrates in stable angina pectoris |
| Q53314965 | Comparison of patients undergoing enhanced external counterpulsation and percutaneous coronary intervention for stable angina pectoris. |
| Q98622282 | Comparison of plaque distribution and wire-free functional assessment in patients with stable angina and non-ST elevation myocardial infarction: an optical coherence tomography and quantitative flow ratio study |
| Q50908719 | Comparison of plasma tissue factor levels in unstable and stable angina pectoris. |
| Q73055226 | Comparison of platelet activation in unstable and stable angina pectoris and correlation with coronary angiographic findings |
| Q72343939 | Comparison of results of intracoronary stenting in patients with unstable vs. stable angina |
| Q74611433 | Comparison of safety and efficacy of carvedilol and metoprolol in stable angina pectoris |
| Q95530324 | Comparison of serum levels of IL-6, IL-8, TGF-β and TNF-α in coronary artery diseases, stable angina and participants with normal coronary artery |
| Q80724149 | Comparison of serum levels of inflammatory markers and allelic variant of interleukin-6 in patients with acute coronary syndrome and stable angina pectoris |
| Q83297050 | Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery |
| Q34447800 | Comparison of single doses of ketanserin and placebo in chronic stable angina |
| Q62590235 | Comparison of the Absorb bioresorbable vascular scaffold to the Xience durable polymer everolimus-eluting metallic stent in routine clinical practice: a propensity score-matched analysis from a multicenter registry |
| Q55228800 | Comparison of the Brachial-ankle Pulse Wave Velocity between Patients with Acute Coronary Syndrome and Effort Angina Pectoris. |
| Q40909126 | Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on Coronary Plaque Determined by Angioscopy and Intravascular Ultrasound in Japanese With Stable Angina Pectoris (from the Aggressive Lipid-Lowering Treatment Approach Using Intensive Rosuvast |
| Q43966843 | Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris |
| Q36386820 | Comparison of the effects of Crataegus oxyacantha extract, aerobic exercise and their combination on the serum levels of ICAM-1 and E-Selectin in patients with stable angina pectoris |
| Q68512320 | Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris |
| Q67882305 | Comparison of the effects of diltiazem and isradipine in adrenergic beta receptor blockade in patients with stable angina pectoris |
| Q67909060 | Comparison of the effects of nifedipine and diltiazem in patients with stable angina pectoris of various severity and pathomorphology of the coronary arteries |
| Q69918416 | Comparison of the effects of two doses of bisoprolol on exercise tolerance in exercise-induced stable angina pectoris |
| Q84029700 | Comparison of the efficacy and safety of statin and statin/ezetimibe therapy after coronary stent implantation in patients with stable angina |
| Q28706249 | Comparison of the efficacy and tolerability of ivabradine and ranolazine in patients of chronic stable angina pectoris |
| Q72015427 | Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina |
| Q53967559 | Comparison of the histopathology of culprit lesions in chronic stable angina, unstable angina, and myocardial infarction. |
| Q69894133 | Comparison of the immediate effects of two beta-blocking drugs: a nonselective and a cardioselective with modest ISA in exercise-induced angina |
| Q53394707 | Comparison of the safety and efficacy of bisoprolol versus atenolol in stable exercise-induced angina pectoris: a Multicenter International Randomized Study of Angina Pectoris (MIRSA) |
| Q53572788 | Comparison of three quality of life instruments in stable angina pectoris: Seattle Angina Questionnaire, Short Form Health Survey (SF-36), and Quality of Life Index-Cardiac Version III. |
| Q82970629 | Comparison of tissue characteristics between acute coronary syndrome and stable angina pectoris. An integrated backscatter intravascular ultrasound analysis of culprit and non-culprit lesions |
| Q34447770 | Comparison of transdermal nitrate and isosorbide dinitrate in chronic stable angina |
| Q70284229 | Comparison of trimetazidine with nifedipine in effort angina: a double-blind, crossover study |
| Q36097748 | Comparison of two calcium antagonists, verapamil and fendiline, in an experimental model of myocardial ischaemia mimicking classical angina on effort |
| Q44054645 | Comparison of urinary biopyrrin levels in acute myocardial infarction (after reperfusion therapy) versus stable angina pectoris and their usefulness in predicting subsequent cardiac events |
| Q46056339 | Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study |
| Q71722091 | Comparison of verapamil and nifedipine in chronic stable angina pectoris |
| Q53563010 | Comparison of virtual histology to intravascular ultrasound of culprit coronary lesions in acute coronary syndrome and target coronary lesions in stable angina pectoris. |
| Q69646765 | Complementary mechanisms of atenolol and diltiazem in the clinical improvement of patients with stable angina |
| Q89469169 | Complex high-risk and indicated percutaneous coronary intervention for stable angina: Does operator volume influence patient outcome? |
| Q36013094 | Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial |
| Q53656943 | Composition of coronary atherosclerotic plaques in patients with acute myocardial infarction and stable angina pectoris determined by contrast-enhanced multislice computed tomography. |
| Q46942495 | Composition of coronary plaques obtained by directional atherectomy in stable angina: its relation to serum lipids and statin treatment |
| Q83265830 | Composition of target lesions by near-infrared spectroscopy in patients with acute coronary syndrome versus stable angina |
| Q92006095 | Compound salvia pellet might be more effective and safer for chronic stable angina pectoris compared with nitrates: A systematic review and meta-analysis of randomized controlled trials |
| Q47233044 | Compound salvia pellet, a traditional Chinese medicine, for the treatment of chronic stable angina pectoris compared with nitrates: a meta-analysis |
| Q34808637 | Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography versus conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina |
| Q36578470 | Congenital coronary artery-left ventricle direct micro-fistulas may cause effort angina and positive stress tests in Western adults |
| Q30667288 | Contemporary management of chronic stable angina |
| Q67337655 | Contemporary medical management of stable angina pectoris |
| Q67696409 | Continuous Oral N-Acetycycsteine Treatment and Development of Nitrate Tolerance in Patients with Stable Angina Pectoris |
| Q67910981 | Continuous measurement of coronary sinus oxygen saturation in patients with effort angina and vasospastic angina |
| Q45796818 | Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study |
| Q72877075 | Conventional and controlled release diltiazem. Bioavailability in healthy volunteers and anti-anginal effects in combination with metoprolol in stable angina pectoris |
| Q53637889 | Coronary Angioplasty in Patients With Stable Angina Pectoris and One-Vessel Disease |
| Q104103268 | Coronary Computed Tomography Angiography Compared With Single Photon Emission Computed Tomography Myocardial Perfusion Imaging as a Guide to Optimal Medical Therapy in Patients Presenting With Stable Angina: The RESCUE Trial |
| Q95474881 | Coronary Stent Placement in Patients with Stable Angina - an Ongoing Debate |
| Q53482861 | Coronary and aortic calcifications inter-relationship in stable angina pectoris: A Coronary Disease Trial Investigating Outcome with Nifedipine GITS (ACTION)--Israeli spiral computed tomography substudy. |
| Q84546278 | Coronary angiographic findings and conventional coronary artery disease risk factors of Indo-Guyanese immigrants with stable angina pectoris and acute coronary syndromes |
| Q70635796 | Coronary angiography during exercise-induced angina with ECG changes |
| Q52886554 | Coronary angioplasty ameliorates hypoperfusion-induced endothelial dysfunction in patients with stable angina pectoris. |
| Q33999816 | Coronary angioplasty in unstable angina and stable angina: a comparison of success and complications |
| Q95805918 | Coronary angioscopic findings eight months after sirolimus-eluting stent implantation: a comparison between ST-elevation myocardial infarction and stable angina pectoris |
| Q71589103 | Coronary artery bypass surgery: a prospective evaluation in stable angina |
| Q72056257 | Coronary artery plaque morphology in stable angina and subsets of unstable angina: an in vivo intracoronary ultrasound study |
| Q35371650 | Coronary artery stenting in unstable angina pectoris: a comparison with stable angina pectoris |
| Q77483700 | Coronary blood flow dynamics during transcutaneous electrical nerve stimulation for stable angina pectoris associated with severe narrowing of one major coronary artery |
| Q40699327 | Coronary bypass for stable angina: a prospective randomized study |
| Q66878354 | Coronary bypass graft for stable angina, impending myocardial infarction and acute myocardial infarction |
| Q37713615 | Coronary bypass surgery for stable angina and unstable angina pectoris |
| Q43423401 | Coronary bypass surgery in stable angina pectoris. A randomized study of the effects on morbidity, mortality and employment. |
| Q38059547 | Coronary computed tomography angiography for stable angina: past, present, and future |
| Q67777793 | Coronary flow reserve and stenosis as the determinant of exercise capacity in patients with stable effort angina |
| Q90784037 | Coronary intervention for stable angina |
| Q26778104 | Coronary revascularization in the elderly with stable angina |
| Q44923110 | Coronary stenosis progression differs in patients with stable angina pectoris with and without a previous history of unstable angina |
| Q84479442 | Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction |
| Q51209358 | Coronary vasomotor abnormalities in patients with stable angina after successful stent implantation but without in-stent restenosis. |
| Q44574039 | Coronary vasomotor response is related to the angiographic extent of coronary sclerosis in patients with stable angina pectoris |
| Q66702831 | Coronary-artery bypass surgery in stable angina pectoris: Survival at two years. European Coronary Surgery Study Group |
| Q95475175 | Coronary-subclavian steal syndrome presenting with stable angina |
| Q43257580 | Correction of metabolic disturbances in patients with stable effort angina and metabolic syndrome |
| Q88938008 | Correction: PCI does not improve outcomes for patients with stable angina |
| Q46323308 | Correlates of coronary angiography in patients with stable angina and geographical differences in its utilisation: the ACTION experience. |
| Q48214344 | Correlation Clustering of Stable Angina Clinical Care Patterns for 506 Thousand Patients. |
| Q104460907 | Correlation between Myocardial Strain by 2-D Speckle-Tracking Echocardiography and Angiographic findings by Coronary Angiogram in Stable Angina |
| Q35945215 | Correlation between body fat distribution, plasma lipids and apolipoproteins with the severity of coronary involvement in patients with stable angina |
| Q91419141 | Correlation between exercise, personal income level and health-related quality of life in patients with newly diagnosed stable angina |
| Q93603602 | Correlation of the exercise ST/HR slope with anatomic and radionuclide cineangiographic findings in stable angina pectoris |
| Q37098298 | Cost of illness for chronic stable angina patients enrolled in a self-management education trial |
| Q37731013 | Cost-effectiveness of enhanced external counterpulsation (EECP) for the treatment of stable angina in the United Kingdom. |
| Q87340716 | Cost-effectiveness of ranolazine added to standard-of-care treatment in patients with chronic stable angina pectoris |
| Q70409499 | Cost-effectiveness of screening strategies for left main coronary artery disease in patients with stable angina |
| Q46977079 | Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values? |
| Q81896443 | Cumulative incidence of coronary lesions with vulnerable characteristics in patients with stable angina pectoris: an intravascular ultrasound and angiographic study |
| Q34522250 | Current Status of Isosorbide-5-Mononitrate Therapy in Chronic Stable Angina Pectoris. |
| Q71839159 | Current approaches to stable angina |
| Q37056175 | Current indications for percutaneous coronary intervention for chronic stable angina: implications of the COURAGE Trial. |
| Q77055868 | Current management of chronic stable angina |
| Q28213164 | Current medical management of chronic stable angina |
| Q72479767 | Current medical management versus coronary arterial bypass grafting in patients with stable angina pectoris |
| Q42760296 | Current status of medical therapy of chronic stable angina pectoris in mainland of China: the second survey |
| Q37752273 | Current treatment status of stable angina: medical treatment versus percutaneous coronary intervention versus coronary artery by-pass grafting. |
| Q37556270 | Cyanate-Impaired Angiogenesis: Association With Poor Coronary Collateral Growth in Patients With Stable Angina and Chronic Total Occlusion |
| Q44393095 | Cytokine response after percutaneous coronary intervention in stable angina: effect of selective glycoprotein IIb/IIIa receptor antagonism |
| Q73011144 | D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction |
| Q30613589 | DATA: a decision aid for management of the patient with stable angina pectoris |
| Q81491114 | DUAAL: atorvastatin provided an unexpectedly potent heart benefit in patients with chronic stable angina |
| Q36201894 | Danhong injection in the treatment of chronic stable angina: study protocol for a randomized controlled trial |
| Q31137920 | Data on the value of elevated circulating mimecan levels for detecting poor coronary collateralization in patients with stable angina and chronic total occlusion |
| Q72551310 | Dazoxiben in stable angina |
| Q44206185 | Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris |
| Q73250509 | Delayed attenuation of myocardial ischemia with repeated exercise in subjects with stable angina: a possible model for the second window of protection? |
| Q70554927 | Design and baseline results of the Scandinavian Simvastatin Survival Study of patients with stable angina and/or previous myocardial infarction |
| Q53644589 | Detailed comparison of intra-stent conditions 12 months after implantation of everolimus-eluting stents in patients with ST-segment elevation myocardial infarction or stable angina pectoris. |
| Q28191296 | Detection of aspirin resistance by PFA-100: prevalence and aspirin compliance in patients with chronic stable angina |
| Q53169542 | Detection of attenuated plaque in stable angina with 64-multidetector computed tomography: a comparison with intravascular ultrasound. |
| Q34276221 | Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris during percutaneous coronary interventions under an adjunctive antithrombotic therapy with abciximab: design and rationale of the High [...] |
| Q79685558 | Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris undergoing elective percutaneous coronary interventions |
| Q53459649 | Detection of coronary stenoses in chronic stable angina by multi-detector CT coronary angiography. |
| Q69637308 | Detection of diseased coronary artery by exercise ST-T maps in patients with effort angina pectoris, single-vessel disease, and normal ST-T wave on electrocardiogram at rest |
| Q80475562 | Detection of postischemic regional left ventricular delayed outward wall motion or diastolic stunning after exercise-induced ischemia in patients with stable effort angina by using color kinesis |
| Q81015430 | Detection of prominent left anterior descending coronary artery stenosis for patients with stable angina using Doppler tissue echocardiography |
| Q69783762 | Detection, frequency and clinical significance of silent myocardial ischaemia in patients with chronic stable angina |
| Q72889424 | Determinants of beneficial effect of heparin exercise treatment on treadmill capacity and long-term efficacy of the therapy in patients with chronic effort angina |
| Q46739674 | Determinants of coronary events in patients with stable angina: results from the impact of nicorandil in angina study |
| Q84656806 | Determination of the cut-off plasma adiponectin level associated with a lower risk of restenosis in patients with stable angina |
| Q70359336 | Determination of the optimal dose of glyceryl trinitrate in the treatment of stable angina |
| Q50667686 | Developing and testing a mobile application programme to support self-management in patients with stable angina: a feasibility study protocol. |
| Q44167040 | Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate |
| Q33771997 | Development of review criteria for assessing the quality of management of stable angina, adult asthma, and non-insulin dependent diabetes mellitus in general practice. |
| Q43222846 | Development of tolerance to nifedipine in patients with stable angina pectoris |
| Q30391413 | Diagnosing coronary artery disease by sound analysis from coronary stenosis induced turbulent blood flow: diagnostic performance in patients with stable angina pectoris |
| Q79088142 | Diagnosis and therapy of stable angina and acute coronary syndromes in the elderly |
| Q28208897 | Diagnosis and therapy of stable angina in Russian Federation (International Study ATP - angina treatment pattern) |
| Q45049506 | Diagnosis of coronary artery disease by thallium-201 myocardial scintigraphy with intravenous infusion of SUNY4001 (adenosine) in effort angina pectoris--the clinical trial report at multi-center: phase II |
| Q92277178 | Diagnostic Approach to Patients with Stable Angina and No Obstructive Coronary Arteries |
| Q35548105 | Diagnostic Value of Electrocardiographic T Wave Inversion in Lead aVL in Diagnosing Coronary Artery Disease in Patients with Chronic Stable Angina |
| Q93247173 | Diagnostic Value of the C-Reactive Protein to Albumin Ratio in Patients With Stable Angina Pectoris: Methodological Issue |
| Q46808377 | Diagnostic accuracy of non-invasive 64-slice CT coronary angiography in patients with stable angina pectoris |
| Q38777129 | Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease. |
| Q39906201 | Diagnostic and therapeutic aspects of stable angina pectoris |
| Q79248847 | Diagnostic coronary angiography induces a systemic inflammatory response in patients with stable angina |
| Q101141271 | Diagnostic utility of mitral annular displacement by speckle tracking echocardiography in predicting significant coronary artery disease in suspected chronic stable angina pectoris |
| Q64083423 | Diastolic-systolic velocity ratio to detect coronary stenoses under physiological resting conditions: a mechanistic study |
| Q91210897 | Dietary choline is related to increased risk of acute myocardial infarction in patients with stable angina pectoris |
| Q51552746 | Dietary factor VII activation does not increase plasma concentrations of prothrombin fragment 1+2 in patients with stable angina pectoris and coronary atherosclerosis. |
| Q83944627 | Difference in risk factors between acute coronary syndrome and stable angina pectoris in the Japanese: smoking as a crucial risk factor of acute coronary syndrome |
| Q35794203 | Differences determined by optical coherence tomography volumetric analysis in non-culprit lesion morphology and inflammation in ST-segment elevation myocardial infarction and stable angina pectoris patients |
| Q39474594 | Differences in Ischemic Threshold and Nitrate Efficacy between Normotensive and Hypertensive Patients with Stable Angina Pectoris |
| Q58314222 | Differences in Microparticle Release in Patients With Acute Coronary Syndrome and Stable Angina |
| Q49168051 | Differences in presentation and management of stable angina from East to West in Europe: a comparison between Poland and the UK. |
| Q68036224 | Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate (ISDN) during acute and short-term administration in stable angina pectoris |
| Q80391486 | Different effect of percutaneous and surgical coronary revascularization on cardiac autonomic function and inflammation in patients with stable angina |
| Q78647531 | Different patterns of interleukin-6 and von Willebrand factor antigen changes after coronary stenting in unstable versus stable angina |
| Q52595364 | Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation; 9-month follow-up optical coherence tomography study. |
| Q81498399 | Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris |
| Q38336769 | Different quantitative apoptotic traits in coronary atherosclerotic plaques from patients with stable angina pectoris and acute coronary syndromes |
| Q37365823 | Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study. |
| Q84077631 | Differential characteristics of inflammatory responses to stent implantation between de novo and intrastent restenosis lesion in patients with stable angina |
| Q74072533 | Differential coronary artery calcification detected by electron beam computed tomography as an indicator of coronary stenosis among patients with stable angina pectoris |
| Q77190907 | Differential coronary calcification on electron-beam CT between syndrome X and coronary artery disease in patients with chronic stable angina pectoris |
| Q46674355 | Differential index: a simple time domain heart rate variability analysis with prognostic implications in stable angina pectoris. |
| Q36464559 | Differential loss of natural killer cell activity in patients with acute myocardial infarction and stable angina pectoris |
| Q68934270 | Diltiazem and propranolol combination for the treatment of chronic stable angina pectoris |
| Q93641724 | Diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study |
| Q70320163 | Diltiazem dose responses in sustained therapy for stable angina pectoris |
| Q68047118 | Diltiazem in comparison with metoprolol in stable angina pectoris |
| Q42212354 | Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment |
| Q71765648 | Diltiazem: a new calcium antagonist for the treatment of chronic stable angina |
| Q43732075 | Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study |
| Q53729314 | Dipyridamole-echocardiography test in effort angina pectoris. |
| Q46701082 | Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation |
| Q43890608 | Discontinuous transdermal nitroglycerin as treatment for stable angina in the elderly: a double-blind multicentre study. The Transdermal TNG Trial Group of Istituto Nazionale Ricovero e Cura Anziani (I.N.R.C.A.). |
| Q70723667 | Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. The Angina and Silent Ischemia Study Group (ASIS) |
| Q67301219 | Dissociation of exercise tolerance and total myocardial ischemic burden in chronic stable angina pectoris |
| Q70037893 | Does exercise-induced myocardial ischaemia cause enhanced platelet activation and fibrin formation in patients with stable angina and severe coronary artery disease? |
| Q50886911 | Does gender make a difference in patients with stable angina pectoris? |
| Q85717837 | Does neutrophil gelatinase-asociated lipocalin have prognostic value in patients with stable angina undergoing elective PCI? A 3-year follow-up study |
| Q68870750 | Does placebo improve indexes of effort-induced myocardial ischemia? An objective study in 150 patients with chronic stable angina pectoris |
| Q61650847 | Does the myocardium become “stunned” after episodes of angina at rest, angina on effort, and coronary angioplasty? |
| Q47095252 | Doppler Versus Thermodilution-Derived Coronary Microvascular Resistance to Predict Coronary Microvascular Dysfunction in Patients With Acute Myocardial Infarction or Stable Angina Pectoris. |
| Q69912661 | Dose response effects of diltiazem on treadmill tolerance in chronic stable angina: a randomized double-blind, placebo-controlled crossover trial |
| Q72028775 | Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group |
| Q72766295 | Double-blind comparison of Diltiazem and placebo in the treatment of exercise-inducible chronic stable angina pectoris |
| Q43729813 | Double-blind comparison of once daily betaxolol versus propranolol four times daily in stable angina pectoris. Betaxolol Investigators Group |
| Q93526474 | Double-blind crossover comparison of amlodipine at three dose levels and placebo in chronic stable angina |
| Q72092912 | Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group |
| Q54722997 | Double-blind parallel placebo-controlled study to evaluate the effect of molsidomine on the endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: the MEDCOR Trial. |
| Q73304554 | Double-blind randomized multicenter study on the efficacy of trapidil versus isosorbide dinitrate in stable angina pectoris |
| Q68192651 | Double-blind trial of the long-term effects of acebutolol and propranolol on serum lipoproteins in patients with stable angina pectoris |
| Q80385567 | Double-blind, multicenter, active-controlled, randomized clinical trial to assess the safety and efficacy of orally administered nicorandil in patients with stable angina pectoris in China |
| Q70366361 | Double-blind, placebo-controlled trial of propranolol given once, twice and four times daily in stable angina pectoris: a multicenter study using serial exercise testing |
| Q72536056 | Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects |
| Q70930934 | Double-blind, randomized, placebo-controlled comparison of propranolol and verapamil in the treatment of patients with stable angina pectoris |
| Q69885233 | Double-blind, randomized, placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol |
| Q85574957 | Dramatic regression of three-vessel disease under statin treatment in patients with stable angina pectoris |
| Q39102158 | Drug Therapy for Stable Angina Pectoris |
| Q30487071 | Drug efficacy in treating stable angina pectoris: a protocol for network meta-analysis of randomised controlled trials |
| Q41333432 | Drug management of stable angina pectoris |
| Q67273898 | Drug treatment of chronic stable angina pectoris |
| Q67288313 | Drug treatment of chronic stable angina pectoris |
| Q47288109 | Drug treatment of stable angina pectoris and mass dissemination of therapeutic guidelines: a randomized controlled trial |
| Q35215653 | Drug treatment of stable angina pectoris in the elderly: defining the place of calcium channel antagonists |
| Q24247602 | Drug-eluting stents versus non-drug eluting stents in people with stable angina or acute coronary syndrome |
| Q72826437 | Drugs for stable angina pectoris |
| Q85894372 | Dynamic Changes in Phenotypic Groups in Patients with Stable Angina Pectoris after Treatment with Xinxuekang Capsule: A Randomized Controlled Trial |
| Q68433645 | Dynamic exercise-induced elevation in plasma levels of atrial natriuretic peptide in patients with effort angina pectoris |
| Q42789899 | Dynamics of structural functional parameters of cardiovascular system in patients with Stable Angina and Congestive Heart Failure treated with Ivabradine for six months |
| Q84062675 | Dyssynchrony contributes to false-positive myocardial perfusion SPECT results in patients with stable angina |
| Q46829973 | ECG and BP monitoring in patients with stable angina and essential hypertension on therapy with monocinque |
| Q53449174 | EFFECT OF RELATIVE GENE EXPRESSION ON PLAQUE VULNERABILITY IN PATIENTS WITH STABLE ANGINA AND PATIENTS WITH ACUTE CORONARY SYNDROME. |
| Q50936293 | Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris. |
| Q46394522 | Early changes in local hemostasis activation following percutaneous coronary intervention in stable angina patients: a comparison between drug-eluting and bare metal stents |
| Q69646226 | Early detection of myocardial ischemia by myocardial free fatty acid extraction in patients with exercise-induced angina pectoris |
| Q94674101 | Early diastolic strain rate by two-dimensional speckle tracking echocardiography is a predictor of coronary artery disease and cardiovascular events in stable angina pectoris |
| Q50067447 | Economic Evaluation of Safflower Yellow Injection for the Treatment of Patients with Stable Angina Pectoris in China: A Cost-Effectiveness Analysis |
| Q47142119 | Economic Impact of Subsequent Depression in Patients With a New Diagnosis of Stable Angina: A Population-Based Study |
| Q36146507 | Economic evaluation of trimetazidine in the management of chronic stable angina in Greece |
| Q45697081 | Editorial: stable angina pectoris: novel therapeutic insights |
| Q80188349 | Education and support groups for patients with chronic stable angina and their families |
| Q91858149 | Effect and Safety of Guanxinning Tablet () for Stable Angina Pectoris Patients with Xin (Heart)-Blood Stagnation Syndrome: A Randomized, Multicenter, Placebo-Controlled Trial |
| Q35754155 | Effect of Atorvastatin and Pioglitazone on Plasma Levels of Adhesion Molecules in Non-Diabetic Patients With Hypertension or Stable Angina or Both |
| Q85908162 | Effect of Diltiazem on Coronary Artery Flow and Myocardial Perfusion in Patients With Isolated Coronary Artery Ectasia and Either Stable Angina Pectoris or Positive Myocardial Ischemic Stress Test |
| Q51662386 | Effect of Ivabradine on Endothelial Function in Patients with Stable Angina Pectoris: Assessment with the Endo-PAT 2000 Device. |
| Q33717188 | Effect of Metoprolol Succinate in Patients with Stable Angina and Elevated Heart Rate Receiving Low-Dose β-Blocker Therapy |
| Q57610318 | Effect of Two-Day Atorvastatin Pretreatment on Long-Term Outcome of Patients With Stable Angina Pectoris Undergoing Elective Percutaneous Coronary Intervention |
| Q41126427 | Effect of Vitamin D on Anginal Episodes in Vitamin D Deficient Patients with Chronic Stable Angina on Medical Management |
| Q110741669 | Effect of a Single Oral Dose of Glutamine on Cardiac Performance during Exercise in Patients with Stable Angina Pectoris: A Double Blind Study |
| Q79436673 | Effect of a hypoglycemic agent on ischemic preconditioning in patients with type 2 diabetes and stable angina pectoris |
| Q72695859 | Effect of acadesine, a new metabolic agent, on exercise-induced myocardial ischemia in chronic stable angina |
| Q46585633 | Effect of amlodipine and lacidipine on left ventricular diastolic and long axis functions in arterial hypertension and stable angina pectoris |
| Q24683728 | Effect of an alpha(2) agonist (mivazerol) on limiting myocardial ischaemia in stable angina |
| Q43269188 | Effect of antianginal drugs in stable angina on predicted mortality risk after surviving a myocardial infarction: a preliminary study (METRO). |
| Q44635351 | Effect of apolipoprotein E alleles and angiotensin-converting enzyme insertion/deletion polymorphisms on lipid and lipoprotein markers in middle-aged men and in patients with stable angina pectoris or healed myocardial infarction |
| Q34580063 | Effect of atorvastatin and clopidogrel co-administration after coronary stenting in korean patients with stable angina |
| Q44650107 | Effect of atorvastatin on exercise-induced myocardial ischemia in patients with stable angina pectoris |
| Q68018999 | Effect of benazepril on myocardial ischaemia in patients with chronic stable angina pectoris |
| Q69880496 | Effect of bepridil in patients with chronic stable angina: results of a multicenter trial |
| Q71631772 | Effect of beta adrenergic receptor blockade on cardiac autonomic tone in patients with chronic stable angina |
| Q53678503 | Effect of beta blockade with betaxolol on left ventricular systolic function in chronic stable angina pectoris and left ventricular dysfunction. |
| Q60168524 | Effect of beta-adrenergic blockade with alprenolol on ST-segment depression and circulatory dynamics during exercise in patients with effort angina |
| Q74598326 | Effect of beta-adrenergic blocker therapy on the circadian rhythm of heart rate variability in patients with chronic stable angina pectoris |
| Q70055104 | Effect of coffee on exercise-induced angina pectoris due to coronary artery disease in habitual coffee drinkers |
| Q69212719 | Effect of diltiazem and propranolol on myocardial ischaemia during unrestricted daily life in patients with effort-induced chronic stable angina pectoris |
| Q68525292 | Effect of dipyridamole at the usual oral dose on exercise-induced myocardial ischemia in stable angina pectoris |
| Q60154857 | Effect of dipyridamole therapy on myocardial ischemia in patients with stable angina pectoris receiving concurrent anti-ischemic therapy |
| Q50666091 | Effect of embolic particles during coronary interventional procedures on regional wall motion in patients with stable angina pectoris. |
| Q45040754 | Effect of enalapril and losartan on cytokines in patients with stable angina pectoris awaiting coronary artery bypass grafting and their interaction with polymorphisms in the interleukin-6 gene |
| Q73995183 | Effect of extended-release isosorbide mononitrate one hour after dosing in patients with stable angina pectoris. IMDUR Study Group |
| Q34921979 | Effect of folic acid supplementation on levels of circulating Monocyte Chemoattractant Protein-1 and the presence of intravascular ultrasound derived virtual histology thin-cap fibroatheromas in patients with stable angina pectoris |
| Q73445620 | Effect of gallopamil on myocardial microperfusion in patients with stable effort angina: a randomized, cross-over, double-blind, placebo-controlled trial |
| Q51775557 | Effect of gender on prognosis following percutaneous coronary intervention for stable angina pectoris and acute coronary syndromes. |
| Q45273794 | Effect of hemosorption on microcirculation, humoral autoimmunity and lipid peroxidation in patients with stable angina pectoris |
| Q73088640 | Effect of heparin in effort angina |
| Q33935192 | Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial |
| Q68195415 | Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina |
| Q69467324 | Effect of isometric hand-grip exercise on left ventricular diastolic filling in patients with effort angina: a pulsed Doppler echocardiographic study |
| Q33617828 | Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials |
| Q68182834 | Effect of ketanserin on proximal and distal coronary constrictor responses to intracoronary infusion of serotonin in patients with stable angina, patients with variant angina, and control patients |
| Q73835675 | Effect of left ventricular function on the assessment of myocardial viability by technectium-99m sestamibi and correlation with positron emission tomography in patients with healed myocardial infarcts or stable angina pectoris, or both |
| Q34346106 | Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial |
| Q45270271 | Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial |
| Q46500992 | Effect of low doses of alcohol on the warm-up phenomenon in patients with stable angina pectoris. |
| Q80812301 | Effect of mean platelet volume on postintervention coronary blood flow in patients with chronic stable angina pectoris |
| Q72074956 | Effect of medical vs surgical treatment on symptoms in stable angina pectoris |
| Q39682321 | Effect of medical vs surgical treatment on symptoms in stable angina pectoris. The Veterans Administration Cooperative Study of surgery for coronary arterial occlusive disease |
| Q83219399 | Effect of metoprolol and amlodipine on myocardial total ischaemic burden in patients with stable angina pectoris |
| Q72724600 | Effect of metoprolol and diltiazem on the total ischaemic burden in patients with chronic stable angina: a randomized controlled trial |
| Q39259007 | Effect of metoprolol on systolic time in patients with stable angina pectoris |
| Q40992157 | Effect of metoprolol on the exercise tolerance in patients with stable angina pectoris (author's transl) |
| Q46108782 | Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group |
| Q41449389 | Effect of naloxone on exercise-induced angina pectoris: a randomized double blind crossover trial |
| Q42364211 | Effect of nicorandil on QT dispersion in patients with stable angina pectoris undergoing elective angioplasty: A triple-blind, randomized, placebo-controlled study |
| Q34124712 | Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial |
| Q41836069 | Effect of nicorandil on exercise performance in patients with effort angina: a multicenter trial using a treadmill exercise test. |
| Q46475953 | Effect of nifedipine on C-reactive protein levels in the coronary sinus and on coronary blood flow in response to acetylcholine in patients with stable angina pectoris having percutaneous coronary intervention. |
| Q70468116 | Effect of nifedipine on exercise-induced left ventricular dysfunction and myocardial hypoperfusion in stable angina |
| Q74369684 | Effect of nipradilol on silent myocardial ischemia and heart rate variability in chronic stable angina |
| Q71495851 | Effect of nipradilol on silent myocardial ischemia, plasma beta-endorphin, and bradykinin in chronic stable angina |
| Q48085388 | Effect of nitrate withdrawal on quality of life and adherence to treatment in patients with stable angina: evidence from a randomized clinical trial |
| Q80384257 | Effect of obesity on the relationship between plasma C-reactive protein and coronary artery stenosis in patients with stable angina |
| Q34063900 | Effect of opium addiction on aspirin resistance in stable angina pectoris |
| Q39200187 | Effect of penbutolol (Hoe 893 d) and practolol on exercise-induced angina pectoris 2 and 24 hours after a single oral dose |
| Q39322646 | Effect of percutaneous coronary intervention on coronary blood flow at rest in myocardial sites remote from the intervention site in patients with stable angina pectoris |
| Q44410878 | Effect of platelet reactivity, endothelial function, and inflammatory status on outcomes in patients with stable angina pectoris on clopidogrel therapy |
| Q60168504 | Effect of propranolol and verapamil on oxygen utilization, acidosis and fatigue during exercise in stable angina pectoris |
| Q30304136 | Effect of raised plasma beta endorphin concentrations on peripheral pain and angina thresholds in patients with stable angina |
| Q42106284 | Effect of repetitive episodes of exercise induced myocardial ischaemia on left ventricular function in patients with chronic stable angina: evidence for cumulative stunning or ischaemic preconditioning? |
| Q47438236 | Effect of shenshao tablet on the quality of life for coronary heart disease patients with stable angina pectoris |
| Q43841856 | Effect of sildenafil citrate upon myocardial ischemia in patients with chronic stable angina in therapy with beta-blockers. |
| Q93606486 | Effect of specific thromboxane-synthetase inhibition on thromboxane and prostaglandin synthesis in stable angina induced by exercise test |
| Q28246683 | Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris |
| Q71588390 | Effect of sustained release diltiazem (Diltiazem-R) in patients with stable effort angina |
| Q44727838 | Effect of the treatment with fenigidin on peripheral hemodynamics in patients with stable angina pectoris |
| Q73114369 | Effect of theophylline on adaptation of the heart to myocardial ischemia during percutaneous transluminal coronary angioplasty in patients with stable angina pectoris |
| Q43066545 | Effect of therapy with trimetazidine modified release on quality of life of patients with stable effort angina survivors after acute myocardial infarction. Results of PRIMA study |
| Q67826833 | Effect of various antianginal agents on the frequency and duration of myocardial ischemic episodes in patients with stable angina pectoris |
| Q36790769 | Effective management of stable angina |
| Q92607805 | Effectiveness and Impact on Adherence of a New Fixed-Dose Combination of Ivabradine and Metoprolol in a Wide Range of Stable Angina Patients in Real-Life Practice |
| Q37250491 | Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice |
| Q58706247 | Effectiveness and safety of Chinese herbal medicine formula Gualou Xiebai Banxia (GLXBBX) decoction for the treatment of stable angina pectoris: Protocol for a systematic review |
| Q49930063 | Effectiveness and safety of anti-ischemic trimetazidine in patients with stable angina pectoris and Type 2 diabetes |
| Q30314307 | Effectiveness of Ivabradine Treatment in Different Subpopulations with Stable Angina in Clinical Practice: A Pooled Analysis of Observational Studies |
| Q26750710 | Effectiveness of Ivabradine in Treating Stable Angina Pectoris |
| Q64971498 | Effectiveness of Long-acting Trimetazidine in Different Clinical Situations in Patients with Stable Angina Pectoris: Findings from ODA Trial. |
| Q95278817 | Effectiveness of Trimetazidine in Patients with Stable Angina Pectoris of Various Durations: Results from ODA |
| Q93641722 | Effectiveness of diltiazem for chronic stable angina pectoris |
| Q66982375 | Effectiveness of isosorbide dinitrate and pentaerythritol tetranitrate by means of acute determination of the coronary reserve on cycloergometer in patients with stable angina pectoris |
| Q66982376 | Effectiveness of oral isosorbide dinitrate and pentaerythritol tetranitrate in the light of long-term determinations of coronary reserve on cycloergometer in patients with stable angina pectoris |
| Q85644002 | Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c |
| Q44123100 | Effects of 8:00 A.M. and 2:00 P.M. Doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris |
| Q70329775 | Effects of Bepridil on exercise tolerance in chronic stable angina: A double-blind, randomized, placebo-controlled, crossover trial |
| Q104106403 | Effects of Danlou tablet for the treatment of stable angina pectoris: A study protocol of a randomized, double-blind, and placebo-controlled clinical trial |
| Q91805713 | Effects of Exercise Training With and Without Ranolazine on Peak Oxygen Consumption, Daily Physical Activity, and Quality of Life in Patients With Chronic Stable Angina Pectoris |
| Q69918059 | Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study |
| Q70679748 | Effects of L-carnitine on exercise tolerance in patients with stable angina pectoris |
| Q63321714 | Effects of Low Frequency Magnetic Field on Exercise Induced Angina |
| Q91843118 | Effects of Metformin Therapy on Coronary Endothelial Dysfunction in Patients With Prediabetes With Stable Angina and Nonobstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study |
| Q50532705 | Effects of Nifedipine and Diltiazem on Myocardial Ischemia in Patients with Severe Stable Angina Pectoris Treated with Nitrates and β-Blockers |
| Q54399171 | Effects of a new second generation calcium channel blocker, nilvadipine (FR34235), on exercise-induced hemodynamic changes in stable angina pectoris. |
| Q69895549 | Effects of a new vasodilating beta-blocking drug, carvedilol, on left ventricular function in stable angina pectoris |
| Q33332841 | Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris |
| Q68300036 | Effects of a single oral administration of Epanolol on exercise tolerance in patients with stable effort angina pectoris |
| Q71523380 | Effects of acebutolol on chronic stable angina pectoris. A placebo-controlled, double-blind, randomized crossover study |
| Q67269238 | Effects of acupuncture in moderate, stable angina pectoris: a controlled study |
| Q73114377 | Effects of acute alcohol ingestion on heart rate variability in patients with documented coronary artery disease and stable angina pectoris |
| Q84489704 | Effects of additional treatment of sarpogrelate to aspirin therapy on platelet aggregation and plasma plasminogen activator inhibitor activity in patients with stable effort angina |
| Q44405854 | Effects of altiazem PP and dilren on clinical symptoms, hemodynamic parameters and their chronologic structure in patients with stable angina |
| Q74287255 | Effects of amlodipine and isosorbide dinitrate on exercise-induced and ambulatory ischemia in patients with chronic stable angina pectoris |
| Q46501483 | Effects of amlodipine and lacidipine on heart rate variability in hypertensive patients with stable angina pectoris and isolated left ventricular diastolic dysfunction |
| Q72255398 | Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina |
| Q42556098 | Effects of angiotensin-converting enzyme inhibitor alacepril in patients with stable effort angina during chronic isosorbide dinitrate treatment |
| Q57633113 | Effects of atenolol, slow-release nifedipine, and their combination on respiratory gas exchange and exercise tolerance in stable effort angina |
| Q43466023 | Effects of atrial pacing and dipyridamole administration on coronary hemodynamics of collateralized myocardial regions in stable angina pectoris |
| Q43525617 | Effects of benazepril, a new ACE inhibitor, in effort angina pectoris |
| Q51595030 | Effects of bepridil on silent myocardial ischemia and eicosanoid metabolism in chronic stable angina pectoris after healing of myocardial infarction. |
| Q69895547 | Effects of beta blockade on systolic and diastolic left ventricular function at rest and during exercise in patients with chronic stable angina pectoris |
| Q44544017 | Effects of beta-adrenergic blockade (propranolol) on left ventricular hemodynamics and the electrocardiogram during exercise-induced angina pectoris |
| Q71598992 | Effects of beta-adrenergic blockade with pindolol versus placebo in coronary patients with stable angina pectoris |
| Q28188389 | Effects of clinical indices and anti-angina therapy on the quality of life in patients with stable angina pectoris |
| Q69957939 | Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris |
| Q41739090 | Effects of coronary artery bypass grafting on resting and exercise hemodynamics in patients with stable angina pectoris: A prospective, randomized study |
| Q68115834 | Effects of defibrotide on fibrinolytic activity in diabetic patients with stable angina pectoris |
| Q54104555 | Effects of diltiazem alone or with isosorbide dinitrate or with atenolol both acutely and chronically for stable angina pectoris. |
| Q28341169 | Effects of diltiazem and isosorbide-5-mononitrate, alone and in combination, on patients with stable angina pectoris |
| Q54338109 | Effects of diltiazem and long-term beta 1-adrenergic blockade on hemodynamics and blood flow during exercise in patients with stable angina pectoris. |
| Q70781788 | Effects of diltiazem-induced calcium blockade upon exercise capacity in effort angina due to chronic coronary artery disease |
| Q71102875 | Effects of diuretic therapy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina |
| Q60302415 | Effects of doxazosin on exercise-induced angina pectoris, ST-segment depression, and insulin sensitivity in patients with syndrome X |
| Q34623705 | Effects of enalapril in normotensive patients with stable effort angina: a double blind, placebo controlled study. |
| Q53316581 | Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. |
| Q72382288 | Effects of felodipine versus nifedipine on exercise tolerance in stable angina pectoris |
| Q45919800 | Effects of gastric medicines on gastroduodenal injury in patients with stable angina during antiplatelet therapy. |
| Q51555079 | Effects of glibenclamide, a K(ATP) channel blocker, on warm-up phenomenon in type II diabetic patients with chronic stable angina pectoris. |
| Q60302458 | Effects of glutamate on exercise tolerance and circulating substrate levels in stable angina pectoris |
| Q41861476 | Effects of iloprost (ZK 36374), a prostacyclin derivative, on platelet function after ischaemic exercise in patients with stable angina pectoris |
| Q44047249 | Effects of iloprost, a stable prostacyclin analog, on exercise capacity and platelet aggregation in stable angina pectoris |
| Q78046201 | Effects of infusion of L-arginine on exercise-induced myocardial ischemic ST-segment changes and capacity to exercise of patients with stable angina pectoris |
| Q73294339 | Effects of inhibition of nitric oxide synthesis in patients with coronary artery disease and stable angina |
| Q43739684 | Effects of inhibitors of the angiotensin-converting enzyme on endothelial dysfunction in patients with stable angina pectoris |
| Q72759897 | Effects of intracoronary felodipine versus nifedipine on left ventricular contractility and coronary sinus blood flow in stable angina pectoris |
| Q72185969 | Effects of intracoronary infusion of atrial natriuretic peptide on pacing-induced myocardial ischemia in patients with effort angina pectoris |
| Q68572788 | Effects of intravenous verapamil on left ventricular relaxation and filling in stable angina pectoris |
| Q72436980 | Effects of isosorbide dinitrate and nicardipine hydrochloride on postprandial blood pressure in elderly patients with stable angina pectoris or healed myocardial infarction |
| Q46829870 | Effects of isosorbide-5-mononitrate on clinical condition, bicycle ergometry results, endothelium-dependent vasodilation in patients with ischemic heart disease with stable effort angina |
| Q48582432 | Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study |
| Q72715825 | Effects of ketanserin on epicardial coronary arteries after coronary angioplasty in patients with stable angina |
| Q33191313 | Effects of laser therapy in patients with functional class II-IV effort angina (using instrumental techniques of the study) |
| Q43771941 | Effects of long-acting calcium antagonists--amlodipine and diltiazem in patients with stable angina of effort: comparative randomized controlled trial |
| Q70489409 | Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina |
| Q79217106 | Effects of long-term oral dipyridamole treatment on coronary microcirculatory function in patients with chronic stable angina: A substudy of the persantine in stable angina (PISA) study |
| Q54098971 | Effects of long-term treatment with calcium antagonists on left ventricular diastolic function in stable angina and heart failure. |
| Q52001745 | Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls. |
| Q71209373 | Effects of metoprolol on effort angina during the postprandial state |
| Q53633096 | Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS) |
| Q36761603 | Effects of myocardial revascularisation in patients with effort angina and those with effort and nocturnal angina |
| Q54377401 | Effects of nicardipine on chronic stable effort angina: a non-invasive assessment. |
| Q70019015 | Effects of nicorandil on exercise tolerance in patients with stable effort angina: a double-blind study |
| Q52876526 | Effects of nicorandil on left ventricular hemodynamics and volume at rest and during exercise-induced angina pectoris. |
| Q70027439 | Effects of nicorandil on rest and effort angina unresponsive to combination therapy with a calcium antagonist and oral nitrate |
| Q41404419 | Effects of nifedipine in the treatment of effort stable angina: a double blind study (author's transl) |
| Q44458368 | Effects of nifedipine on myocardial perfusion during exercise in chronic stable angina pectoris |
| Q70201364 | Effects of nifedipine, acebutolol, and their association on exercise tolerance in patients with effort angina |
| Q69914100 | Effects of nipradilol, a new beta-blocking agent with vasodilating properties, on exercise tolerance in patients with stable effort angina: a double-blind study |
| Q54355730 | Effects of nisoldipine on systemic and leg blood flow, oxygen transport and metabolism, and hemodynamics during exercise in effort angina pectoris. |
| Q73186981 | Effects of oral L-arginine supplementation on exercise-induced QT dispersion and exercise tolerance in stable angina pectoris |
| Q84283252 | Effects of pantoprazole on dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention |
| Q36229924 | Effects of percutaneous coronary intervention on depressive symptoms in chronic stable angina patients |
| Q79756762 | Effects of perhexiline and nitroglycerin on vascular, neutrophil and platelet function in patients with stable angina pectoris |
| Q84357556 | Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized tri |
| Q71656149 | Effects of short-term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia |
| Q53719086 | Effects of single doses of alprenolol and two cardioselective beta-blockers (H 87-07 and H 93-26) on exercise-induced angina pectoris. |
| Q42286144 | Effects of sublingual nitroglycerin on the gas exchange response to exercise in stable angina pectoris |
| Q46548435 | Effects of supplementing qi and activating blood circulation method on platelet aggregation rate, adhesion rate and thromboxane B2 level in patients with stable angina pectoris and intolerable to aspirin |
| Q71003306 | Effects of the administration of acebutolol in patients with chronic angina of effort |
| Q40888750 | Effects of the association of Ca-antagonists with nitroderivatives or betablocking drugs in effort angina pectoris (author's transl) |
| Q67586245 | Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectoris |
| Q70351892 | Effects of the combination nifedipine-acebutolol in patients with stable angina pectoris. Comparative double-blind study with the same drugs used separately |
| Q71697570 | Effects of the new calcium antagonist efonidipine hydrochloride on resting and exercise hemodynamics in patients with stable effort angina |
| Q54135828 | Effects of the new calcium antagonist mibefradil (Ro 40-5967) on exercise duration in patients with chronic stable angina pectoris: a multicenter, placebo-controlled study. Ro 40-5967 International Study Group. |
| Q70023674 | Effects of the platelet inhibitor ticlopidine on exercise tolerance in stable angina pectoris |
| Q42637459 | Effects of the repeated administration of adenosine and heparin on myocardial perfusion in patients with chronic stable angina pectoris |
| Q44911637 | Effects of theophylline, atenolol and their combination on myocardial ischemia in stable angina pectoris |
| Q69927127 | Effects of ticlopidine of platelet function in men with stable angina pectoris |
| Q72301272 | Effects of transdermal nitroglycerin in combination with an ACE inhibitor in patients with chronic stable angina pectoris |
| Q41998423 | Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris |
| Q68745216 | Effects of verapamil on the anaerobic threshold and peak oxygen consumption in effort angina pectoris |
| Q35584813 | Effects of vitamin C on intracoronary L-arginine dependent coronary vasodilatation in patients with stable angina |
| Q73370460 | Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris. Zatebradine Investigators |
| Q54019502 | Efficacy and Safety of Bepridil in Chronic Stable Angina Pectoris Refractory to Nifedipine. |
| Q45974836 | Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial. |
| Q35763860 | Efficacy and Safety of Dorocontin(®) versus Sustac(®) in the Treatment of Stable Angina Pectoris: A Randomized, Double-Blind Comparative Trial |
| Q77649311 | Efficacy and Safety of Evening Administration of Controlled-Delivery Diltiazem Capsules in Chronic Stable Angina Patients |
| Q87076231 | Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris |
| Q67890905 | Efficacy and duration of the effect of gallopamil sustained release in patients with chronic stable effort angina |
| Q92367606 | Efficacy and safety of Xinnaoning capsule in treating chronic stable angina (qi stagnation and blood stasis syndrome): Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial |
| Q33151781 | Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials |
| Q46450477 | Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris |
| Q67539219 | Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina |
| Q79359976 | Efficacy and safety of controlled-release isosorbide-5-mononitrate in Japanese patients with stable effort angina pectoris |
| Q28200088 | Efficacy and safety of coronary stenting during diagnostic coronary angiography in patients with stable angina |
| Q72646535 | Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris |
| Q46802477 | Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial |
| Q42247556 | Efficacy and safety of incremental doses of diltiazem for the treatment of stable angina pectoris |
| Q45241783 | Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris |
| Q42207703 | Efficacy and safety of nicardipine for chronic, stable angina pectoris: a multicenter randomized trial |
| Q83213916 | Efficacy and safety of once- and twice-daily formulations of molsidomine in patients with stable angina pectoris: double-blind and open-label studies |
| Q91910003 | Efficacy and safety of oral Guanxinshutong capsules in patients with stable angina pectoris in China: a prospective, multicenter, double-blind, placebo-controlled, randomized clinical trial |
| Q34383219 | Efficacy and safety of ranolazine in patients with chronic stable angina |
| Q49941384 | Efficacy and safety of smiltiorrhizadepsidesal combined with conventional western medicine treatment for stable angina pectoris |
| Q46438918 | Efficacy and safety of sustained-release diltiazem as replacement therapy for beta blockers and diuretics for stable angina pectoris and coexisting essential hypertension: a multicenter trial |
| Q68857995 | Efficacy and safety of sustained-release diltiazem in stable angina pectoris |
| Q72281566 | Efficacy and safety of the 200-300 mg sustained release formulation of diltiazem administered once daily in patients with stable angina |
| Q35091375 | Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials |
| Q44584892 | Efficacy and tolerability of trimetazidine in the treatment of stable effort angina (TRIUMPH Study in Russia) |
| Q45829479 | Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis |
| Q37495353 | Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris |
| Q57312494 | Efficacy of Ivabradine in Combination with Beta-Blocker Versus Uptitration of Beta-Blocker in Patients with Stable Angina |
| Q51744045 | Efficacy of Ivabradine in Combination with Beta-Blockers Versus Uptitration of Beta-Blockers in Patients with Stable Angina (CONTROL-2 Study). |
| Q78602594 | Efficacy of Terminalia arjuna in chronic stable angina |
| Q44042792 | Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate. |
| Q70380124 | Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris |
| Q67232183 | Efficacy of a new transdermal nitroglycerin system in the treatment of stable angina pectoris |
| Q44260013 | Efficacy of a single dose of slow-release isosorbide dinitrate in the treatment of silent or painful myocardial ischemia in stable angina pectoris |
| Q71624700 | Efficacy of acebutolol in chronic stable angina using single-blind and randomized double-blind protocol |
| Q69953994 | Efficacy of atenolol in the short and long-term treatment of patients with effort stable angina |
| Q50101459 | Efficacy of cardiac shock wave therapy in patients with stable angina: The design of randomized, triple blind, sham-procedure controlled study. |
| Q28333483 | Efficacy of continuous and intermittent transdermal treatment with nitroglycerin in effort angina pectoris: a multicentric study. The Collaborative Nitro Group |
| Q44109724 | Efficacy of controlled-release isosorbide-5-mononitrate as adjunctive treatment to beta-blocking agents in patients with stable angina pectoris |
| Q58136324 | Efficacy of conventional and sustained-release verapamil in stable angina pectoris |
| Q69869871 | Efficacy of diltiazem for medically refractory stable angina: long-term follow-up |
| Q70217228 | Efficacy of diltiazem in angina on effort: a multicenter trial |
| Q68922645 | Efficacy of incremental doses of tiapamil on exercise performance in patients with chronic stable angina pectoris |
| Q72416931 | Efficacy of intermittent (eight hours off) transdermal nitrate therapy in stable angina |
| Q44996920 | Efficacy of ivabradine in patients with stable angina and comorbid chronic obstructive pulmonary disease |
| Q28276346 | Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina |
| Q43183736 | Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus |
| Q35052175 | Efficacy of monotherapy compared with combined antianginal drugs in the treatment of chronic stable angina pectoris: a meta-analysis |
| Q67804525 | Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study |
| Q45503587 | Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up |
| Q68386938 | Efficacy of pentoxifylline in patients with stable angina pectoris |
| Q68932614 | Efficacy of sustained-release verapamil in chronic stable angina pectoris |
| Q37112685 | Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial |
| Q37687311 | Efficacy of the long-acting nitro vasodilator pentaerithrityl tetranitrate in patients with chronic stable angina pectoris receiving anti-anginal background therapy with beta-blockers: a 12-week, randomized, double-blind, placebo-controlled trial |
| Q41310243 | Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris |
| Q44257650 | Efficacy of trimetazidine in stable angina pectoris refractory to traditional treatment |
| Q70313932 | Efficacy, duration and mechanism of action of nifedipine in stable exercise-induced angina pectoris |
| Q46453732 | Effort angina in a middle-aged woman with abnormally high levels of serum high-density lipoprotein cholesterol: a case of cholesteryl-ester transfer protein deficiency |
| Q41980955 | Effort angina in a patient with advanced coronary artery disease. Role played by coronary angiography, Ivus and cardiac CT: case report |
| Q40914094 | Effort angina pectoris syndrome and complete auriculo-ventricular block revealing an extra-articular form of Bouillaud's disease |
| Q69591883 | Effort angina pectoris without electrocardiographic changes in coronary disease patients: correlations between scintigraphic and coronary angiographic findings |
| Q69875863 | Effort angina with adequate beta-receptor blockade: comparison with diltiazem alone and in combination |
| Q41916161 | Effort angina with an anomalous origin of the left circumflex coronary artery |
| Q87766563 | Effort angina with coronary-pulmonary and bronchial-pulmonary artery fistulae |
| Q69903203 | Effort angina without coronary obstruction in a patient with Takayasu's aortitis: a case report |
| Q80074003 | Effort angina, normal coronary angiogram, and dynamic left ventricular obstruction |
| Q72001507 | Eicosanoid biosynthesis in patients with stable angina: beneficial effects of very low dose aspirin |
| Q41352274 | Electrocardiogram in the "typical angina of effort with normal arteriography" syndrome |
| Q92756765 | Elevated Plasma Adiponectin Levels Are Associated with Abnormal Corrected QT Interval in Patients with Stable Angina |
| Q46497691 | Elevated coronary calcium scores are associated with higher residual platelet aggregation after clopidogrel treatment in patients with stable angina pectoris |
| Q43999341 | Elevated homocysteine levels might be associated with coronary artery remodeling in patients with stable angina: an intravascular ultrasound study. |
| Q43283819 | Elevated levels of neopterin are associated with carotid plaques with complex morphology in patients with stable angina pectoris |
| Q74530447 | Elevated plasma lipoprotein(a) is associated with coronary artery disease in patients with chronic stable angina pectoris |
| Q83383948 | Elevated platelet density and enhanced platelet reactivity in stable angina pectoris complicated by diabetes mellitus type II |
| Q46809934 | Elevated platelet reactivity in stable angina pectoris without significant coronary flow obstruction. |
| Q35963358 | Elevated serum adipocyte fatty acid-binding protein concentrations are independently associated with renal dysfunction in patients with stable angina pectoris |
| Q61684227 | Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction |
| Q40449493 | Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. |
| Q51065264 | Endocan Levels and Coronary Collateral Circulation in Stable Angina Pectoris: A Pilot Study. |
| Q49042138 | Endocan: a novel biomarker associated with well-developed coronary collateral circulation in patients with stable angina and chronic total occlusion |
| Q48127018 | Endothelial damage effects of circulating microparticles from patients with stable angina are reduced by aspirin through ERK/p38 MAPKs pathways. |
| Q46639261 | Endothelial progenitor cells and long-term prognosis in patients with stable angina treated with percutaneous coronary intervention |
| Q87019685 | Endothelial progenitor cells and long-term prognosis in patients with stable angina treated with percutaneous coronary intervention--reply |
| Q43640922 | Endothelial progenitor cells predict long-term prognosis in patients with stable angina treated with percutaneous coronary intervention: five-year follow-up of the PROCREATION study |
| Q72158195 | Endothelin release and enhanced regional myocardial ischemia induced by cold-air inhalation in patients with stable angina |
| Q73200695 | Endothelin-1 release from atherosclerotic plaque after percutaneous transluminal coronary angioplasty in stable angina pectoris and single-vessel coronary artery disease |
| Q43703668 | Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance |
| Q41236384 | Enhanced Platelet Toll-like Receptor 2 and 4 Expression in Acute Coronary Syndrome and Stable Angina Pectoris. |
| Q68024992 | Enhanced effectiveness of combined sustained-release forms of isosorbide dinitrate and diltiazem for stable angina pectoris |
| Q52657888 | Enhanced expression of hemoglobin scavenger receptor CD163 in accumulated macrophages within filtered debris between acute coronary syndromes and stable angina pectoris. |
| Q37466799 | Enhanced external counterpulsation for the treatment of stable angina and heart failure: a systematic review and economic analysis. |
| Q43693913 | Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; evaluation by(13)N-ammonia positron emission tomography |
| Q51138560 | Enhanced inflammatory response following coronary stent implantation in stable angina patients. |
| Q71307899 | Enhanced platelet aggregability under high shear stress after treadmill exercise in patients with effort angina |
| Q68926246 | Enhanced platelet sensitivity to prostacyclin after isosorbide-5-mononitrate in patients with stable angina pectoris |
| Q52881035 | Enhanced vasomotor responses of complex coronary stenoses to acetylcholine in stable angina pectoris. |
| Q67740542 | Enhancement of the efficacy of isosorbide dinitrate by captopril in stable angina pectoris |
| Q71627336 | Enoximone in chronic stable angina: a double-blind placebo-controlled cross-over trial |
| Q69925862 | Ergometric evaluation of the effects of captopril in hypertensive patients with stable angina |
| Q69825820 | Ergometric evaluation of the effects of enalapril maleate in normotensive patients with stable angina |
| Q67001924 | Ergometric evaluation of the long-term treatment with nifedipine and a nitro derivative in subjects with angina of effort |
| Q40997045 | Ergometric evaluation of the therapeutic effect of prolonged oral administration of delayed-action verapamil on 20 patients with stable effort angina |
| Q40997038 | Ergometric evaluation of the therapeutic effect on exercise tolerance of the prolonged oral administration of nifedipine in stable effort angina |
| Q42350494 | Erratum: Two-year clinical outcomes in stable angina and acute coronary syndrome after percutaneous coronary intervention of left main coronary artery disease |
| Q39541640 | Establishing the cost-effectiveness of percutaneous coronary intervention for chronic total occlusion in stable angina: a decision-analytic model |
| Q33224199 | Estimating utility data from clinical indicators for patients with stable angina |
| Q42033366 | Estimation of myocardial oxygen extraction dynamics in effort angina by continuous measurement of coronary venous saturation |
| Q46138923 | Evaluated plasma interleukin-18/interleukin-10 ratio is a risk factor for acute coronary syndromes in patients with stable angina pectoris |
| Q101374359 | Evaluation and Management of Patients With Stable Angina: Beyond the Ischemia Paradigm: JACC State-of-the-Art Review |
| Q69924805 | Evaluation of a new antianginal agent, nipradilol, in effort angina using holter monitoring |
| Q68895295 | Evaluation of a step care approach in medical management of stable angina |
| Q54130201 | Evaluation of a sustained-release buccal nitroglycerin preparation in stable angina pectoris. |
| Q44587070 | Evaluation of antianginal effects of running pulse magnetic field and drug therapy on the physical working capacity and hemodynamics in patients with stable angina pectoris |
| Q70461273 | Evaluation of bepridil, a new antianginal agent: clinical and hemodynamic alterations during the treatment of stable angina pectoris |
| Q80902443 | Evaluation of coronary artery remodeling in patients with acute coronary syndrome and stable angina by multislice computed tomography |
| Q92466120 | Evaluation of fractional flow reserve in patients with stable angina: can CT compete with angiography? |
| Q35945159 | Evaluation of leptin and adiponectin levels in patients with stable angina pectoris. |
| Q41270485 | Evaluation of local carotid stiffness and inflammatory biomarkers in stable angina pectoris |
| Q43520084 | Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris |
| Q28222418 | Evaluation of platelet and leukocyte functions in effort angina patients using high shear conditions in small-sized collagen bead columns |
| Q35828274 | Evaluation of primary care patients with chronic stable angina: guidelines from the American College of Physicians |
| Q30824583 | Evaluation of quantum therapy for the treatment of stable angina |
| Q45038648 | Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina). |
| Q67801983 | Evaluation of the Antianginal Effect of Isosorbide-5-Mononitrate in Patients with Chronic Stable Angina Pectoris |
| Q55044154 | Evaluation of the Antianginal and Anti-Ischemic Efficacy of Slow-Release Isosorbide-5-Mononitrate Capsules, Bupranolol and Their Combination, in Patients with Chronic Stable Angina Pectoris |
| Q40459132 | Evaluation of the effectiveness of nifedipine in a group of patients with stable angina of effort |
| Q70300891 | Evaluation of the effects of a new calcium antagonist, diltiazem, in patients with stable effort angina and a therapeutic comparison with nifedipine |
| Q70292939 | Evaluation of the effects of gallopamil in patients with effort angina by transesophageal atrial pacing two-dimensional echocardiography |
| Q37741936 | Evaluation of the patient with stable angina following coronary artery bypass surgery. |
| Q33728667 | Evaluation of the systemic micro- and macrovasculature in stable angina: A case-control study |
| Q61684218 | Evaluation of various electrocardiographic criteria for left ventricular hypertrophy in patients with stable angina pectoris: influence of using modified limb electrodes |
| Q42252501 | Evaluation of verapamil and high dose nifedipine in patients with chronic stable angina with objective methods |
| Q46450820 | Evaluation on tolerability and safety of long-term administration with shexiang baoxin pill in patients with coronary heart disease of stable angina pectoris |
| Q72711416 | Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina |
| Q71596557 | Evidence of compensatory preload adjustment on early filling phase in patients with stable angina pectoris and good left ventricular systolic function |
| Q82676107 | Evidence of improved regional myocardial function in patients with chronic stable angina and apparent normal ventricular function--a tissue Doppler study before and after percutaneous coronary intervention |
| Q73662356 | Evidence-based guideline for the primary care management of stable angina |
| Q98207422 | Evolution of symptoms in patients with stable angina after normal regadenoson myocardial perfusion imaging: The Radionuclide Imaging and Symptomatic Evolution study (RISE) |
| Q50956677 | Exaggerated luminal loss a few minutes after successful percutaneous transluminal coronary angioplasty in patients with recent myocardial infarction compared with stable angina: an intracoronary ultrasound study. |
| Q33217666 | Excimer laser coronary angioplasty: experience with a prototype multifibre catheter in patients with stable angina pectoris |
| Q96121223 | Exercise Electrocardiography and Computed Tomography Coronary Angiography for Patients With Suspected Stable Angina Pectoris: A Post Hoc Analysis of the Randomized SCOT-HEART Trial |
| Q69305748 | Exercise capacity after single and twice-daily doses of nicorandil in chronic stable angina pectoris |
| Q68687331 | Exercise capacity and muscle fibre types in effort angina |
| Q70506416 | Exercise capacity with transdermal nitroglycerin in patients with stable angina pectoris |
| Q70877544 | Exercise echocardiography: interventricular septal thickness and motion in patients with effort angina during ergometer exercise (author's transl) |
| Q101210643 | Exercise electrocardiography and computed tomography coronary angiography: use of combined functional and anatomical testing in stable angina pectoris |
| Q71744546 | Exercise parameters for the prediction of post-training increase in exercise tolerance in patient with stable angina pectoris |
| Q37077445 | Exercise performance, physical activity, and health-related quality of life in participants with stable angina |
| Q44107860 | Exercise test predictors of ambulatory silent ischemia during daily life in stable angina pectoris |
| Q73777457 | Exercise testing, still the method of choice when evaluating patients with chronic stable angina pectoris |
| Q57914770 | Exercise-based cardiac rehabilitation for patients with stable angina |
| Q64922656 | Exercise-based cardiac rehabilitation for stable angina: systematic review and meta-analysis. |
| Q71072235 | Exercise-induced ST segment elevation in a patient with effort angina pectoris and normal coronary arteries |
| Q83063998 | Exercise-induced T wave normalization in a patient with stable angina pectoris |
| Q73547032 | Exercise-induced U-wave alterations as a marker of well-developed and well-functioning collateral vessels in patients with effort angina |
| Q68670031 | Exercise-induced angina alleviated by intracoronary SIN-1 |
| Q54795133 | Exercise-induced angina in the cold. |
| Q70781929 | Exercise-induced angina provoked by aspirin administration in patients with variant angina |
| Q71718417 | Exercise-induced angina with intermittent ST-segment elevation |
| Q79595443 | Experience with the anoxemia test in patients with typical angina of effort and in pathents with atypical pain which may be due to coronary insufficiency |
| Q35697397 | Expression characteristics of neutrophil and mononuclear-phagocyte related genes mRNA in the stable angina pectoris and acute myocardial infarction stages of coronary artery disease |
| Q84129507 | Expression levels of Toll-like receptor genes in coronary atherosclerotic lesions of patients with acute coronary syndrome or stable angina pectoris |
| Q92623615 | Expression profiles and potential functions of long non-coding RNA in stable angina pectoris patients from Uyghur population of China |
| Q35193935 | Extended-release ranolazine: critical evaluation of its use in stable angina |
| Q80969165 | Extent of myocardial ischemia during coronary occlusion in single vessel disease. A comparison between patients with exercise-induced angina and patients with recurrent angina at rest |
| Q74586082 | External counterpulsation for treatment of chronic stable angina pectoris |
| Q77178495 | External counterpulsation for treatment of chronic stable angina pectoris |
| Q73881996 | External counterpulsation for treatment of chronic stable angina pectoris |
| Q82609739 | External counterpulsation for treatment of chronic stable angina pectoris and chronic heart failure |
| Q67548600 | External counterpulsation: coronary hemodynamics and use in treatment of patients with stable angina pectoris |
| Q83463030 | Factors associated with the presence of circulating active tissue factor and activated factor XI in stable angina patients |
| Q42639759 | Factors influencing efficacy of nitrate therapy for stable angina pectoris: a multiple linear regression analysis |
| Q71838931 | Factors influencing the treatment of chronic stable angina pectoris with nifedipine |
| Q70790526 | Failure of thromboxane synthetase inhibition to improve exercise tolerance in patients with stable angina pectoris |
| Q70509245 | Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, double crossover trial |
| Q73132881 | Fate of collateral vessels after successful coronary angioplasty in patients with effort angina |
| Q35771209 | Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS). |
| Q73349022 | Felodipine and amlodipine in stable angina pectoris: results of a randomized double-blind crossover trial |
| Q68669658 | Felodipine in chronic stable angina: a randomized, double-blind, placebo-controlled, crossover study |
| Q74423470 | Fibrinolysis/proteolysis balance in stable angina pectoris in relation to angiographic findings |
| Q57651184 | Fibrinolytic Variables and Cardiovascular Prognosisin Patients With Stable Angina Pectoris Treated With Verapamil or Metoprolol |
| Q61684256 | Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm |
| Q81784531 | Finding the courage to reconsider medical therapy for stable angina |
| Q41279354 | First effort angina; second wind in angina pectoris |
| Q45337316 | Five-year effect of medical and surgical therapy on resting left ventricular function in stable angina: Veterans administration cooperative study |
| Q50108897 | Five-year mortality for stable angina in a medical practice study and a randomized trial |
| Q41997862 | Formulation and evaluation of buccal film of Ivabradine hydrochloride for the treatment of stable angina pectoris |
| Q68104864 | Four-year prognostic value of exercise-induced angina and painless ST segment depression early after myocardial infarction |
| Q42009806 | Fractional flow reserve measurements to identify justified targets for PCI in patients with stable angina: FAME 2 and beyond |
| Q47869355 | Frequency and angiographic characteristics of coronary microvascular dysfunction in stable angina: a hybrid imaging study |
| Q46883344 | Frequency and efficacy of repeat enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry). |
| Q81811390 | Frequency and predictor of coronary thin-cap fibroatheroma in patients with acute myocardial infarction and stable angina pectoris a 3-vessel optical coherence tomography study |
| Q44354035 | Frequency of ST-segment depression produced by mental stress in stable angina pectoris from coronary artery disease |
| Q50939007 | Functional result following direct coronary artery stenting with drug eluting stents in chronic stable angina is similar to stenting after balloon predilatation. |
| Q93131197 | Functional status and life satisfaction of patients with stable angina pectoris in Austria |
| Q67593155 | Gallopamil in chronic stable angina: antianginal effect and mechanism of action. A randomized, placebo-controlled, double-blind, cross-over trial |
| Q81100571 | Gender and stable angina pectoris: women have greater thrombin-evoked platelet activity but similar adenosine diphosphate-induced platelet responses |
| Q43117189 | Gender differences in cardiac remodeling and clinical outcomes in chronic stable angina pectoris (from the ACTION Trial). |
| Q51594763 | Gender differences in coronary plaque characteristics in patients with stable angina: a virtual histology intravascular ultrasound study. |
| Q35026901 | Gender differences in pain characteristics of chronic stable angina and perceived physical limitation in patients with coronary artery disease |
| Q43450860 | Gender differences in patients with stable angina attending primary care practices. |
| Q33799107 | Gender differences of plaque characteristics in elderly patients with stable angina pectoris: an intravascular ultrasonic radiofrequency data analysis |
| Q44244598 | Gene expression profiling reveals multiple differences in platelets from patients with stable angina or non-ST elevation acute coronary syndrome |
| Q33147209 | Giant hiatal hernia presenting with stable angina pectoris and syncope--a case report |
| Q83316201 | Glucose intolerance, insulin resistance and metabolic syndrome in patients with stable angina pectoris. Obesity predicts coronary atherosclerosis and dysglycemia |
| Q86195603 | Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial |
| Q53578997 | Glycated hemoglobin and long-term prognosis in patients with suspected stable angina pectoris without diabetes mellitus: a prospective cohort study. |
| Q33804317 | Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina |
| Q57808985 | Guanxinjing capsule in the treatment of chronic stable angina: study protocol for a randomized controlled trial |
| Q74785638 | Guidelines for the management of patients with chronic stable angina |
| Q50683752 | Guidelines for the management of patients with chronic stable angina: diagnosis and risk stratification. |
| Q28190241 | Guidelines for the management of patients with chronic stable angina: treatment |
| Q81497098 | Guidelines for the treatment of chronic stable angina |
| Q43188533 | Guidelines on managing stable angina omit important point |
| Q79209068 | Guidelines on the management of stable angina pectoris |
| Q34573219 | Guidelines on the management of stable angina pectoris. Executive summary |
| Q33996248 | Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology |
| Q79294225 | Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology |
| Q43451841 | Guidelines on the management of stable angina pectoris; the experts of the European Society of Cardiology on the management of stable angina pectoris |
| Q71705852 | Haemodynamic and clinical effects of isosorbide-dinitrate in patients with severe effort angina on beta-blocking treatment |
| Q34207212 | Haemodynamic and metabolic agents in the treatment of stable angina: publication review |
| Q70381328 | Haemodynamic effects of combined oral nifedipine and sublingual nitroglycerin in patients with chronic stable angina |
| Q70759539 | Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris |
| Q84725574 | Head-to-head comparison of the cardio-ankle vascular index between patients with acute coronary syndrome and stable angina pectoris |
| Q91965927 | Healed Plaques in Patients With Stable Angina Pectoris |
| Q57914883 | Heart Rate Dynamics in Patients With Stable Angina Pectoris and Utility of Fractal and Complexity Measures |
| Q70880353 | Heart rate reduction in the treatment of chronic stable angina pectoris: experiences with a sinus node inhibitor |
| Q74601673 | Heart rate variability and ischaemia in patients with coronary heart disease and stable angina pectoris; influence of drug therapy and prognostic value. TIBBS Investigators Group. Total Ischemic Burden Bisoprolol Study |
| Q72074804 | Hemodynamic Mechanisms of the Antianginal Action of a Novel Vasodilator FK409 in Dynamic Exercise-Induced Angina |
| Q69885239 | Hemodynamic actions of bepridil during treatment of stable angina pectoris |
| Q54454291 | Hemodynamic and coronary effects of molsidomine at basal state, during atrial pacing, and during cold pressor test in patients with stable angina pectoris. |
| Q70320027 | Hemodynamic effects of high-dose sustained-action oral isosorbide dinitrate in stable angina |
| Q54492232 | Hemodynamic effects of intravenous prostacyclin in stable angina pectoris |
| Q42255379 | Hemodynamic effects of nifedipine during upright exercise in stable angina pectoris and either normal or severely impaired left ventricular function |
| Q28335106 | Hemodynamic mechanisms of antianginal action of calcium channel blocker nisoldipine in dynamic exercise-induced angina |
| Q83172965 | Hemorheological abnormalities in stable angina and acute coronary syndromes |
| Q45961912 | Hemorheological abnormalities in stable angina and acute coronary syndromes. |
| Q68010493 | Heparin exercise treatment following percutaneous transluminal coronary angioplasty in a patient with effort angina |
| Q48246340 | High Resting Heart Rate and High BMI Predicted Severe Coronary Atherosclerosis Burden in Patients With Stable Angina Pectoris by SYNTAX Score. |
| Q69621267 | High dose dipyridamole echocardiography test in effort angina pectoris |
| Q60730185 | High frequency home-based exercise decreases levels of vascular endothelial growth factor in patients with stable angina pectoris |
| Q43420634 | High on-clopidogrel treatment platelet reactivity in Thai patients with chronic stable angina scheduled for percutaneous coronary intervention |
| Q83416946 | High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary ar |
| Q30989975 | High prevalence of intramural coronary infection in patients with drug-resistant cardiac syndrome X: comparison with chronic stable angina and normal controls. |
| Q43175056 | High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention |
| Q42856887 | High-dose allopurinol in patients with stable angina pectoris |
| Q45457919 | High-dose allopurinol in patients with stable angina pectoris |
| Q58812310 | High-dose allopurinol in patients with stable angina pectoris – Authors' reply |
| Q49699306 | High-dose allopurinol in patients with stable angina pectoris. |
| Q35883711 | High-dose single administration of isosorbide dinitrate: effect on diurnal distribution of transitory myocardial ischemia in patients with stable angina pectoris |
| Q53757334 | High-intensity aerobic interval training in a patient with stable angina pectoris. |
| Q84779602 | High-sensitivity C-reactive protein and plaque composition in patients with stable angina pectoris: a virtual histology intravascular ultrasound study |
| Q42291279 | Higher coronary artery calcification score is associated with adverse prognosis in patients with stable angina pectoris |
| Q45216964 | Highlighting the need for better patient care in stable angina: results of the international Angina Treatment Patterns (ATP) Survey in 7074 patients. |
| Q36008813 | How cardiologists present the benefits of percutaneous coronary interventions to patients with stable angina: a qualitative analysis |
| Q44542644 | Hybrid myocardial perfusion SPECT/CT coronary angiography and invasive coronary angiography in patients with stable angina pectoris lead to similar treatment decisions |
| Q82119179 | I'm 69 and have stable angina, but I sometimes worry that I might be having a heart attack that mirrors a bout of angina. How can I distinguish one event from the other? |
| Q40616510 | IL-6 and IL-1 receptor antagonist in stable angina pectoris and relation of IL-6 to clinical findings in acute myocardial infarction |
| Q41188525 | If channels: a new target for the treatment of stable angina: Munich, 31 August 2004. |
| Q41183168 | If inhibition: from pure heart rate reduction to treatment of stable angina: Stockholm, 6 September 2005. |
| Q47986589 | Immediate and long-term clinical outcome after spinal cord stimulation for refractory stable angina pectoris |
| Q37675863 | Immune Cell Repertoire and Their Mediators in Patients with Acute Myocardial Infarction or Stable Angina Pectoris |
| Q42573925 | Immune and inflammatory responses in subjects with stable angina and acute myocardial infarction |
| Q40265832 | Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study. |
| Q40736980 | Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Dr |
| Q34429549 | Impact of Framingham risk score, flow-mediated dilation, pulse wave velocity, and biomarkers for cardiovascular events in stable angina |
| Q40089872 | Impact of High-Dose Statin Pretreatment in Patients with Stable Angina during Off-Pump Coronary Artery Bypass. |
| Q51228102 | Impact of Paradoxical Decrease in High-density Lipoprotein Cholesterol Levels After Statin Therapy on Major Adverse Cardiovascular Events in Patients with Stable Angina Pectoris. |
| Q37716587 | Impact of angina frequency on health utility values of patients with chronic stable angina |
| Q43484455 | Impact of angiotensin II receptor blocker therapy (olmesartan or valsartan) on coronary atherosclerotic plaque volume measured by intravascular ultrasound in patients with stable angina pectoris |
| Q72230705 | Impact of coronary angioplasty on coronary vasodilator response of normal nondilated coronary arteries in patients with stable angina |
| Q49197793 | Impact of coronary plaque composition on cardiac troponin elevation after percutaneous coronary intervention in stable angina pectoris: a computed tomography analysis. |
| Q46776387 | Impact of enhanced external counterpulsation on Canadian Cardiovascular Society angina class in patients with chronic stable angina: a meta-analysis |
| Q88333263 | Impact of glycemic variability on the occurrence of periprocedural myocardial infarction and major adverse cardiovascular events (MACE) after coronary intervention in patients with stable angina pectoris at 6months follow-up |
| Q71774407 | Impact of intensive physical exercise and low-fat diet on collateral vessel formation in stable angina pectoris and angiographically confirmed coronary artery disease |
| Q85518024 | Impact of intensive statin use on the level of inflammation and platelet activation in stable angina after percutaneous coronary intervention: a clinical study |
| Q54117451 | Impact of paclitaxel-coated balloon versus newer-generation drug-eluting stent on periprocedural myocardial infarction in stable angina patients. |
| Q90692073 | Impact of periprocedural biomarker elevation on mortality in stable angina pectoris patients undergoing elective coronary intervention: a systematic review and meta-analysis including 24 666 patients |
| Q83246733 | Impact of platelet reactivity to adenosine diphosphate before implantation of drug-eluting stents on subsequent adverse cardiac events in patients with stable angina |
| Q36836647 | Impact of post-challenge hyperglycemia on clinical outcomes in Japanese patients with stable angina undergoing percutaneous coronary intervention |
| Q92324912 | Impact of renal dysfunction on the choice of diagnostic imaging, treatment strategy, and outcomes in patients with stable angina |
| Q37623371 | Impact of self-management interventions on stable angina symptoms and health-related quality of life: a meta-analysis |
| Q51331594 | Impact of severe lesion calcification on clinical outcome of patients with stable angina, treated with newer generation permanent polymer-coated drug-eluting stents: A patient-level pooled analysis from TWENTE and DUTCH PEERS (TWENTE II). |
| Q91194630 | Impact of stable angina on health status and quality of life perception of currently treated patients. The BRIDGE 2 survey |
| Q90590366 | Impact of statins preloading before PCI on periprocedural myocardial infarction among stable angina pectoris patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials |
| Q84472008 | Impact of the first-generation drug-eluting stent implantation on periprocedural myocardial injury in patients with stable angina pectoris |
| Q72722791 | Impact of treatment with acetylsalicylic acid on the proaggregatory effects of adrenaline in vitro in patients with stable angina pectoris: influence of the anticoagulant |
| Q44933496 | Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment: a long-term follow-up study. |
| Q71755243 | Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1 |
| Q42875813 | Implantation of the paclitaxel-eluting stent Apollo in patients with stable angina pectoris: long-term angiographic and clinical results |
| Q28660419 | Implications of C1q/TNF-related protein-3 (CTRP-3) and progranulin in patients with acute coronary syndrome and stable angina pectoris |
| Q74571786 | Importance of alpha 1-sympathetic activity for diurnal change in ischemic threshold in patients with stable angina |
| Q67969038 | Importance of coronary collateral circulation for increased treadmill exercise capacity by nitrates in patients with stable effort angina pectoris |
| Q70014247 | Importance of generalized defective perception of painful stimuli as a cause of silent myocardial ischemia in chronic stable angina pectoris |
| Q69856983 | Improved accuracy of the exercise electrocardiogram: identification of three-vessel coronary disease in stable angina pectoris by analysis of peak rate-related changes in ST segments |
| Q93587914 | Improved coronary supply: prevailing mechanism of action of nitrates in chronic stable angina |
| Q71286051 | Improved efficacy of high-dose versus medium- and low-dose diltiazem therapy for chronic stable angina pectoris |
| Q71739762 | Improved exercise performance following single daily dose of atenolol in stable angina |
| Q71461657 | Improved exercise performance in persons with stable angina pectoris receiving diltiazem |
| Q68039590 | Improved exercise tolerance by i.v. fructose-1,6-diphosphate in chronic, stable angina pectoris |
| Q68941249 | Improved left ventricular performance during exercise with verapamil or nifedipine in patients with chronic stable angina |
| Q33439135 | Improved myocardial perfusion in stable angina pectoris by oral lumbrokinase: a pilot study |
| Q69971458 | Improvement in exercise performance with nisoldipine, a new second-generation calcium blocker, in stable angina patients |
| Q67255904 | Improvement in left ventricular diastolic function in patients with stable angina after chronic treatment with verapamil and nicardipine |
| Q52594951 | Improvement in left ventricular diastolic function in patients with stable angina after chronic treatment with verapamil and nicardipine. |
| Q85160528 | Improvement in left ventricular systolic and diastolic performance during ranolazine treatment in patients with stable angina |
| Q40653544 | Improvement of angina of effort after aortocoronary bypass. Correlations with the exercise electrocardiogram and postoperative angiographic findings |
| Q77700118 | Improvement of exercise capacity by sarpogrelate as a result of augmented collateral circulation in patients with effort angina |
| Q43495227 | In patients with chronic stable angina, secondary prevention appears better in the very old compared to younger patients: the Coronary Artery Disease in gENeral practiCE (CADENCE) Substudy. |
| Q49386697 | In vitro inhibition of platelets aggregation with generic form of clopidogrel versus branded in patients with stable angina pectoris |
| Q88649359 | In vivo assessment of vasa vasorum neovascularization using intravascular ultrasound: A comparison between acute coronary syndrome and stable angina pectoris |
| Q43114471 | Inadequate control of heart rate in patients with stable angina: results from the European heart survey |
| Q36053300 | Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study |
| Q50779014 | Incidence and prognostic implications of stable angina pectoris among women and men. |
| Q69047976 | Increase in S-wave amplitude during ischemic ST-segment depression in stable angina pectoris |
| Q28168511 | Increase in troponin levels after coronary angioplasty (PTCA) in stable angina pectoris |
| Q99629201 | Increased Serum Malondialdehyde-Modified Low-Density Lipoprotein and Coronary Angiographic Progression After Drug-Eluting Stent Implantation in Patients With Stable Angina |
| Q69580049 | Increased exercise tolerance and reduced electrocardiographic ischaemia 3 and 12 hours after oral felodipine in effort angina |
| Q70367710 | Increased exercise tolerance and reduced electrocardiographic ischemia with diltiazem in patients with stable angina pectoris |
| Q33895002 | Increased levels of leukocyte-derived MMP-9 in patients with stable angina pectoris |
| Q64954264 | Increased plasma C-reactive protein level predicts rapid progression of non-target atherosclerotic lesions in patients with stable angina after stenting. |
| Q58421522 | Increased plasminogen activator inhibitor antigen levels in diabetic patients with stable angina |
| Q78162510 | Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin |
| Q74787732 | Increased release of nitric oxide in ischemic hearts after exercise in patients with effort angina |
| Q83351533 | Increased serum leptin concentrations in patients with chronic stable angina pectoris and ST-elevated myocardial infarction |
| Q87710658 | Increased serum level of CTRP1 is associated with low coronary collateralization in stable angina patients with chronic total occlusion |
| Q68798324 | Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina |
| Q40711106 | Indications for Surgical Treatment of Stable Angina Pectoris |
| Q34277439 | Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations |
| Q36645685 | Inequity of access to investigation and effect on clinical outcomes: prognostic study of coronary angiography for suspected stable angina pectoris |
| Q94074446 | Inequity of access to investigation and effect on clinical outcomes: prognostic study of coronary angiography for suspected stable angina pectoris |
| Q44431760 | Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm. |
| Q47685534 | Inflammatory profile in unstable angina versus stable angina in patients undergoing percutaneous interventions |
| Q47981043 | Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris |
| Q53237144 | Influence of coronary computed tomographic angiography on patient treatment and prognosis in patients with suspected stable angina pectoris. |
| Q28218850 | Influence of preventive therapy with quinapril on IL-6 level in patients with chronic stable angina |
| Q46489993 | Influence of race on the prediction of cardiac events with stress technetium-99m sestamibi tomographic imaging in patients with stable angina pectoris |
| Q36812977 | Influence of the autonomic nervous system on circadian patterns of myocardial ischaemia: comparison of stable angina with the early postinfarction period |
| Q70297465 | Influence of transdermal nitrates on exercise capacity in patients with stable angina |
| Q84107206 | Influence of warm‑up ischemia on the effects of exercise training in patients with stable angina |
| Q72564447 | Inhibitory effect of nitroglycerin and sodium nitroprusside on platelet activation across the coronary circulation in stable angina pectoris |
| Q83672467 | Innate immunity markers in culprit plaques of acute myocardial infarction or stable angina |
| Q38046957 | Insight to the pathophysiology of stable angina pectoris. |
| Q85777542 | Insulin like growth factor-1 and lipoprotein metabolism in stable angina patients |
| Q51562621 | Integrity(®) bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience(®) everolimus-eluting stents in stable angina patients. |
| Q71569334 | Interim report of multicenter double-blind, placebo-controlled studies of nifedipine in chronic stable angina |
| Q44636631 | Interleukin-6 and E-selectin in acute coronary syndromes and stable angina pectoris. A comparative study. |
| Q37598013 | Intermediate-Risk Chronic Stable Angina: Neutrophil-Lymphocyte Ratio and Fibrinogen Levels Improved Predicting Angiographically-Detected Coronary Artery Disease. |
| Q44766402 | Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule |
| Q34662548 | Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina |
| Q69183034 | Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina |
| Q81547305 | Interpreting the ACTION study - benefits in patients with stable angina and raised blood pressure |
| Q52932012 | Interpretive intra- and interobserver reproducibility of rest/stress 99Tcm-sestamibi myocardial perfusion SPECT in a consecutive group of male patients with stable angina pectoris before and after percutaneous transluminal angioplasty. |
| Q54213436 | Interrelated cathepsin S-lowering and LDL subclass profile improvements induced by atorvastatin in the plasma of stable angina patients. |
| Q41632953 | Intracoronary adenosine to prevent myonecrosis in patients with stable angina undergoing percutaneous interventions: a double-blinded randomized controlled trial |
| Q74267519 | Intracoronary thrombi in stable angina: observations with angioscopy |
| Q91347019 | Intramural Coronary Amyloidosis Mimicking Effort Angina Pectoris Preceding Fatal Heart Failure |
| Q72552315 | Intravascular ultrasound imaging in patients with acute myocardial infarction: comparison with chronic stable angina pectoris |
| Q38843177 | Invasive angiography and revascularization in patients with stable angina following prior coronary artery bypass grafting: Results from the East Denmark heart registry |
| Q64976480 | Inverse relationship between the severity of gingivitis and platelet reactivity in stable angina pectoris. |
| Q46596632 | Inverse relationships between coronary blood flow obstruction and platelet reactivity in stable angina pectoris. |
| Q101039433 | Investigating Prescriptions and Mechanisms of Acupuncture for Chronic Stable Angina Pectoris: An Association Rule Mining and Network Analysis Study |
| Q72726261 | Investigation and management of stable angina |
| Q93877298 | Investigation and management of stable angina |
| Q35371968 | Investigation and management of stable angina: revised guidelines 1998. Joint Working Party of the British Cardiac Society and Royal College of Physicians of London. |
| Q33599181 | Iproniazid in the treatment of angina of effort |
| Q50021075 | Is Exercise Treadmill Time or Reduction in Myocardial Ischemia the Appropriate Primary Endpoint to Assess Success of Percutaneous Coronary Intervention in Stable Angina (ORBITA)? |
| Q39031322 | Is In-Stent Restenosis After a Successful Coronary Stent Implantation Due to Stable Angina Associated With TG/HDL-C Ratio? |
| Q72622408 | Is ST/HR slope a predictor of coronary artery lesion in effort angina pectoris? A comparison of exercise hemodynamic variables |
| Q36011273 | Is the ratio of apoB/apoA-1 the best predictor for the severity of coronary artery lesions in Chinese diabetics with stable angina pectoris? An assessment based on Gensini scores |
| Q35691400 | Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment? |
| Q50886902 | Ischaemia during exercise and ambulatory monitoring in patients with stable angina pectoris and healthy controls. Gender differences and relationships to catecholamines. |
| Q38202085 | Ischaemia testing in patients with stable angina: which test for whom? |
| Q73018573 | Ischemic preconditioning detected by treadmill exercise tests in patients with stable angina |
| Q69229209 | Ischemic threshold varies in response to different types of exercise in patients with chronic stable angina |
| Q64077044 | Isolated congenital left ventricular diverticulum presenting as stable angina pectoris and surgical treatment |
| Q67938235 | Isosorbide 5-mononitrate (delayed release) in stable effort angina |
| Q33585391 | Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris |
| Q69982354 | Isosorbide-5-mononitrate--effective monotherapy in chronic stable angina |
| Q67902639 | Isradipine therapy in chronic stable angina pectoris—comparison with nifedipine |
| Q24544613 | Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina |
| Q98565537 | Ivabradine for the Therapy of Chronic Stable Angina Pectoris |
| Q98161499 | Ivabradine for the Therapy of Chronic Stable Angina Pectoris: a Systematic Review and Meta-Analysis |
| Q33159163 | Ivabradine for the treatment of stable angina pectoris in octogenarians |
| Q30316010 | Ivabradine in Combination with Metoprolol Improves Symptoms and Quality of Life in Patients with Stable Angina Pectoris: A post hoc Analysis from the ADDITIONS Trial |
| Q38814851 | Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction |
| Q30316766 | Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention |
| Q83521199 | Ivabradine in combination with a beta-blocker. Stable angina: do not use instead, of or, with a beta-blocker |
| Q30318221 | Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study |
| Q48066135 | Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study |
| Q43068312 | Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice |
| Q37184428 | Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases |
| Q61669089 | Ivabradine: a Selective If Current Inhibitor in the Treatment of Stable Angina |
| Q80214132 | Ivabradine: new drug. Best avoided in stable angina |
| Q86422997 | Japanese postmarketing surveillance of clopidogrel in patients with non-ST-segment elevation acute coronary syndrome, stable angina, old myocardial infarction, and ST-segment elevation myocardial infarction after percutaneous coronary intervention i |
| Q39673686 | Khellin in the treatment of angina of effort |
| Q73777066 | L-carnitine moderately improves the exercise tolerance in chronic stable angina |
| Q67709727 | Lack of Negative Inotropic Effects of the New Calcium Antagonist Ro 40–5967 in Patients with Stable Angina Pectoris |
| Q39881839 | Lack of Serum Creatinine Decrease After Coronary Angiography Despite Prophylactic Hydration After Routine Coronary Angiography/Angioplasty in Stable Angina Patients--Pilot Study |
| Q43799373 | Lack of antagonism between nicorandil and sulfonylurea in stable angina pectoris. |
| Q44872597 | Lack of anti-ischemic efficacy of the potassium channel opener bimakalim in patients with stable angina pectoris |
| Q57515027 | Lack of association between NFKBIL1/LTA polymorphisms and hypertension, myocardial infarct, unstable angina and stable angina in a large Irish population sample |
| Q68253201 | Lack of diurnal variation in maximal symptom-limited exercise test response in chronic stable angina |
| Q72623104 | Lack of effect of disopyramide on chronic stable angina |
| Q68084700 | Lack of indication of myocardial cell damage after myocardial ischaemia in patients with severe stable angina |
| Q33612417 | Lack of rebound during intermittent transdermal treatment with glyceryl trinitrate in patients with stable angina on background beta blocker |
| Q72660395 | Lack of rebound during intermittent transdermal treatment with glyceryl trinitrate in patients with stable angina on background beta blocker |
| Q36449328 | Laser recanalisation of coronary arteries by metal-capped optical fibres: early clinical experience in patients with stable angina pectoris |
| Q86692403 | Late differences in outcomes of patients with stable angina and an isolated lesion in the proximal left anterior descending artery treated with new-generation drug-eluting stents |
| Q70262105 | Late exercise test results from a prospective randomized study of bypass surgery for stable angina |
| Q35939475 | Late results of aortocoronary bypass grafts in 100 patients with stable angina pectoris |
| Q58695173 | Layer-specific strain analysis in patients with suspected stable angina pectoris and apparently normal left ventricular wall motion |
| Q52088887 | Learning by heart: a focused group study to determine the self-management learning needs of chronic stable angina patients. |
| Q72081649 | Left Ventricular Hemodynamics in Exercise-Induced Angina Pectoris |
| Q89474299 | Left Ventricular Noncompaction: A Rare Cause of Effort Angina Unveiled During Left Heart Catheterization |
| Q66972295 | Left ventricular pump function in effort angina |
| Q98730285 | Letter by Alfaddagh Regarding Article, "Healed Plaques in Patients With Stable Angina Pectoris" |
| Q51010102 | Letter by Huqi et al regarding article, "revascularization decisions in patients with stable angina and intermediate lesions: results of the international survey on interventional strategy". |
| Q91037415 | Letter to the Editor: "Serum Carnitine Metabolites and Incident Type 2 Diabetes Mellitus in Patients With Suspected Stable Angina Pectoris" |
| Q67488892 | Leucocytes and Free Radicals in Stable Angina Pectoris |
| Q41185991 | Lidoflazine and physical training in the treatment of stable angina pectoris |
| Q87213947 | Limitations of coronary computed tomographic angiography for delineating the lumen and vessel contours of coronary arteries in patients with stable angina |
| Q69740659 | Limitations of dipyridamole-echocardiography in effort angina pectoris |
| Q28340639 | Limited usefulness of intermittent nitroglycerin patches in stable angina |
| Q69209085 | Lipid markers, coronary score and coronary artery disease of stable angina pectoris type |
| Q38464811 | Lipoprotein analyses in patients with stable angina and acute coronary syndrome |
| Q90604838 | Living with stable angina: patients' pathway and needs in angina |
| Q68293208 | Local conduction delay causes R-wave amplitude increase in patients with effort angina |
| Q85000598 | Local persistent hypercoagulability after sirolimus-eluting stent implantation in patients with stable angina |
| Q78114228 | Long non-iatrogenic right coronary artery dissection in stable angina pectoris treated with stenting |
| Q58008315 | Long term outcome of elective day case percutaneous coronary intervention in patients with stable angina |
| Q98186711 | Long-Term Follow-Up in Patients With Stable Angina and Unobstructed Coronary Arteries Undergoing Intracoronary Acetylcholine Testing |
| Q72733903 | Long-Term Persistence of Antianginal Effect of Oral Verapamil in Chronic Stable Angina |
| Q34423662 | Long-acting diltiazem HCl for the chronotherapeutic treatment of hypertension and chronic stable angina pectoris. |
| Q44075930 | Long-acting isosorbide dinitrate and molsidomin in the treatment of effort angina in patients with arterial hypotension |
| Q38025119 | Long-term beta blockers for stable angina: systematic review and meta-analysis |
| Q99633300 | Long-term clinical outcomes of coronary artery bypass graft surgery compared to those of percutaneous coronary intervention with second generation drug eluting stents in patients with stable angina and an isolated lesion in the proximal left anterio |
| Q53542153 | Long-term effect of molsidomine, a direct nitric oxide donor, as an add-on treatment, on endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: results of the MEDCOR trial. |
| Q43720483 | Long-term effects of captopril treatment on the course of stable effort angina pectoris and structural-functional characteristics of platelets in patients with hypertension and ischemic heart disease |
| Q69939921 | Long-term efficacy of bepridil in patients with chronic stable angina pectoris: results of a multicenter, placebo-controlled study of extended bepridil use |
| Q68024997 | Long-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris |
| Q70386328 | Long-term efficacy of diltiazem assessed with multistage graded exercise tests in patients with chronic stable angina pectoris |
| Q44698971 | Long-term efficacy of diltiazem controlled release versus metoprolol in patients with stable angina pectoris |
| Q71587606 | Long-term efficacy of diltiazem in chronic stable angina associated with atherosclerosis: effect on treadmill exercise |
| Q72875236 | Long-term efficacy of heparin exercise treatment for patients with chronic effort angina: evaluation by exercise Tl-201 myocardial scintigraphy |
| Q69881204 | Long-term efficacy of high-dose diltiazem for chronic stable angina pectoris: 16-month serial studies with placebo controls |
| Q54094534 | Long-term efficacy of nitroglycerin patch in stable angina pectoris. |
| Q100415237 | Long-term impact of baseline anaemia on clinical outcomes following percutaneous coronary intervention in stable angina |
| Q61455250 | Long-term impact of secondary preventive treatments in patients with stable angina |
| Q30632676 | Long-term outcomes of patients receiving zotarolimus-eluting stents in ST elevation myocardial infarction, non-ST elevation acute coronary syndrome, and stable angina: data from the Resolute program |
| Q84901294 | Long-term prognosis in stable angina; medical treatment or coronary revascularization in patients younger than 70 years? |
| Q40255352 | Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris. |
| Q83636225 | Long-term prognostic value of CK-MB and the troponins after angioplasty in patients with stable angina |
| Q34890042 | Long-term prognostic value of creatine kinase-myocardial band mass after cardiac surgery in low-risk patients with stable angina |
| Q72539786 | Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. European Coronary Surgery Study Group |
| Q46529863 | Long-term safety and efficacy of nicardipine in the treatment of stable angina pectoris |
| Q34577293 | Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE). |
| Q39998164 | Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction. |
| Q67820073 | Long-term treatment of stable angina pectoris with gallopamil |
| Q39804065 | Long-term use of oral nicorandil stabilizes coronary plaque in patients with stable angina pectoris |
| Q37481637 | Long-term use of short- and long-acting nitrates in stable angina pectoris |
| Q58706916 | Low bone mineral density is associated with global coronary atherosclerotic plaque burden in stable angina patients |
| Q40659591 | Low dose acetylsalicylic acid in the antithrombotic treatment of patients with stable angina pectoris and acute coronary syndromes (unstable angina pectoris and acute myocardial infarction). |
| Q51984132 | Low hot pain threshold predicts shorter time to exercise-induced angina: results from the psychophysiological investigations of myocardial ischemia (PIMI) study. |
| Q43508339 | Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study |
| Q34187257 | Lymphocyte subpopulations in lymph nodes and peripheral blood: a comparison between patients with stable angina and acute coronary syndrome |
| Q86180627 | Macrophage heterogeneity of culprit coronary plaques in patients with acute myocardial infarction or stable angina |
| Q39038912 | Malondialdehyde-modified low-density lipoprotein is a predictor of cardiac events in patients with stable angina on lipid-lowering therapy after percutaneous coronary intervention using drug-eluting stent |
| Q28265404 | Management of Patients With Stable Angina and Type 2 Diabetes |
| Q38957123 | Management of Stable Angina - Current Guidelines: A Critical Appraisal |
| Q41618525 | Management of Stable Angina with Ivabradine as Safe Alternative to Patients with Myasthenia Gravis |
| Q64058348 | Management of a patient with chronic stable angina |
| Q33647620 | Management of chronic stable angina |
| Q28187338 | Management of chronic stable angina pectoris from a sceptic's view point |
| Q37462817 | Management of chronic stable angina pectoris. |
| Q68997152 | Management of chronic stable angina with once-daily bisoprolol or atenolol and long-term efficacy of bisoprolol |
| Q41695848 | Management of chronic stable angina: medical therapy, percutaneous transluminal coronary angioplasty, and coronary artery bypass graft surgery. Lessons from the randomized trials |
| Q104740777 | Management of chronic stable angina: modern microbiomedical research provides insights into Traditional Chinese Medicine treatments |
| Q28193734 | Management of coronary heart disease: stable angina, acute coronary syndrome, myocardial infarction |
| Q39454972 | Management of patients with chronic stable angina at low risk for serious cardiac events |
| Q35168657 | Management of stable angina |
| Q67281864 | Management of stable angina |
| Q84253246 | Management of stable angina |
| Q38341283 | Management of stable angina pectoris |
| Q91176689 | Management of stable angina pectoris in private healthcare settings in South Africa |
| Q73168101 | Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology |
| Q39738089 | Management of stable angina: A commentary on the European Society of Cardiology guidelines |
| Q95590984 | Management of stable angina: Evidence Update September 2012: A summary of selected new evidence relevant to NICE clinical guideline 126 ‘Management of stable angina’ (2011) |
| Q83320855 | Management of stable angina: summary of NICE guidance |
| Q84707109 | Management of stable angina: summary of NICE guidance |
| Q72576491 | Managing stable angina pectoris: nitroglycerin, beta blockers and risk factor reduction |
| Q73674499 | Managing stable angina: time to re-evaluate medical therapy |
| Q42328756 | Managing the treatment of the patients with stable angina like a chess player: making moves considering the next move of atherosclerosis |
| Q53268048 | Manual therapy for patients with stable angina pectoris: a nonrandomized open prospective trial. |
| Q62694077 | Markers of fibrinolytic potency and clotting activation in stable angina pectoris: role of urokinase, assessment of atrioventricular differences and correlation with coronary patency |
| Q45069609 | Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. |
| Q49941285 | Mechanism of Salvianolate injection combined with aspirin in treatment of stable angina pectoris based on biomolecules network |
| Q69461305 | Mechanisms of arrhythmias accompanying ST-segment depression on ambulatory monitoring in stable angina pectoris |
| Q67959514 | Mechanisms of development of microcirculatory disorders in patients with stable angina pectoris |
| Q39333597 | Medical Management and Diagnostic Testing among Stable Angina Patients in India: The STable Angina obseRvational (STAR) Registry |
| Q74277749 | Medical device therapy for chronic stable angina |
| Q26773268 | Medical management of chronic stable angina |
| Q40082152 | Medical management of patients with chronic stable angina pectoris |
| Q41000632 | Medical management of stable angina and unstable angina in the elderly with coronary artery disease |
| Q41905897 | Medical management of stable angina pectoris |
| Q72599926 | Medical management of stable angina pectoris |
| Q68606437 | Medical therapy of chronic stable angina pectoris |
| Q36495363 | Medical therapy of stable angina pectoris |
| Q53679015 | Medical therapy or coronary artery bypass graft surgery for chronic stable angina: an update using decision analysis. |
| Q28193813 | Medical treatment of patients with stable angina pectoris referred for coronary angiography: failure of treatment or failure to treat |
| Q38890026 | Medical treatment of stable angina: A tailored therapeutic approach |
| Q35792940 | Medical versus interventional management of stable angina |
| Q41203191 | Medical versus surgical treatment of stable angina pectoris: progress report of a large scale study |
| Q46219602 | Melatonin in combined therapy of patients with stable angina and arterial hypertension |
| Q58394559 | Meta-analysis of Trials Comparing β-Blockers, Calcium Antagonists, and Nitrates for Stable Angina |
| Q35791864 | Meta-analysis of acupuncture therapy for the treatment of stable angina pectoris. |
| Q38631654 | Metabolomic Evaluation of the Consequences of Plasma Cystathionine Elevation in Adults with Stable Angina Pectoris |
| Q59640824 | Metabolomic discrimination between patients with stable angina, non-ST elevation myocardial infarction, and acute myocardial infarct |
| Q38384427 | Methylenetetrahydrofolate Dehydrogenase 1 Polymorphisms Modify the Associations of Plasma Glycine and Serine With Risk of Acute Myocardial Infarction in Patients With Stable Angina Pectoris in WENBIT (Western Norway B Vitamin Intervention Trial). |
| Q40459815 | Metoprolol effect on ECG exercise test in patients with stable angina pectoris. Computer analysis (author's transl) |
| Q70282698 | Metoprolol, nifedipine, and the combination in stable effort angina pectoris |
| Q73673626 | Mibefradil in the treatment of chronic stable angina pectoris: comparative studies with other calcium antagonists |
| Q45054905 | Mibefradil, a T-type channel-selective calcium antagonist: clinical trials in chronic stable angina pectoris |
| Q33286111 | Microcirculatory effects of hemosorption in patients with stable angina pectoris, based on data from radionuclide imaging |
| Q71671850 | Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris |
| Q38210452 | Mono- or combination therapy for stable angina pectoris. |
| Q79579095 | Monocyte cAMP content is decreased in patients with stable angina |
| Q87397499 | Monocyte expression of Toll-like receptor-4 in patients with stable angina undergoing percutanoeus coronary intervention |
| Q68311057 | Monotherapy of stable angina pectoris with bopindolol in comparison with diltiazem |
| Q45048351 | Monotherapy of stable angina with nicardipine hydrochloride: double-blind, placebo-controlled, randomized study |
| Q73147168 | Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris |
| Q74370457 | Monotherapy with nifedipine GITS compared with atenolol in stable angina pectoris. The Working Group on Cardiovascular Research (WCN) |
| Q33999181 | Morphological characteristics of clinically significant coronary artery stenosis in stable angina |
| Q77227731 | Morphometric and histological study of coronary plaques in stable angina and acute myocardial infarctions |
| Q44281158 | Mortality in stable angina pectoris: medical versus surgical treatment. |
| Q90976984 | Multi-slice CT coronary angiography assessment of remodeling index in patients with low- to intermediate-risk stable angina |
| Q80349251 | Multiple complex stenoses and chronic stable angina pectoris |
| Q57726578 | Multislice spiral computed tomography coronary angiography in patients with stable angina pectoris |
| Q53620876 | Multislice spiral computed tomography coronary angiography in patients with stable angina pectoris. |
| Q82433396 | Multivessel percutaneous coronary intervention in patients with stable angina: a common approach? Lessons learned from the EHS PCI registry |
| Q73493330 | Muscle characteristics in effort angina before and after CABG |
| Q73206659 | Muscle fibers, ubiquinone and exercise capacity in effort angina |
| Q42550276 | Muscle ubiquinone in male effort angina patients |
| Q53409739 | Muscular tenderness in the anterior chest wall in patients with stable angina pectoris is associated with normal myocardial perfusion. |
| Q34072878 | Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina |
| Q47605880 | Myocardial Injury Is Distinguished from Stable Angina by a Set of Candidate Plasma Biomarkers Identified Using iTRAQ/MRM-Based Approach |
| Q37184990 | Myocardial infarction patients show altered lipoprotein properties and functions when compared with stable angina pectoris patients |
| Q64965527 | Myocardial ischaemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. |
| Q41194546 | Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris |
| Q71947910 | Myocardial ischemia detected by Holter monitoring: analysis of therapeutical trials realised in stable angina |
| Q67839174 | Myocardial ischemia with stable angina pectoris: clinico-ergometric evaluation after the use of diltiazem |
| Q42943440 | Myocardial perfusion SPECT and dobutamine stress tissue Doppler imaging in evaluation of patients with stable angina pectoris |
| Q74048790 | Myocardial perfusion imaging and coronary angiography in patients with known or suspected stable angina pectoris |
| Q67462906 | Myocardial release of lactate, inosine and hypoxanthine during atrial pacing and exercise-induced angina |
| Q48405453 | Myocardial strain analysis by 2-dimensional speckle tracking echocardiography improves diagnostics of coronary artery stenosis in stable angina pectoris |
| Q43491786 | N-3 polyunsaturated fatty acids do not influence the efficacy of dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention |
| Q53608813 | N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. |
| Q80472861 | NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine? |
| Q72583955 | Nadolol compared to propranolol for treating chronic stable angina pectoris |
| Q50056392 | National Prevalence of Self-Reported Coronary Heart Disease and Chronic Stable Angina Pectoris: Factor Analysis of the Underlying Cardiometabolic Risk Factors in the Fourth Round of the SuRFNCD-2011. |
| Q58701059 | Neopterin and Cardiovascular Events Following Coronary Stent Implantation in Patients with Stable Angina Pectoris |
| Q45939786 | Neopterin levels and left ventricular dysfunction in patients with chronic stable angina pectoris. |
| Q64056872 | Neutrophil count as the centerpiece in the joined association networks of inflammatory and cell damage markers, and neuroendocrine stress markers in patients with stable angina pectoris following stenting |
| Q71796050 | Neutrophil hyper-reactivity after exercise-induced angina pectoris |
| Q81528747 | New agent ivabradine (Procoralan) for treatment of chronic stable angina |
| Q34446965 | Nicardipine for stable angina pectoris |
| Q45807204 | Nicardipine in chronic stable angina: Objective assessment with computer-assisted exercise testing and ambulatory ST segment monitoring |
| Q57495852 | Nicorandil and Long-acting Nitrates: Vasodilator Therapies for the Management of Chronic Stable Angina Pectoris |
| Q57163712 | Nicorandil improves clinical outcomes in patients with stable angina pectoris requiring PCI: a systematic review and meta-analysis of 14 randomized trials |
| Q87154239 | Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study |
| Q44229475 | Nicorandil-induced preconditioning as evidenced by troponin T measurements after coronary angioplasty in patients with stable angina pectoris |
| Q35871153 | Nicorandil: a review of its use in the management of stable angina pectoris, including high-risk patients |
| Q74370472 | Nifedipine GITS versus diltiazem in chronic stable angina: a randomised multicentre study |
| Q44211623 | Nifedipine and isosorbide dinitrate alone and in combination for patients with chronic stable angina: a double-blind crossover study |
| Q43432234 | Nifedipine gastrointestinal therapeutic system in stable angina pectoris. Results of a multicenter open-label crossover comparison with standard nifedipine |
| Q73024601 | Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris. The Netherlands Working Group on Cardiovascular Research (WCN) |
| Q70427261 | Nifedipine in chronic stable angina: a double-blind placebo-controlled crossover trial |
| Q39692051 | Nifedipine therapy for stable angina pectoris: Preliminary results of effects on angina frequency and treadmill exercise response |
| Q40511134 | Nisoldipine coat core as concomitant therapy in chronic stable angina pectoris. |
| Q45002957 | Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenolol |
| Q77990788 | Nitrate resistance in platelets from patients with stable angina pectoris |
| Q54037549 | Nitrate resistance in platelets from patients with stable angina pectoris. |
| Q41703358 | Nitrate therapy for stable angina pectoris |
| Q39656381 | Nitrate therapy in stable angina pectoris |
| Q70371327 | Nitrate therapy in stable angina pectoris |
| Q77438264 | Nitrate tolerance in patients with effort angina |
| Q41436504 | Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure |
| Q39460113 | Nitrate-Induced Headache in Patients with Stable Angina Pectoris: Beneficial Effect of Starting on a Low Dosage. |
| Q39464285 | Nitrate-induced headache in patients with stable angina pectoris: beneficial effect of starting on a low dosage. 5-ISMN headache study group |
| Q38004987 | Nitrates as an integral part of optimal medical therapy and cardiac rehabilitation for stable angina: review of current concepts and therapeutics. |
| Q37765974 | Nitrates for stable angina: a systematic review and meta-analysis of randomized clinical trials |
| Q44702286 | Nitrates in therapy of effort angina in hypotensive patients |
| Q69946326 | Nitroderm TTS in exercise-induced angina pectoris--a randomized double-blind study |
| Q46114484 | Nitroglycerin in chronic stable angina pectoris |
| Q39723952 | Nitroglycerin ointment in angina of effort |
| Q41368394 | Nitrozell retard in the light of effort tolerance tests on cyclo-ergometer in patients with stable angina pectoris |
| Q93513425 | No evidence of platelet activation during atrial pacing in subjects with stable angina |
| Q53219878 | Non-invasive diagnostic workup of patients with suspected stable angina by combined computed tomography coronary angiography and magnetic resonance perfusion imaging. |
| Q53541755 | Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography. |
| Q46175649 | Noradrenergic activity and silent ischaemia in hypertensive patients with stable angina: effect of metoprolol |
| Q71017716 | North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management angina. North of England Stable Angina Guideline Development Group |
| Q38046952 | Novel anti-platelet agents for the treatment of stable angina pectoris |
| Q55324680 | Nuclear myocardial perfusion imaging in stable angina pectoris : Sometimes being wrong is all right. |
| Q83393028 | Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation |
| Q85070129 | OX40 ligand levels and high-sensitivity C-reactive protein levels in blood from local coronary plaque and the femoral artery in patients with acute coronary syndrome or stable angina |
| Q85852116 | Obesity and antiplatelet effects of acetylsalicylic acid and clopidogrel in patients with stable angina pectoris after percutaneous coronary intervention |
| Q92517227 | Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina (ORBITA) and coronary stents: A case study in the analysis and reporting of clinical trials |
| Q54155591 | Objective evaluation of PY-108-068, a new calcium channel inhibitor for the treatment of chronic stable angina pectoris. |
| Q71688921 | Objective evaluation of three dose levels of diltiazem in patients with chronic stable angina |
| Q52970831 | Observer variability in the evaluation of dual-isotope Tl-201/Tc-99m sestamibi rest/stress myocardial perfusion SPECT in men and women with known or suspected stable angina pectoris. |
| Q40587850 | Ointments and transdermal nitroglycerin patches for stable angina pectoris |
| Q85737990 | Old and New Drugs for Treatment of Stable Angina |
| Q38301828 | Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization |
| Q55030847 | On-Pump Beating/Non-Beating CABG in Stable Angina Have Similar Outcomes. |
| Q72400874 | Once- versus twice-daily administration of controlled-release isosorbide-5-mononitrate 60 mg in the treatment of stable angina pectoris. A randomized, double-blind, cross-over study. The Swedish Multicentre Group |
| Q71630896 | Once-daily treatment of stable angina pectoris |
| Q69963324 | Once-daily verapamil--an objective evaluation in stable angina pectoris using treadmill exercise testing |
| Q55470681 | One down, one to go: coronary anomaly dual LAD blood supply with worsening chronic stable angina and 100% occluded left short LAD type IV variant. |
| Q90301447 | One-year clinical outcomes of coronary chronic total occlusion intervention in patients with acute coronary syndrome versus stable angina: from the Korean chronic total occlusion registry |
| Q33612696 | Optimal control of myocardial ischaemia: the benefit of a fixed combination of atenolol and nifedipine in patients with chronic stable angina |
| Q44458711 | Optimal initial diagnostic strategies for the evaluation of stable angina patients: a multicenter, prospective study on myocardial perfusion imaging, computed tomographic angiography, and coronary angiography |
| Q52839771 | Optimal medical therapy and percutaneous coronary intervention for stable angina: why patients should 'be taking' and 'keep taking' the tablets. |
| Q74709936 | Optimum treatment of stable angina pectoris |
| Q36755157 | Oral labetalol in the management of stable angina pectoris in normotensive patients |
| Q48038383 | Oral nicorandil reduces ischemic attacks in patients with stable angina: A prospective, multicenter, open-label, randomized, controlled study |
| Q46895134 | Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: effects on lipid profiles, inflammation markers, and quality of life |
| Q70461258 | Oral sustained-release nitroglycerin in chronic stable angina: a multicenter, double-blind, randomized crossover trial |
| Q58580159 | Ostial left main coronary artery chronic total occlusion presenting as chronic stable angina |
| Q58973480 | Outcome of Percutaneous Coronary Intervention in Unstable Angina Pectoris Versus Stable Angina Pectoris in Two Different Time Periods |
| Q47434606 | Outcome of patients with stable angina pectoris treated with or without percutaneous coronary intervention. |
| Q57315494 | Outcome of stable angina in a working population: the burden of sickness absence |
| Q44531660 | Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial |
| Q63341256 | P3312 Patients with stable angina and intermediate lesions on coronary angiography have a high risk of coronary events |
| Q91446659 | PCI Equal to Sham PCI for Exercise Tolerance in Patients with Stable Angina Plus Severe CAD |
| Q50100014 | PCI for stable angina: A missed opportunity for shared decision-making |
| Q36291180 | PTCA in patients with stable angina pectoris and multivessel disease: Is incomplete revascularization acceptable? |
| Q38372732 | Pain syndromes of the chest muscles; resemblance to effort angina and myocardial infarction, and relief by local block |
| Q69258660 | Pain threshold and tolerance in women with syndrome X and women with stable angina pectoris |
| Q69353557 | Painful versus silent myocardial ischemia during leg and arm exercise testing in stable angina pectoris |
| Q46761705 | Paired bicycle exercise test in assessment of clinical efficacy of isosorbide-5-mononitrate in patients with stable angina of effort |
| Q67748994 | Paradoxical effect of long-term treatment of nifedipine on total ischemic load in patients with stable angina pectoris |
| Q34628656 | Partial fatty acid oxidation inhibitors for stable angina |
| Q92599309 | Pathogenetic role of nitrogen monoxide efficiency of pharmacotherapy in patients with gastroesophageal reflux disease and stable angina of tension |
| Q37713607 | Pathophysiology of stable angina pectoris. |
| Q92581251 | Patient-Clinician Decision Making for Stable Angina: The Role of Health Literacy |
| Q72657210 | Patterns of coronary artery stenosis vasomotion: observed versus "predicted" stenosis reactivity in patients with chronic stable angina |
| Q77395593 | Pentoxifylline decreases neutrophil respiratory bursts in patients with stable angina |
| Q39373204 | Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Stable Angina in Advanced CKD: A Decision Analysis. |
| Q37459136 | Percutaneous coronary intervention for chronic stable angina: a reassessment |
| Q48499995 | Percutaneous coronary intervention for poor coronary microcirculation reperfusion of patients with stable angina pectoris |
| Q90484864 | Percutaneous coronary intervention for stable angina in ORBITA |
| Q95595659 | Percutaneous coronary intervention for stable angina in ORBITA |
| Q95595661 | Percutaneous coronary intervention for stable angina in ORBITA |
| Q95595662 | Percutaneous coronary intervention for stable angina in ORBITA |
| Q95595664 | Percutaneous coronary intervention for stable angina in ORBITA |
| Q95595665 | Percutaneous coronary intervention for stable angina in ORBITA |
| Q95595666 | Percutaneous coronary intervention for stable angina in ORBITA |
| Q95595668 | Percutaneous coronary intervention for stable angina in ORBITA |
| Q95595669 | Percutaneous coronary intervention for stable angina in ORBITA |
| Q90484896 | Percutaneous coronary intervention for stable angina in ORBITA - Authors' reply |
| Q43528174 | Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. |
| Q45968256 | Percutaneous coronary intervention versus coronary artery bypass graft for stable angina: meta-regression of randomized trials. |
| Q34153703 | Percutaneous coronary intervention vs coronary artery bypass grafting in the management of chronic stable angina: A critical appraisal |
| Q87366457 | Percutaneous coronary intervention vs medical treatment in stable angina: the never-ending story |
| Q37972132 | Percutaneous coronary intervention with optimal medical therapy vs. optimal medical therapy alone for patients with stable angina pectoris |
| Q84030343 | Percutaneous coronary interventions affect concentrations of interleukin 6 and its soluble receptors in coronary sinus blood in patients with stable angina |
| Q73832115 | Percutaneous interventions alter the hemostatic profile of patients with unstable versus stable angina |
| Q67481831 | Percutaneous transluminal coronary angioplasty in unstable and stable angina pectoris: a comparison of immediate success and complications |
| Q34036961 | Percutaneous transluminal coronary angioplasty in unstable angina: comparison with stable angina |
| Q39455534 | Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affa |
| Q24244873 | Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes |
| Q43284525 | Percutaneous treatment with drug-eluting stent vs bypass surgery in patients suffering from chronic stable angina with multivessel disease involving significant proximal stenosis in left anterior descending artery |
| Q47715919 | Performing stable angina pectoris: an ethnographic study |
| Q35631916 | Periodontal disease in relation to selected parameters of the cardiovascular system in a group of patients with stable angina pectoris |
| Q48024390 | Persistent angina: highly prevalent and associated with long-term anxiety, depression, low physical functioning, and quality of life in stable angina pectoris |
| Q54041067 | Pharmacokinetics and additional anti-ischaemic effectiveness of amlodipine, a once-daily calcium antagonist, during acute and long-term therapy of stable angina pectoris in patients pre-treated with a beta-blocker. |
| Q34398366 | Pharmacokinetics of epanolol after acute and chronic oral dosing in elderly patients with stable angina pectoris |
| Q42625952 | Pharmacokinetics of epanolol in elderly patients with stable angina pectoris |
| Q57243495 | Pharmacologic management of stable angina: role of ivabradine |
| Q38920729 | Pharmacological Agents Targeting Myocardial Metabolism for the Management of Chronic Stable Angina : an Update. |
| Q38841829 | Pharmacological Management of Chronic Stable Angina: Focus on Ranolazine |
| Q36290559 | Pharmacological approaches to the symptomatic treatment of chronic stable angina: a historical perspective and future directions |
| Q71952767 | Pharmacological evaluation of the clinical importance of some useful cardiovascular influences produced by the adrenergic system in angina of effort |
| Q38087608 | Pharmacological treatment of chronic stable angina pectoris. |
| Q43013406 | Physical training after percutaneous coronary intervention in patients with stable angina: effects on working capacity, metabolism, and markers of inflammation |
| Q57446684 | Physicians' attitudes to the pharmacological treatment of patients with stable angina pectoris |
| Q42279386 | Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris |
| Q53596776 | Plaque ruptures in stable angina pectoris compared with acute coronary syndrome. |
| Q50084196 | Plasma 25-hydroxyvitamin D and mortality in patients with suspected stable angina pectoris |
| Q58127362 | Plasma Cystathionine and Risk of Incident Stroke in Patients With Suspected Stable Angina Pectoris |
| Q36877698 | Plasma Glycine and Risk of Acute Myocardial Infarction in Patients With Suspected Stable Angina Pectoris |
| Q52982596 | Plasma MicroRNA-126-5p is Associated with the Complexity and Severity of Coronary Artery Disease in Patients with Stable Angina Pectoris. |
| Q59275976 | Plasma choline, smoking, and long-term prognosis in patients with stable angina pectoris |
| Q51339744 | Plasma dimethylglycine and risk of incident acute myocardial infarction in patients with stable angina pectoris. |
| Q92992989 | Plasma fatty acid-binding protein 4 (FABP4) level is associated with abnormal QTc interval in patients with stable angina and chronic kidney disease |
| Q30320971 | Plasma fibrinogen in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction |
| Q71384172 | Plasma immunoreactive endothelin concentration correlates with severity of coronary artery disease in patients with stable angina pectoris and normal ventricular function |
| Q53631354 | Plasma levels of C1q/TNF-related protein 1 and interleukin 6 in patients with acute coronary syndrome or stable angina pectoris. |
| Q79713192 | Plasma levels of TNF-alpha, IL-6, and IL-10 and their relationship with left ventricular diastolic function in patients with stable angina pectoris and preserved left ventricular systolic performance |
| Q79756144 | Plasma levels of oxidized low density lipoprotein are associated with stable angina pectoris and modalities of acute coronary syndrome |
| Q36804760 | Plasma α1-antitrypsin: a neglected predictor of angiographic severity in patients with stable angina pectoris |
| Q52020185 | Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris. |
| Q34225741 | Platelet proteome and clopidogrel response in patients with stable angina undergoing percutaneous coronary intervention |
| Q39699608 | Platelet-activating factor acetylhydrolase activity in patients with chronic stable angina (preliminary results). |
| Q73418652 | Platelet-associated and secreted PAF-acetylhydrolase activity in patients with stable angina: sequential changes of the enzyme activity after angioplasty |
| Q79383023 | Platelet-derived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris |
| Q53249126 | Platelet-monocyte cross talk and tissue factor expression in stable angina vs. unstable angina/non ST-elevation myocardial infarction. |
| Q93544678 | Points from Letters: Drug treatment of chronic stable angina pectoris |
| Q67954138 | Positive and negative exercise test results with and without exercise-induced angina in patients with one healed myocardial infarction: analysis of baseline variables and long-term prognosis |
| Q44632032 | Possibilities of potentiating the antianginal action of nitrates by methionine in patients with stable effort angina pectoris |
| Q91200655 | Postsystolic shortening on echocardiography as a gateway to cardiac computed tomography in patients with suspected stable angina pectoris |
| Q34255430 | Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering? |
| Q52992776 | Potential impact of myocardial perfusion scintigraphy as gatekeeper for invasive examination and treatment in patients with stable angina pectoris: observational study without post-test referral bias. |
| Q43109922 | Potentiation of anti-ischemic and anti-anginal action of nitrates by hydrogen sulfide balneotherapy in patients with angina of effort |
| Q92251466 | Practical Recommendations for the Diagnosis and Medical Management of Stable Angina: An Expert Panel Consensus |
| Q90229507 | Prasugrel monotherapy after PCI with the SYNERGY stent in patients with chronic stable angina or stabilised acute coronary syndromes: rationale and design of the ASET pilot study |
| Q38843355 | Pravastatin improves postprandial endothelial dysfunction and hemorheological deterioration in patients with effort angina pectoris |
| Q73226882 | Pre-existing arterial remodeling is associated with in-hospital and late adverse cardiac events after coronary interventions in patients with stable angina pectoris |
| Q72872296 | Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss--a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina |
| Q44073280 | Preconditioning effect during coronary angioplasty in patients with stable angina pectoris. |
| Q34334496 | Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study |
| Q92676976 | Prediction of Coronary Revascularization in Stable Angina: Comparison of FFRCT With CMR Stress Perfusion Imaging |
| Q71948888 | Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina |
| Q39858553 | Prediction of cardiovascular death and myocardial infarction by the QRS-T angle and T vector loop morphology after angioplasty in stable angina pectoris: an 8-year follow-up |
| Q61875197 | Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina |
| Q77178269 | Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina |
| Q47745042 | Predictive value of depression and anxiety for long-term mortality: differences in outcome between acute coronary syndrome and stable angina pectoris |
| Q71906135 | Predictive value of hemostatic factors for sudden death in patients with stable angina pectoris |
| Q58816577 | Predictive value of local and core laboratory echocardiographic assessment of cardiac function in patients with chronic stable angina: The ACTION study |
| Q87765059 | Predictors of In-Stent Restenosis in Patients With Stable Angina Pectoris |
| Q35674008 | Predictors of coronary intervention-related myocardial infarction in stable angina patients pre-treated with statins. |
| Q61651408 | Predictors of hospital mortality in the elderly undergoing percutaneous coronary intervention for acute coronary syndromes and stable angina |
| Q91676103 | Predictors of poorly developed coronary collateral circulation in patients with subclinical hypothyroidism suffered from chronic stable angina |
| Q39475534 | Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry |
| Q28167810 | Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris |
| Q76432534 | Prenylamine ("Segontin") in angina of effort |
| Q33485903 | Presence of irregularity in region between -1115 and -784 nt in P1 promoter of insulin-like growth factor-1 gene may indicate beneficial effect on coronary arteries in a group of patients with stable angina: preliminary data |
| Q36873903 | Presentation of stable angina pectoris among women and South Asian people. |
| Q90910675 | Prevalence and Clinical Significance of Layered Plaque in Patients With Stable Angina Pectoris - Evaluation With Histopathology and Optical Coherence Tomography |
| Q46401326 | Prevalence and patterns of silent myocardial ischemia during daily life in stable angina patients receiving conventional antianginal drug therapy |
| Q73017329 | Prevalence and prognostic significance of unrecognized systemic hypertension in patients with diabetes mellitus and healed myocardial infarction and/or stable angina pectoris |
| Q86773853 | Prevalence of Stable Angina in Spain. Results of the OFRECE Study |
| Q28195788 | Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement |
| Q68094583 | Prevention of coronary spasms during aorto-coronary (A-C) bypass surgery for variant angina and effort angina with ST-elevation |
| Q81412199 | Prevention of nitrate tolerance with angiotensin II receptor type 1 blocker in patients with stable angina: yet another failed strategy to prevent tolerance |
| Q35910072 | Primary care management of chronic stable angina and asymptomatic suspected or known coronary artery disease: a clinical practice guideline from the American College of Physicians |
| Q42944578 | ProCor: an extramural screening on heart rate reduction in patients with chronic stable angina pectoris in Austria |
| Q39636488 | Prognosis in stable angina pectoris and silent myocardial ischemia |
| Q41013689 | Prognosis of patients with stable angina pectoris on antianginal drug therapy. |
| Q36014116 | Prognosis of stable angina pectoris: why we need larger population studies with higher endpoint resolution |
| Q57651156 | Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study In Stockholm [APSIS]) |
| Q35579973 | Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris. |
| Q90301483 | Prognostic implications of coronary artery stenosis and coronary spasm in patients with stable angina: 5-year follow-up of the Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries (ACOVA) study |
| Q43513611 | Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris |
| Q72340446 | Prognostic implications of mental stress-induced silent left ventricular dysfunction in patients with stable angina pectoris |
| Q61684200 | Prognostic implications of renal dysfunction in patients with stable angina pectoris |
| Q57651141 | Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from The Angina Prognosis Study In Stockholm (APSIS) |
| Q95459211 | Prognostic usefulness of IL-6 and VEGF for the occurrence of changes in coronary arteries of patients with stable angina and implanted stents |
| Q80679305 | Prognostic value of circulating pregnancy-associated plasma protein-A (PAPP-A) and proform of eosinophil major basic protein (pro-MBP) levels in patients with chronic stable angina pectoris |
| Q33826524 | Prognostic value of coronary artery calcium score in patients with stable angina pectoris after percutaneous coronary intervention |
| Q46743742 | Prognostic value of impaired fasting glucose for outcomes of patients with stable angina pectoris treated with percutaneous coronary interventions |
| Q57214902 | Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients |
| Q50788014 | Prognostic value of myocardial perfusion imaging in patients with known or suspected stable angina pectoris: evaluation in a setting in which myocardial perfusion imaging did not influence the choice of treatment. |
| Q37255966 | Prognostic value of myocardial perfusion scintigraphy in type 2 diabetic patients with mild, stable angina pectoris. |
| Q41271492 | Prognostic value of stress echocardiography in stable angina or after myocardial infarction. |
| Q72238837 | Progression and regression of coronary artery disease in one year. Quantitative angiographic assessment in patients with stable angina pectoris |
| Q38588043 | Progression of Coronary Artery Disease (CAD) from Stable Angina (SA) Towards Myocardial Infarction (MI): Role of Oxidative Stress |
| Q67281155 | Progression of coronary artery disease in patients with stable angina pectoris. Arteriographic, ventriculographic and other correlation studies |
| Q47256157 | Progression of non-culprit coronary artery atherosclerosis after acute myocardial infarction in comparison with stable angina pectoris |
| Q67985460 | Prolonged action nitrates in stable angina pectoris |
| Q45095668 | Propranolol treatment of effort angina in patients with arterial hypotension |
| Q53656345 | Prospective comparison of coronary artery remodeling between acute coronary syndrome and stable angina in single‐vessel disease: Correlation between C‐reactive protein and extent of arterial remodeling |
| Q96690820 | Prospective partially randomized comparison of clopidogrel loading versus maintenance dosing to prevent periprocedural myocardial infarction after stenting for stable angina pectoris: Results from the "Method of Clopidogrel Pre-treatment Undergoing |
| Q72429219 | Prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Second interim report by the European Coronary Surgery Study Group |
| Q70238171 | Prospective randomized study of coronary artery bypass surgery in stable angina pectoris: a progress report on survival |
| Q72469359 | Prostacyclin, nitroglycerin, and effort angina |
| Q52316757 | Protective Effect of Remote Ischemic Preconditioning on Myocardial Damage After Percutaneous Coronary Intervention in Stable Angina Patients With Complex Coronary Lesions - Subanalysis of a Randomized Controlled Trial. |
| Q50951636 | Psychosocial variables in female vs male patients with stable angina pectoris and matched healthy controls. |
| Q40776644 | Psychosocial variables in relation to various risk factors in patients with stable angina pectoris. |
| Q43117266 | Puerarin inhibits C-reactive protein expression via suppression of nuclear factor kappaB activation in lipopolysaccharide-induced peripheral blood mononuclear cells of patients with stable angina pectoris |
| Q77156463 | Pulsatility of ascending aorta and restenosis after coronary angioplasty in patients >60 years of age with stable angina pectoris |
| Q98779154 | Quality Control Procedures and Baseline Values for Electroretinography, Perimetry, Color Vision, and Visual Acuity in an International Multicenter Study: Observations from a Safety Trial in Chronic Stable Angina Pectoris |
| Q48798559 | Quality of life and health status after percutaneous coronary intervention in stable angina patients: results from the real-world practice |
| Q84642414 | Quality of life assessment for chronic stable angina |
| Q34135786 | Quality of life of chronic stable angina patients 4 years after coronary angioplasty or coronary artery bypass surgery |
| Q34498277 | Quality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal population |
| Q110633165 | Quality of the Evidence Supporting the Role of Acupuncture for Stable Angina Pectoris: An Umbrella Review of Systematic Reviews |
| Q73369877 | Radial versus femoral approach for diagnostic coronary angiography in stable angina pectoris |
| Q70781794 | Radionuclide ejection fraction and regional wall motion during atrial pacing in stable angina pectoris: Comparison with metabolic and hemodynamic parameters |
| Q67927860 | Random exercise stress test in diagnosing effort angina |
| Q37576710 | Randomised, double-blind, placebo-controlled study investigating the effects of inorganic nitrate on vascular function, platelet reactivity and restenosis in stable angina: protocol of the NITRATE-OCT study |
| Q68526197 | Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris |
| Q44047888 | Randomized comparison of T-type versus L-type calcium-channel blockade on exercise duration in stable angina: results of the Posicor Reduction of Ischemia During Exercise (PRIDE) trial |
| Q70329778 | Randomized double-blind comparison of gallopamil and propranolol in stable angina pectoris |
| Q67944893 | Randomized double-blind comparison of metoprolol, nifedipine, and their combination in chronic stable angina: effects on total ischemic activity and heart rate at onset of ischemia |
| Q68858566 | Randomized double-blind placebo-controlled comparison of nicardipine and nifedipine in patients with chronic stable angina pectoris |
| Q70419750 | Randomized double-blind study of pindolol in patients with stable angina pectoris |
| Q70241813 | Randomized, double-blind comparison of propranolol alone and a propranolol-verapamil combination in patients with severe angina of effort |
| Q80536696 | Ranolazine (Ranexa) for chronic stable angina |
| Q24187560 | Ranolazine for stable angina pectoris |
| Q38971758 | Ranolazine for stable angina pectoris |
| Q36258672 | Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective |
| Q39055752 | Ranolazine in treatment of stable angina in woman with atrial fibrillation and intermittent left bundle branch block - a case report |
| Q80496354 | Ranolazine--a nicely timed new medical therapy for stable angina |
| Q43224959 | Ranolazine--new treatment of chronic stable angina pectoris |
| Q26765421 | Ranolazine: A Contemporary Review |
| Q34614076 | Ranolazine: a potential new treatment for chronic stable angina |
| Q38074900 | Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris |
| Q34566582 | Ranolazine: a review of its use in chronic stable angina pectoris |
| Q82642239 | Ranolazine: a review of its use in chronic stable angina pectoris |
| Q64068775 | Ranolazine: impact on quality of life in patients with stable angina pectoris, results from an observational study in Austria - the ARETHA AT study |
| Q36266000 | Ranolazine: new approach for the treatment of stable angina pectoris |
| Q84539300 | Ranolazine: new drug. Stable angina: not worth the risk |
| Q41433744 | Rational medical therapy for stable angina pectoris |
| Q33724340 | Rationale and design of the Randomized Evaluation of patients with Stable angina Comparing Utilization of noninvasive Examinations (RESCUE) trial |
| Q54975427 | Re chronic stable angina guidelines. |
| Q41172972 | Reaction of patients with effort angina to cold exposure during exercise |
| Q70160267 | Reactivity of proximal and distal angiographically normal and stenotic coronary segments in chronic stable angina pectoris |
| Q33739083 | Reasons for overprescription of mononitrates: the paradigm of stable angina pectoris treatment |
| Q84113600 | Recanalization of isolated chronic total occlusions in patients with stable angina |
| Q34068784 | Recent advances in the management of chronic stable angina I: Approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities |
| Q24605881 | Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization |
| Q83905721 | Recent changes in practice of elective percutaneous coronary intervention for stable angina |
| Q40155695 | Recent characteristics and outcomes of Japanese stable angina pectoris after percutaneous coronary intervention. An observational cohort study using the Shinken Database |
| Q51666127 | Recurrent and refractory angina following revascularization procedures in patients with stable angina pectoris. |
| Q82637813 | Reduced apelin levels in stable angina |
| Q72315687 | Regional diastolic function in effort angina pectoris: assessment with biplane left ventriculography |
| Q73928932 | Regional distribution and timing of wall motion abnormalities during echo-dipyridamole stress test in patients with stable angina: the elusive link between coronary stenoses and myocardial ischemia |
| Q72541387 | Regional myocardial blood flow in stable angina pectoris associated with isolated significant narrowing of either the left anterior descending or left circumflex coronary artery |
| Q44603500 | Regression of an atherosclerotic coronary artery plaque demonstrated by multislice spiral computed tomography in a patient with stable angina pectoris |
| Q72107415 | Regression of left ventricular wall mass index after coronary artery bypass surgery (CBS) in a group of patients with stable angina pectoris |
| Q72906515 | Relation between clinical presentation and angiographic findings in unstable angina pectoris, and comparison with that in stable angina |
| Q72842476 | Relation between collateral channel filling and flow grade in recipient coronary arteries in patients with stable effort angina |
| Q73315665 | Relation between plaque composition and vascular remodeling in coronary lesions with different degrees of lumen narrowing as assessed with three-dimensional intravascular ultrasound in patients with stable angina pectoris |
| Q73989779 | Relation between plasma fibrinogen level and coronary plaque morphology in patients with stable angina pectoris |
| Q73139591 | Relation between platelet response to exercise and coronary angiographic findings in patients with effort angina |
| Q67594645 | Relation between stimulation site of cardiac afferent nerves by adenosine and distribution of cardiac pain: results of a study in patients with stable angina |
| Q79757474 | Relation of C-reactive protein to coronary collaterals in patients with stable angina pectoris and coronary artery disease |
| Q85364928 | Relation of C-reactive protein to coronary plaque characteristics on grayscale, radiofrequency intravascular ultrasound, and cardiovascular outcome in patients with acute coronary syndrome or stable angina pectoris (from the ATHEROREMO-IVUS study) |
| Q41750657 | Relation of C-reactive protein to extent and severity of coronary narrowing in patients with stable angina pectoris or abnormal exercise tests |
| Q61528011 | Relation of Various Plasma Growth Factor Levels in Patients With Stable Angina Pectoris and Total Occlusion of a Coronary Artery to the Degree of Coronary Collaterals |
| Q42466382 | Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention |
| Q74519082 | Relation of heart rate variability and serum lipoproteins in type 1 diabetes mellitus and chronic stable angina pectoris |
| Q73727661 | Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia |
| Q46543532 | Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris |
| Q70393060 | Relation of severity of symptoms to prognosis in stable angina pectoris |
| Q80962694 | Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris |
| Q52318193 | Relationship between C-reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectoris. |
| Q84290340 | Relationship between coronary artery remodeling and cumulative incidence of coronary angiographic lesions with vulnerable characteristics in patients with stable angina pectoris |
| Q84742436 | Relationship between functional exercise capacity and functional stenosis in patients with stable angina and intermediate coronary stenosis |
| Q91750921 | Relationship between mild renal dysfunction and coronary artery disease in young patients with stable angina pectoris |
| Q35937005 | Relationship between peripheral leukocyte count and the severity of stable angina determined by coronary angiography |
| Q77706323 | Relationship between pressure-derived collateral blood flow and diabetes mellitus in patients with stable angina pectoris: a study based on coronary pressure measurement |
| Q36178268 | Relationship between resistin level in serum and acute coronary syndrome or stable angina pectoris |
| Q43903750 | Relationship between the red cell distribution width and one-year outcomes in chinese patients with stable angina pectoris |
| Q46136457 | Relationship between the red cell distribution width and the one-year outcomes in Chinese patients with stable angina pectoris |
| Q51476584 | Relationship of C-reactive protein to adverse cardiovascular events in patients treated by percutaneous coronary intervention for stable angina pectoris. |
| Q52036342 | Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise test. |
| Q81486750 | Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina |
| Q48018263 | Relationship of depression, stress and endothelial function in stable angina patients |
| Q50907205 | Relationship of mean platelet volume to lymphocyte ratio and coronary collateral circulation in patients with stable angina pectoris. |
| Q80967700 | Relationship of metabolic syndrome with quantum of coronary artery disease in Indian patients with chronic stable angina |
| Q45148060 | Relationship of serum cardiac markers following successful percutaneous coronary intervention and subsequent exercise capacity in patients with chronic stable angina: a pilot study |
| Q91725142 | Relationship of systemic pentraxin-3 values with coronary plaque components on optical coherence tomography and post-percutaneous coronary intervention outcomes in patients with stable angina pectoris |
| Q30677014 | Relationships between inflammatory mediators and coronary plaque composition in patients with stable angina investigated by ultrasound radiofrequency data analysis |
| Q53165762 | Relative clinical and economic impact of exercise echocardiography vs. exercise electrocardiography, as first line investigation in patients without known coronary artery disease and new stable angina: a randomized prospective study. |
| Q38207815 | Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: A systematic review and meta-analysis |
| Q93539223 | Relative roles of preload increase and coronary constriction in ergonovine-induced myocardial ischemia in stable angina pectoris |
| Q73724595 | Report compares treatments for stable angina |
| Q68058209 | Reproducibility and relation to the degree of myocardial ischemia of postexercise electrocardiographic changes in stable angina pectoris |
| Q69008680 | Reproducibility and validity of ambulatory ST segment monitoring in patients with chronic stable angina pectoris |
| Q67978056 | Reproducibility of functional classification in patients with stable angina pectoris |
| Q70589157 | Reproducibility of multistage graded exercise testing in patients with chronic stable angina |
| Q70876318 | Reproducibility of time and frequency domain analysis of heart rate variability in patients with chronic stable angina |
| Q61863775 | Resource allocation for chronic stable angina: a systematic review of effectiveness, costs and cost-effectiveness of alternative interventions |
| Q57605757 | Respective contribution of conventional risk factors and antihypertensive treatment to stable angina pectoris and acute coronary syndrome as the first presentation of coronary heart disease: the PRIME Study |
| Q50470075 | Response 1: relationship between the red cell distribution width and one-year outcomes in patients with stable angina pectoris in a Chinese population. |
| Q50470068 | Response 2: relationship between the red cell distribution width and one-year outcomes in patients with stable angina pectoris in a Chinese population. |
| Q98730284 | Response by Russo et al Regarding Article, "Healed Plaques in Patients With Stable Angina Pectoris" |
| Q67733278 | Response of angina and ischemia to long-term treatment in patients with chronic stable angina: A double-blind randomised individualized dosing trial of nifedipine, propranolol and their combination |
| Q91037622 | Response to Letter to the Editor: "Serum Carnitine Metabolites and Incident Type 2 Diabetes Mellitus in Patients With Suspected Stable Angina Pectoris" |
| Q51010096 | Response to letter regarding article, "revascularization decisions in patients with stable angina and intermediate lesions: results of the international survey on interventional strategy". |
| Q74798491 | Resting 123I-BMIPP scintigraphy in diagnosis of effort angina pectoris with reference to subsets of the disease |
| Q43644876 | Restriction of the referral of patients with stable angina for CT coronary angiography by clinical evaluation and calcium score: impact on clinical decision making |
| Q73370400 | Results of coronary stenting for unstable versus stable angina pectoris |
| Q44639401 | Results of international study of quality of life of patients with stable angina treated with nitrates (IQOLAN) |
| Q51040725 | Revascularization decisions in patients with stable angina and intermediate lesions: results of the international survey on interventional strategy. |
| Q41690825 | Revascularization strategies in patients with stable angina pectoris |
| Q48059711 | Revascularization with percutaneous coronary intervention does not affect androgen status in males with chronic stable angina pectoris |
| Q42465130 | Reversal of left ventricular "rigid body rotation" during dipyridamole-induced stress in a patient with stable angina: a case from the three-dimensional speckle tracking echocardiographic MAGYAR-Stress Study |
| Q78342574 | Revisiting the Canadian Cardiovascular Society grading of stable angina pectoris after a quarter of a century of use |
| Q81692817 | Revisiting the role of percutaneous coronary interventions in stable angina: The landscape after the COURAGE trial |
| Q71020570 | Right and left ventricular function during exercise-induced angina pectoris in patients with coronary artery disease (author's transl) |
| Q91286496 | Risk factors and in-hospital outcomes of acute kidney injury that developed after coronary artery bypass grafting in patients with stable angina |
| Q92444097 | Risk factors for coronary artery disease in young patients with stable angina pectoris |
| Q70177565 | Risk factors for operative mortality and morbidity in patients undergoing coronary artery bypass surgery for stable angina pectoris |
| Q44497504 | Risk factors in schoolchildren associated with a family history of unheralded myocardial infarction or uncomplicated stable angina in male relatives. |
| Q51283747 | Risk prediction in stable angina pectoris. |
| Q34081514 | Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients |
| Q69772708 | Risk stratification in stable angina pectoris |
| Q73855889 | Risk-sensitive therapeutic strategies for coronary artery disease: toward testing-driven therapy in stable angina patients with low-to-intermediate risk cardiac imaging results |
| Q69876890 | Role of alpha-adrenergic coronary tone in exercise-induced angina pectoris |
| Q41240309 | Role of coronary vasomotor tone in patients with stable angina pectoris. |
| Q42006721 | Role of dongchongxiacao (Cordyceps) in prevention of contrast-induced nephropathy in patients with stable angina pectoris |
| Q72594221 | Role of heart rate in pathophysiology of chronic stable angina |
| Q54961020 | Role of ivabradine in management of stable angina in patients with different clinical profiles. |
| Q87353205 | Role of plaque calcification regulators osteoprotegerin and matrix Gla-proteins in stable angina and acute myocardial infarction |
| Q44368636 | Role of plasma C-reactive protein in predicting in-stent restenosis in patients with stable angina after coronary stenting. |
| Q50452471 | Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting. |
| Q50441202 | Role of red blood cell distribution width in predicting contrast induced nephropathy in patients with stable angina pectoris undergoing percutaneous coronary intervention. |
| Q70171361 | Routine coronary angiography for effort angina |
| Q68238076 | ST 567 (alinidine) in stable angina: a comparison with metoprolol |
| Q68238081 | ST 567 compared with propranolol in stable angina |
| Q36432698 | ST segment analysis in 24-hour long-term ECG in patients with stable angina pectoris and angiographically detected coronary sclerosis |
| Q38650810 | SYNTAX Score and Pre- and Poststent Optical Coherence Tomography Findings in the Left Anterior Descending Coronary Artery in Patients With Stable Angina Pectoris |
| Q33174345 | Safety and compatibility of betaxolol hydrochloride combined with diltiazem or nifedipine therapy in stable angina pectoris |
| Q39430863 | Safety and efficacy of Hartone in stable angina pectoris--an open comparative trial |
| Q34349562 | Safety and efficacy of beta-blockers in the treatment of stable angina pectoris. |
| Q70217223 | Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: report of a cooperative clinical trial |
| Q95818399 | Safety and efficacy of extended-release ranolazine in patients aged 70 years or older with chronic stable angina pectoris |
| Q73106162 | Safety and efficacy of monotherapy with fantofarone, a novel calcium channel antagonist, in patients with chronic stable angina pectoris. Fantofarone Study Group |
| Q70546139 | Safety and efficacy of pentoxifylline in stable angina pectoris |
| Q72560573 | Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty |
| Q51100563 | Safety and efficacy of short-term celecoxib before elective percutaneous coronary intervention for stable angina pectoris. |
| Q96167508 | Safety assessment and results of coronary spasm provocation testing in patients with myocardial infarction with unobstructed coronary arteries compared to patients with stable angina and unobstructed coronary arteries |
| Q34565845 | Safety of nifedipine GITS in stable angina: the ACTION trial. |
| Q28318942 | Safety profile of bepridil determined from clinical trials in chronic stable angina in the United States |
| Q77077255 | Safety, tolerability, and antiischaemic efficacy of ITF-296, a nitric oxide donor, in patients with chronic stable angina |
| Q35581156 | Same day discharge following elective percutaneous coronary intervention in patients with stable angina |
| Q93731698 | Scoring prognosis in stable angina |
| Q50084994 | Screening and verification of plasma biomarkers for stable angina pectoris: a differential proteomic analysis |
| Q74752546 | Selection of drug therapy in stable angina pectoris |
| Q72260261 | Selection of medical treatment in stable angina pectoris: results of the International Multicenter Angina Exercise (IMAGE) Study |
| Q28194412 | Selection of optimal therapy for chronic stable angina |
| Q40742593 | Selection of revascularization for patients with stable angina pectoris. |
| Q46850224 | Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate |
| Q44047882 | Selective L-type, T-type, and nonspecific calcium-channel blockers for stable angina pectoris |
| Q60195536 | Sensitive troponin and N-terminal probrain natriuretic peptide in stable angina |
| Q41833137 | Sensitivity, specificity and predictive values of linear and nonlinear indices of heart rate variability in stable angina patients |
| Q50147010 | Serial 3-Vessel Optical Coherence Tomography and Intravascular Ultrasound Analysis of Changing Morphologies Associated With Lesion Progression in Patients With Stable Angina Pectoris |
| Q43470232 | Serial exercise testing in patients with effort angina: variable tolerance, fixed threshold |
| Q71782613 | Serial thallium-201 imaging at rest in patients with unstable and stable angina pectoris: relationship of myocardial perfusion at rest to presenting clinical syndrome |
| Q38381282 | Serum Acylcarnitines and Risk of Cardiovascular Death and Acute Myocardial Infarction in Patients With Stable Angina Pectoris |
| Q79382077 | Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis |
| Q50084455 | Serum Carnitine Metabolites and Incident Type 2 Diabetes Mellitus in Patients with Suspected Stable Angina Pectoris |
| Q90576549 | Serum Endocan Levels Predict Drug-Eluting Stent Restenosis in Patients with Stable Angina Pectoris |
| Q94924792 | Serum VEGF: Diagnostic Value of Acute Coronary Syndrome from Stable Angina Pectoris and Prognostic Value of Coronary Artery Disease |
| Q87535075 | Serum adiponectin and markers of endothelial dysfunction in stable angina pectoris patients undergoing coronary artery bypass grafting (CABG) |
| Q42868073 | Serum choline levels in patients with stable angina and acute coronary syndromes: relation to the severity of coronary artery disease |
| Q51453441 | Serum creatinine is independently associated with angiographic extent of coronary artery disease in patients with stable angina pectoris. |
| Q43082025 | Serum levels of total p-cresylsulphate are associated with angiographic coronary atherosclerosis severity in stable angina patients with early stage of renal failure |
| Q59275996 | Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris |
| Q46927817 | Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris |
| Q77430557 | Serum sialic acid concentration is not associated with the extent or severity of coronary artery disease in patients with stable angina pectoris |
| Q39161716 | Serum total p-cresylsulfate level is associated with abnormal QTc interval in stable angina patients with early stage of renal failure. |
| Q44579499 | Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes |
| Q90547724 | Serum visfatin level is associated with complexity of coronary artery disease in patients with stable angina pectoris |
| Q46643884 | Severity of silent myocardial ischemia on ambulatory electrocardiographic monitoring in patients with stable angina pectoris: relation to prognostic determinants during exercise stress testing and coronary angiography |
| Q38734075 | Sex Differences in Cardiac Medication Use Post-Catheterization in Patients Undergoing Coronary Angiography for Stable Angina with Nonobstructive Coronary Artery Disease |
| Q40891460 | Sex and Ethnic Differences in Outcomes of Acute Coronary Syndrome and Stable Angina Patients With Obstructive Coronary Artery Disease. |
| Q46142348 | Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease |
| Q33971180 | Sexual intercourse and stable angina pectoris |
| Q57452932 | Shenzhu Guanxin Recipe Granules () for Improving Exercise Tolerance in Patients with Stable Angina (SERIES Trial): A Protocol of Multicenter, Randomized, Double-Blind, Placebo Parallel Controlled Clinical Trial |
| Q42071527 | Short and long term outcome of percutaneous transluminal coronary angioplasty in unstable versus stable angina pectoris: a report of the 1985-1986 NHLBI PTCA Registry |
| Q40587843 | Short and long-acting oral nitrates for stable angina pectoris |
| Q55423763 | Short term clinical outcomes of Everolimus-eluting stents in patients with stable angina pectoris. |
| Q53583156 | Short- and long-term effects of molsidomine retard and molsidomine nonretard on exercise capacity and clinical status in patients with stable angina: a multicenter randomized double-blind crossover placebo-controlled trial. |
| Q70389596 | Short- and long-term efficacy of nicardipine, assessed by placebo-controlled single- and double-blind crossover trials in patients with chronic stable angina |
| Q73265850 | Short- and long-term risk factors for sudden death in patients with stable angina |
| Q30443914 | Short- and long-term treatment of stable effort angina with nicardipine, a new calcium channel blocker: a double-blind, placebo-controlled, randomised, repeated cross-over study |
| Q71805700 | Short-Term Effects of Captopril on Exercise Tolerance in Patients with Chronic Stable Angina pectoris and Normal Left Ventricular Function |
| Q38057398 | Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal |
| Q74501827 | Should troponin-T be assessed during exercise stress testing in patients with stable angina pectoris? |
| Q68377767 | Significance of changes in phospholipid condition of cell membranes in the development of tolerance to long-acting nitrates in patients with exercise-induced angina pectoris |
| Q74012776 | Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina |
| Q68715414 | Silent ischemia during daily life is an independent predictor of mortality in stable angina |
| Q31982089 | Silent ischemic interval on exercise test is a predictor of response to drug therapy: a randomized crossover trial of metoprolol versus diltiazem in stable angina |
| Q33999851 | Silent myocardial ischaemia in chronic stable angina: a study of its frequency and characteristics in 150 patients |
| Q71667629 | Silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with effort angina |
| Q39354526 | Simultaneous recording of continuous arterial pressure, heart rate, and ST segment in ambulant patients with stable angina pectoris |
| Q43905073 | Six-month xenical (orlistat) therapy of patients with stable angina pectoris concomitant with obesity and hyperlipidemia |
| Q70855534 | Slow channel calcium blockers in the treatment of chronic stable angina |
| Q34397959 | Slow release nifedipine plus atenolol in chronic stable angina pectoris |
| Q67807980 | Slow-release gallopamil in patients with stable effort angina |
| Q44993872 | Smaller HDL particles are associated with absence of obstructive coronary artery disease in stable angina pectoris patients |
| Q42452532 | Spontaneous superoxide generation by polymorphonuclear leukocytes isolated from patients with stable angina after physical exercise |
| Q36643746 | Spotlight on ranolazine in chronic stable angina pectoris |
| Q64091904 | Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence |
| Q73236779 | Stable Angina Pectoris |
| Q89363528 | Stable Angina in Advanced CKD |
| Q95462293 | Stable Angina: Methods, Evidence & Guidance |
| Q45944272 | Stable angina and ST-segment depression: diagnostic value in patients undergoing coronary angiography. |
| Q43636285 | Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets |
| Q73488545 | Stable angina and coronary angioplasty |
| Q39404009 | Stable angina as a manifestation of ischemic heart disease: medical management |
| Q45256036 | Stable angina in Spain and its impact on quality of life. The AVANCE registry |
| Q88052240 | Stable angina in the elderly: diagnostic and therapeutic approach |
| Q37828049 | Stable angina in women: lessons from the National Heart, Lung and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation |
| Q68696082 | Stable angina pectoris and controlled ischemia: what causes the abnormalities in whole blood filterability? |
| Q28221880 | Stable angina pectoris can be treated successfully by drugs alone--pro |
| Q61875223 | Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events |
| Q46938082 | Stable angina pectoris, angina pectoris of effort, stable angina pectoris of effort |
| Q38212580 | Stable angina pectoris. |
| Q68902987 | Stable angina pectoris. Risk stratification and therapeutic options |
| Q38142753 | Stable angina pectoris: 1. Clinical patterns |
| Q38142756 | Stable angina pectoris: 2. Cardiac evaluation and diagnostic testing |
| Q37579772 | Stable angina pectoris: 3. Medical treatment |
| Q37924086 | Stable angina pectoris: antianginal therapies and future directions |
| Q38046959 | Stable angina pectoris: current medical treatment. |
| Q39713563 | Stable angina pectoris: head-to-head comparison of prognostic value of cardiac CT and exercise testing |
| Q40867104 | Stable angina pectoris: recent advances in predicting prognosis and treatment |
| Q37994290 | Stable angina pectoris: the medical management of symptomatic myocardial ischemia |
| Q73463907 | Stable angina pectoris: treatment and referral options |
| Q34130288 | Stable angina pectoris: what does the current clinical evidence tell us? |
| Q86578056 | Stable angina: current state of disease management |
| Q39456152 | Stable angina: drugs, angioplasty or surgery? |
| Q71955634 | Stable angina: long-term results |
| Q73225453 | Stable angina: maximal medical therapy is not the same as optimal medical therapy |
| Q42753252 | Stable angina: role of ivabradine unchanged between 2006 and 2010. |
| Q74426123 | Stable angina: two important trials--RITA-2 and ACIP( Asymptomatic Cardiac Ischaemia Pilot) |
| Q48188618 | Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need |
| Q28175181 | Standard pharmacological therapy associated with percutaneous coronary interventions in patients with stable angina |
| Q83161367 | States, rates and traits: prognosis research and chronic stable angina |
| Q51484977 | Statins for treating stable angina: can statins improve the plaque morphology and angina? |
| Q88861301 | Statins in Stable Angina Pectoris |
| Q35124093 | Stenosis level, plaque morphology and intima-media thickness of internal carotid artery in chronic stable angina and acute coronary syndrome; a comparative study |
| Q37864836 | Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris |
| Q49565150 | Stenting Does Not Relieve Stable Angina Symptoms |
| Q24247580 | Stents versus coronary artery bypass graft in people with stable angina or acute coronary syndrome |
| Q42769652 | Studies in meta-analysis of treatment of stable angina had methodological flaws |
| Q76498128 | Study of the fundus oculi in subjects suffering from coronary disease (Angina of effort and myocardial infarct) or arteriopathy of the lower extremities |
| Q80799360 | Study stirs debate about treatment of stable angina |
| Q51991866 | Suboptimal pharmacotherapeutic management of chronic stable angina in the primary care setting. |
| Q80297225 | Summaries for patients. Diagnosis and evaluation of patients with chronic stable angina: recommendations from the American College of Physicians |
| Q71577721 | Superiority of verapamil to propranolol in stable angina pectoris: a double-blind, randomized crossover trail |
| Q72925344 | Superoxide dismutase and catalase activity in patients with stable angina pectoris |
| Q42526406 | Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris |
| Q43753581 | Suppression of exercise-induced angina by magnesium sulfate in patients with variant angina |
| Q67932378 | Suppression of exercise-induced angina by magnesium sulfate in patients with variant angina |
| Q66875340 | Surgical treatment for stable angina pectoris. Prospective randomized study |
| Q67498640 | Surgical versus medical treatment for stable angina pectoris: prospective randomized study with 1- to 4-year follow-up |
| Q95589914 | Surveillance report 2016 – Stable angina: management (2011) NICE guideline CG126 |
| Q38596133 | Survival of men treated for chronic stable angina pectoris. A cooperative randomized study |
| Q69733273 | Sustained effect of and lack of development of tolerance to controlled-release isosorbide-5-mononitrate in chronic stable angina pectoris |
| Q70328377 | Sustained release verapamil, a once daily preparation: objective evaluation using exercise testing, ambulatory monitoring and blood levels in patients with stable angina |
| Q68817919 | Sustained-release diltiazem in patients with effort angina and severe coronary artery sclerosis |
| Q69406063 | Sustained-release diltiazem versus metoprolol in stable angina pectoris |
| Q68084719 | Sustained-release verapamil and nifedipine in exercise-induced angina pectoris |
| Q67255889 | Sustained-release verapamil in stable angina |
| Q34788795 | Symptom clusters and health-related quality of life in people with chronic stable angina |
| Q84535196 | Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting |
| Q95318420 | Systemic Cardiac Troponin T Associated With Incident Atrial Fibrillation Among Patients With Suspected Stable Angina Pectoris |
| Q77771410 | Systemic T-cell activation in stable angina pectoris |
| Q69899141 | Systemic and coronary hemodynamic effects of combined alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress test responses |
| Q68448529 | Systemic and coronary hemodynamic effects of combined oral alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress tests |
| Q54292241 | Systemic neurohumoral activation and vasoconstriction during pacing-induced acute myocardial ischemia in patients with stable angina pectoris. |
| Q72369023 | T lymphocyte activation in stable angina pectoris and after percutaneous transluminal coronary angioplasty |
| Q39672487 | TWO CASES OF TEMPORAL ARTERITIS: ONE WITH ANGINA OF EFFORT |
| Q57117871 | Tailor treatment to the patient in stable angina |
| Q51059922 | Tailored antiplatelet therapy to improve prognosis in patients exhibiting clopidogrel low-response prior to percutaneous coronary intervention for stable angina or non-ST elevation acute coronary syndrome. |
| Q64047757 | Takayasu arteritis masquerading as stable angina in a 29-year-old man |
| Q40081976 | Technetium-99m pyrophosphate myocardial uptake in patients with stable angina pectoris |
| Q71611664 | Tenuous link between ischaemic threshold and both ambulatory ischaemia and symptom status over time in stable angina: a 5-year follow-up study |
| Q35112258 | Terminalia arjuna in Chronic Stable Angina: Systematic Review and Meta-Analysis. |
| Q74562149 | The "warm-up" phenomenon occurs in patients with chronic stable angina but not in patients with syndrome X |
| Q34597185 | The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension |
| Q81619550 | The AbCs of modem management of chronic stable angina pectoris |
| Q88688147 | The Effectiveness of Trimetazidine Treatment in Patients with Stable Angina Pectoris of Various Durations: Results from the CHOICE-2 Study |
| Q74540442 | The Effects of Sublingual Administration of Captopril on Parameters of Exercise Test and Neurohormonal Activation in Patients With Stable Angina Pectoris |
| Q34183152 | The Estimation of GC Repeats in Promoter P1 of IGF-1 Gene and Their Influence on IGF-1 Plasma Levels in Stable Angina Patients |
| Q90590361 | The ORBITA trial: Why is it not the last nail for coronary angioplasty in stable angina patients? |
| Q46201551 | The PRIMA study: trimetazidin in the treatment of patients with stable angina pectoris after myocardial infarction. Epidemiological and clinical phases |
| Q37041300 | The Pleiotropic Effects of Atorvastatin on Stable Angina Patients: Evidence by Analysis of High-Density Lipoprotein Size and Subclasses, and Plasma mRNA. |
| Q96641855 | The Role of Revascularization in Chronic Stable Angina: Do We Have an Answer? |
| Q35065844 | The Seattle angina questionnaire: reliability and validity in women with chronic stable angina |
| Q40248462 | The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris. |
| Q45337504 | The Veterans Administration Cooperative Study of stable angina: current status |
| Q45334864 | The Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery for Stable Angina: a continuing debate after 22 years |
| Q67783914 | The ability of captopril to enhance the anti-anginal effect of isosorbide dinitrate in patients with stable exercise-induced angina pectoris |
| Q68093303 | The acute and chronic effects of 50 mg of isosorbide 5-mononitrate with delayed action in patients with stable angina of effort |
| Q70378082 | The anti-anginal effect of a new Hungarian long-acting nitroglycerin drug (Nitromint retard) in stable effort angina pectoris |
| Q43557790 | The anti-ischemic effect of gallopamil-retard in comparison with nifedipine-retard in stable angina pectoris |
| Q74455516 | The assessment of platelet derived growth factor concentration in post myocardial infarction and stable angina patients |
| Q34613379 | The association between coronary slow flow and platelet distribution width among patients with stable angina pectoris |
| Q30457953 | The association of angiographic collaterals with long-term clinical outcomes in patients with chronic stable angina |
| Q47219609 | The associatıon between serum serglycin level and coronary artery disease severity in patients with stable angina pectoris |
| Q70475012 | The beneficial effect of diltiazem on exercise-induced ST depression, measured by body surface mapping, in stable effort angina pectoris |
| Q50936362 | The characteristic of certain personality features in men with angina of effort (author's transl) |
| Q46390908 | The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina |
| Q89124853 | The clinical significance of echo-attenuated plaque in stable angina pectoris compared with acute coronary syndromes: A combined intravascular ultrasound and optical coherence tomography study |
| Q32102463 | The comparison of the efficacy of atenolol and isosorbide dinitrate therapy in chronic hypotension patients with stable angina pectoris |
| Q37660901 | The conundrum of detecting stable angina pectoris in the community setting |
| Q89367237 | The correlation between speckle tracking echocardiography and coronary artery disease in patients with suspected stable angina pectoris |
| Q35169226 | The current practice of percutaneous transluminal coronary angioplasty (PTCA) and stent deployment and their long-term results in unstable and stable angina |
| Q81737251 | The current practice of percutaneous transluminal coronary angioplasty (PTCA) and stent deployment and their long-term results in unstable and stable angina |
| Q69703748 | The development and reversal of tolerance to antianginal effect of isosorbide dinitrate in patients with effort angina |
| Q61455267 | The development of heart failure in patients with stable angina pectoris |
| Q38195172 | The diagnostic accuracy and outcomes after coronary computed tomography angiography vs. conventional functional testing in patients with stable angina pectoris: a systematic review and meta-analysis |
| Q49949793 | The diagnostic process of stable angina: still many doubts since Heberden's first description 250 years ago. |
| Q53215322 | The diagnostic value of computed tomographic coronary angiography in patients with acute myocardial infarction versus stable angina pectoris: a preliminary report. |
| Q87561985 | The different association of epicardial fat with coronary plaque in patients with acute coronary syndrome and patients with stable angina pectoris: analysis using integrated backscatter intravascular ultrasound |
| Q74611586 | The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter S |
| Q46883918 | The editor's roundtable: chronic stable angina pectoris |
| Q47164065 | The effect of Danshen extract on lipoprotein-associated phospholipase A2 levels in patients with stable angina pectoris: study protocol for a randomized controlled trial - the DOLPHIN study |
| Q42260267 | The effect of diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study |
| Q79486229 | The effect of intravenous aminophylline on the capacity for effort without pain in patients with angina of effort |
| Q43661325 | The effect of long-term administration of isosorbide 5-mononitrate (Mononit), nitric oxide donor, on gallbladder emptying in patients with chronic stable angina |
| Q70767884 | The effect of nitrate on the oxygen availability during exercise in effort angina pectoris |
| Q69283767 | The effect of nitroglycerin ointment on exercise-induced angina: a multicenter trial |
| Q70465359 | The effect of sodium cromoglycate on the development of exercise-induced angina pectoris |
| Q72707986 | The effect of sulfinpyrazone on treadmill exercise-induced angina pectoris |
| Q42255660 | The effect on left ventricular performance of nifedipine and metoprolol singly and together in exercise-induced angina pectoris |
| Q92637595 | The effectiveness of moxibustion for stable angina pectoris: A meta-analysis and trial sequential analysis protocol |
| Q90470738 | The effects of Melissa officinalis (lemon balm) in chronic stable angina on serum biomarkers of oxidative stress, inflammation and lipid profile |
| Q89124357 | The effects of Melissa officinalis supplementation on depression, anxiety, stress, and sleep disorder in patients with chronic stable angina |
| Q54392033 | The effects of antianginal drugs on left ventricular function in patients with effort angina pectoris. Comparison among isosorbide dinitrate, nifedipine and propranolol by PANOVA. |
| Q55037195 | The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group |
| Q68211064 | The effects of captopril in stable angina pectoris |
| Q72992409 | The effects of dyslipidemia on left ventricular systolic function in patients with stable angina pectoris |
| Q46050457 | The effects of enhanced external counterpulsation on myocardial perfusion in patients with stable angina: a multicenter radionuclide study |
| Q39565374 | The effects of lidoflazine on exercise performance and thallium stress scintigraphy in patients with stable angina pectoris |
| Q70400486 | The effects on exercise tolerance of a new transdermal therapeutic system containing nitroglycerine, in patients with stable angina pectoris |
| Q42532002 | The effects on left ventricular performance of nifedipine and verapamil in exercise-induced angina pectoris |
| Q54449401 | The effects on left ventricular performance of verapamil and metoprolol singly and together in exercise-induced angina pectoris. |
| Q69377365 | The efficacy and safety of dilevalol in patients with chronic stable angina pectoris |
| Q87734053 | The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris |
| Q50865904 | The efficacy and safety of mibefradil in subgroups of patients with chronic stable angina pectoris. |
| Q42789892 | The efficacy and safety of the combination of β-blocker bisoprolol and if inhibitor I(f) ivabradine in patients with stable angina and chronic obstructive pulmonary disease |
| Q68345842 | The efficacy and tolerance to three doses of diltiazem in elderly patients with stable angina |
| Q90144968 | The efficacy of acupuncture for stable angina pectoris: A systematic review and meta-analysis |
| Q38281542 | The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials |
| Q41783921 | The effort test in the diagnosis of typical stable effort angina (author's transl) |
| Q44760546 | The exercise test that indicates a low risk of events. Differences in prognostic significance between patients with chronic stable angina and patients with unstable angina |
| Q84066815 | The impact of beta-blockers on mortality in stable angina: a meta-analysis |
| Q89184058 | The impact of blood pressure variability on coronary plaque vulnerability in stable angina: an analysis using optical coherence tomography |
| Q46714456 | The impact of diabetes or elevated fasting blood glucose on cardiovascular prognosis in patients with stable angina pectoris |
| Q38960864 | The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable angina |
| Q44453526 | The independent relationship between systemic inflammation and fragmented QRS complexes in patients with stable angina pectoris. |
| Q72655305 | The long-term safety and tolerability of transdermal glyceryl trinitrate, when used with a patch-free interval in patients with stable angina |
| Q42634311 | The long-term treatment of stable angina pectoris with verapamil |
| Q40936049 | The management of patients with stable angina and multivessel disease. PTCA or coronary bypass surgery? |
| Q72208080 | The management of stable angina |
| Q77140771 | The management of stable angina |
| Q77847450 | The medical management of chronic stable angina |
| Q57620981 | The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability |
| Q36055295 | The pharmacokinetics of trinitroglycerin and its metabolites in patients with chronic stable angina |
| Q33770930 | The place of metabolic agents in the management of stable angina pectoris |
| Q95315934 | The predictive value of speckle tracking during dobutamine stress echocardiography in patients with chronic stable angina |
| Q49035276 | The prevalence of weekly angina among patients with chronic stable angina in primary care practices: The Coronary Artery Disease in General Practice (CADENCE) Study |
| Q80342686 | The pro- and anti-inflammatory markers in patients with acute myocardial infarction and chronic stable angina |
| Q47859322 | The prognostic value of combined fractional flow reserve and TIMI frame count measurements in patients with stable angina pectoris and acute coronary syndrome |
| Q43532313 | The program ALTERNATIVA--investigation of antianginal efficacy and tolerability of coraxan (ivabradine) and assessment of quality of life of patients with stable angina: results of an epidemiological stage |
| Q64899936 | The prolonged effect of pentaerythritol tetranitrate on exercise capacity in stable effort angina pectoris. |
| Q52985279 | The relation between coronary tortuosity and calcium score in patients with chronic stable angina and normal coronaries by CT angiography. |
| Q87176054 | The relation between the levels of osteoprotegerin and the degree of coronary artery disease in patients with acute coronary syndrome and stable angina pectoris |
| Q86560510 | The relation of platelet-lymphocyte ratio and coronary collateral circulation in patients with stable angina pectoris and chronic total occlusion |
| Q35945126 | The relationship between ankle-brachial index and number of involved coronaries in patients with stable angina |
| Q43917554 | The relationship between diastolic pressure and coronary collateral circulation in patients with stable angina pectoris and chronic total occlusion |
| Q80541507 | The relationship between plasma C-reactive protein levels and presence and severity of coronary stenosis in patients with stable angina |
| Q91886792 | The relationship between prolactin levels and the results of holter monitoring in patients with stable angina of tension and gastroesophageal reflux disease |
| Q53473296 | The relationship between revascularization extent and the long-term prognosis of patients with stable angina pectoris and three-vessel disease treated by percutaneous coronary intervention in the era of drug-eluting stents. |
| Q33594888 | The relevance of sympathetic activity in the pharmacological treatment of chronic stable angina |
| Q36606732 | The reproducibility of hemodynamic, electrocardiographic, and gas exchange data during treadmill exercise in patients with stable angina pectoris |
| Q36745665 | The risk assessment for a fatal outcome in patients with stable angina based on the data from a long-term prospective observation (a comparison of the 5-year survival prognosis with the data at the 6th to 12th years of the observation) |
| Q50936369 | The risk factors in a group of men with angina of effort (author's transl) |
| Q35129946 | The role of multi-slice computed tomography in stable angina management: a current perspective |
| Q39469860 | The role of nitrates, beta blockers, and calcium antagonists in stable angina pectoris |
| Q58580295 | The role of polysaccharide peptide of Ganoderma lucidum as a potent antioxidant against atherosclerosis in high risk and stable angina patients |
| Q39462302 | The role of triple therapy in patients with chronic stable angina pectoris |
| Q77636435 | The roles for coronary surgery and angioplasty in the management of patients with stable angina: evidence and decision making |
| Q68527864 | The sensitivity of the symptom angina pectoris as a marker of transient myocardial ischaemia in chronic stable angina pectoris |
| Q62476900 | The significance of human platelet-activating factor-acetylhydrolase in patients with chronic stable angina |
| Q55044940 | The therapeutic effect of L-carnitine in patients with exercise-induced stable angina: a controlled study. |
| Q68353970 | The therapeutic effect of nitromint retard on patients with stable angina pectoris |
| Q69964258 | The time of onset of action of sublingual nitroglycerin in exercise-induced angina pectoris. A methodological study |
| Q37668815 | The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention. |
| Q80282662 | The treatment of angina of effort |
| Q72143890 | The treatment of exercise-inducible chronic stable angina with diltiazem. Effect on treadmill exercise |
| Q35267778 | The treatment of stable angina pectoris |
| Q34399982 | The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials |
| Q47331027 | The value of peripheral blood eosinophil count in predicting in-stent restenosis in patients with stable angina pectoris undergoing drug eluting stenting |
| Q34000264 | The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina |
| Q68244414 | Therapeutic double blind study of Gallopamil in patients with reproducible stable angina pectoris |
| Q28319089 | Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia |
| Q71536836 | Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia |
| Q43863541 | Therapeutic perspectives in the treatment of stable angina |
| Q36137967 | Therapy for stable angina in women |
| Q70664116 | Therapy for stable angina pectoris |
| Q81335058 | Therapy of stable angina pectoris: the uncomplicated patient |
| Q39428060 | Thirty years of coronary revascularization in stable angina pectoris. Results of randomized controlled trials |
| Q93081108 | Three-Dimensional Fibrous Cap Structure of Coronary Lipid Plaque - ST-Elevation Myocardial Infarction vs. Stable Angina |
| Q72142109 | Three-month efficacy and safety of once-daily diltiazem in chronic stable angina pectoris |
| Q73515213 | Thrombelastography in healthy volunteers, patients with stable angina and acute chest pain |
| Q81634954 | Thrombin activatable fibrinolysis inhibitor (TAFI) in stable angina pectoris patients undergoing coronary artery bypass grafting (CABG) |
| Q87383390 | Thrombus and antiplatelet therapy in type 2 diabetes mellitus. A prospective study after non-ST elevation acute coronary syndrome and a randomised, blinded, placebo-controlled study in stable angina |
| Q69589880 | Tiapamil, a new calcium channel blocking agent for the treatment of effort induced chronic stable angina pectoris |
| Q72340466 | Time course of "warm-up" in stable angina |
| Q48734799 | Tissue Doppler echocardiography improves the diagnosis of coronary artery stenosis in stable angina pectoris. |
| Q85622892 | Tissue characteristics of non-culprit plaque in patients with acute coronary syndrome vs. stable angina: a color-coded intravascular ultrasound study |
| Q79271028 | Tolerability to 1-year treatment with once-daily molsidomine in patients with stable angina |
| Q67879115 | Tolerance to standard and non-ionic contrast media in patients with ischemic heart disease and stable angina pectoris during coronary angiography |
| Q45350363 | Total left main coronary artery occlusion presenting with stable angina and normal ECG. |
| Q67901665 | Total occlusion of left main coronary artery in a patient with chronic, stable angina |
| Q68000930 | Total occlusion of the left main coronary artery in chronic stable angina pectoris |
| Q69419175 | Total occlusion of the left main coronary artery in chronic stable angina pectoris |
| Q50744597 | Tracking coronary calcification and atherosclerotic lesions in patients with stable angina pectoris undergoing nifedipine therapy. |
| Q24235299 | Traditional Chinese herbal products for stable angina |
| Q34517505 | Traditional Chinese medicine for stable angina pectoris via TCM pattern differentiation and TCM mechanism: study protocol of a randomized controlled trial |
| Q24247803 | Traditional chinese interventions for stable angina |
| Q53608484 | Transcoronary sinus administration of autologous bone marrow in patients with chronic refractory stable angina Phase 1. |
| Q67872325 | Transdermal monotherapy with mepindolol BIO TSD in patients with stable angina pectoris. Placebo-controlled, crossover investigation of a new therapeutic concept with 12-hours overnight application |
| Q44179051 | Transdermal nitroglycerin efficacy in patients with chronic stable angina pectoris as related to sympathetic and renin-angiotensin-aldosterone activity |
| Q67839172 | Transdermal nitroglycerin in patients with stable angina |
| Q93373778 | Transient left septal fascicular block in a patient with stable effort angina and critical proximal obstruction of left anterior descending coronary artery |
| Q67965112 | Transient myocardial ischaemia during ambulatory monitoring out of hospital in patients with chronic stable angina pectoris |
| Q69919022 | Transient myocardial ischemia after abrupt withdrawal of antianginal therapy in chronic stable angina |
| Q70533656 | Transient myocardial ischemia during nifedipine therapy in stable angina pectoris, and its relation to coronary collateral flow and comparison with metoprolol |
| Q70304907 | Transmucosal and transdermal nitroglycerin delivery systems for prevention of chronic stable angina pectoris |
| Q94602131 | Transsulfuration metabolites and the association with incident atrial fibrillation - An observational cohort study among Norwegian patients with stable angina pectoris |
| Q83105891 | Trapidil is as effective as isosorbide-dinitrate for treating stable angina pectoris: a multinational, multicenter, double-blind, randomized study |
| Q53128488 | Treating stable angina - is there a NICE way towards an international consensus? |
| Q33699764 | Treatment of Stable Angina Pectoris |
| Q36536868 | Treatment of Stable Angina Pectoris With Ivabradine in Everyday Practice: A Pan-Hellenic, Prospective, Noninterventional Study |
| Q47139170 | Treatment of Stable Angina with a New Fixed-Dose Combination of Ivabradine and Metoprolol: Effectiveness and Tolerability in Routine Clinical Practice |
| Q79561105 | Treatment of angina of effort with androgens |
| Q35537250 | Treatment of chronic stable angina pectoris |
| Q45369980 | Treatment of chronic stable angina pectoris with angiotensin converting enzyme inhibition--a randomized, placebo-controlled, double-blind cross-over study |
| Q70128190 | Treatment of chronic stable angina with carvedilol in comparison with nifedipine s.r. |
| Q77153692 | Treatment of chronic stable angina with carvedilol: a multiple-action neurohormonal antagonist. A review of controlled clinical trials |
| Q83247981 | Treatment of effort angina with sex hormones: preliminary report |
| Q71590042 | Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine |
| Q33711927 | Treatment of stable angina |
| Q80480009 | Treatment of stable angina |
| Q71609355 | Treatment of stable angina of effort with verapamil: a double-blind, placebo-controlled randomized crossover study |
| Q43271252 | Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study |
| Q39460455 | Treatment of stable angina pectoris with calcium antagonists alone or combined with beta-blocking agents: a review of the literature. |
| Q57651197 | Treatment of stable angina pectoris with calcium antagonists and beta-blockers. The APSIS study. Angina Prognosis Study in Stockholm |
| Q46698171 | Treatment of stable angina pectoris with trimetazidine modified release in Indian primary-care practice |
| Q71566685 | Treatment of stable angina pectoris with verapamil hydrochloride: a double blind cross-over study |
| Q43732071 | Treatment of stable angina pectoris: is there a role for dipyridamole? |
| Q72808885 | Treatment of stable angina pectoris: when to operate? |
| Q44378569 | Treatment of stable angina with low dose diltiazem in combination with the metabolic agent trimetazidine |
| Q36193239 | Treatment of stable angina: medical and invasive therapy--implications for the elderly |
| Q67541609 | Treatment of transient myocardial ischemia in patients with stable angina: a comparative study of verapamil slow-release and nifedipine plus propranolol |
| Q93022034 | Treatment selection and medication adherence for stable angina: The role of area-based health literacy |
| Q74798048 | Trial of drugs for angina of effort: the oral use of pentaerythritol tetranitrate, including a comparison with aminophylline and dihydroxypropyltheophylline |
| Q74404135 | Trial of drugs for angina of effort; the oral use of dihydroxypropyltheophylline and aminophylline |
| Q54599925 | Trial of labetalol in effort angina pectoris |
| Q71984930 | Trimetazidine European Multicenter Study Versus Propranolol in Stable Angina Pectoris: Contribution of Holter Electrocardiographic Ambulatory Monitoring |
| Q80378969 | Trimetazidine Modified Release in the Treatment of Stable Angina : TRIUMPH StudyTRImetazidine MR in Patients with Stable Angina: Unique Metabolic PatH |
| Q68531628 | Trimetazidine and stable angina a double-blind trial |
| Q24245946 | Trimetazidine for stable angina |
| Q34241059 | Trimetazidine for stable angina pectoris |
| Q45232317 | Trimetazidine in Angina Combination Therapy--the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study |
| Q38371888 | Trimetazidine in Practice: Review of the Clinical and Experimental Evidence |
| Q44720207 | Trimetazidine in geriatric patients with stable angina pectoris: the tiger study. |
| Q28370486 | Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions |
| Q64105784 | Trimethylamine N-Oxide, Circulating Endothelial Progenitor Cells, and Endothelial Function in Patients with Stable Angina |
| Q39878747 | Troponin release following exercise test in patients with stable angina pectoris - risk factors and prognostic significance |
| Q74024976 | Troponin-T in patients with unstable and stable angina pectoris undergoing coronary bypass surgery |
| Q31106727 | Twelve months clinical outcome after bioresorbable vascular scaffold implantation in patients with stable angina and acute coronary syndrome. Data from the Polish National Registry |
| Q34347031 | Twenty-four hour efficacy of two dose levels of a once daily sustained-release diltiazem formulation in stable angina: a placebo-controlled trial. The Dildurang Study Group |
| Q45285413 | Twenty-four-hour activity of felodipine extended release in chronic stable angina pectoris |
| Q67541915 | Twenty-four-hour beta-blockade in stable angina pectoris: a study of atenolol and betaxolol |
| Q55620786 | Two-year clinical outcomes after implantation of an everolimus-eluting bioresorbable scaffold (Absorb) in stable angina and acute coronary syndrome patients. Single-centre real-life registry data. |
| Q37392428 | Two-year clinical outcomes in stable angina and acute coronary syndrome after percutaneous coronary intervention of left main coronary artery disease |
| Q46954286 | Two-year outcomes after enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry [IEPR]). |
| Q57243511 | Unmet medical needs and therapeutic opportunities in stable angina |
| Q41360546 | Unstable Saphenous Vein Graft Atheroma in Patients With Stable Angina Pectoris |
| Q67244550 | Unusual hemodynamic response during exercise-induced angina pectoris |
| Q26852952 | Update on evidence for treatment with ranolazine in stable angina |
| Q38730878 | Update on the clinical utility of coronary computed tomographic angiography in stable angina pectoris |
| Q61455255 | Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome |
| Q43210226 | Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. |
| Q93681836 | Use a score to predict risks of stable angina |
| Q67924829 | Use of captopril as an isolated agent for the management of stable angina pectoris--a double blind randomised trial |
| Q43717493 | Use of isosorbide dinitrate and antagonists of angiotensin II in patients with stable angina pectoris in early stages of cardiac insufficiency |
| Q44975419 | Use of myocardial perfusion imaging to predict the effectiveness of coronary revascularisation in patients with stable angina pectoris |
| Q87927777 | Use of ranolazine in patients with stable angina pectoris |
| Q72058286 | Usefulness of 123I-BMIPP myocardial imaging in patients with stable effort angina and unstable angina |
| Q57177148 | Usefulness of Higher Levels of Cardiac Troponin T in Patients With Stable Angina Pectoris to Predict Risk of Acute Myocardial Infarction |
| Q68824029 | Usefulness of Holter monitoring to improve the sensitivity of exercise testing in determining the degree of myocardial revascularization after coronary artery bypass grafting for stable angina pectoris |
| Q99561956 | Usefulness of Lipoprotein (a) for Predicting Outcomes after Percutaneous Coronary Intervention for Stable Angina Pectoris in Patients on Hemodialysis |
| Q57172526 | Usefulness of Postsystolic Shortening to Diagnose Coronary Artery Disease and Predict Future Cardiovascular Events in Stable Angina Pectoris |
| Q46154508 | Usefulness of ambulatory silent myocardial ischemia added to the prognostic value of exercise test parameters in predicting risk of cardiac death in patients with stable angina pectoris and exercise-induced myocardial ischemia |
| Q69891175 | Usefulness of bevantolol for chronic, stable angina pectoris |
| Q80579393 | Usefulness of brain natriuretic peptide levels to discriminate patients with stable angina pectoris without and with electrocardiographic myocardial ischemia and patients with healed myocardial infarction |
| Q72158268 | Usefulness of endogenous and exogenous nitric oxide to identify degrees of endothelial dysfunction in patients with stable angina pectoris |
| Q72997660 | Usefulness of endothelin(A) receptor antagonists for the prevention of in-stent restenosis in patients with stable angina pectoris or silent myocardial ischemia |
| Q71774400 | Usefulness of heart rate variability in predicting drug efficacy (metoprolol vs diltiazem) in patients with stable angina pectoris |
| Q44319645 | Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction |
| Q73291983 | Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectoris |
| Q77225684 | Usefulness of isometric hand grip exercise in detecting coronary artery disease during dobutamine atropine stress echocardiography in patients with either stable angina pectoris or another type of positive stress test |
| Q92950002 | Usefulness of layer-specific strain in diagnosis of coronary artery disease in patients with stable angina pectoris |
| Q28333606 | Usefulness of oral nisoldipine for stable angina pectoris. The Nisoldipine Multicenter Angina Study Group |
| Q41042521 | Usefulness of persistent silent myocardial ischemia in predicting a high cardiac event rate in men with medically controlled, stable angina pectoris |
| Q44364406 | Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study). |
| Q81270909 | Usefulness of real-time myocardial perfusion imaging to evaluate alterations of myocardial blood flow in patients with stable angina pectoris undergoing elective percutaneous coronary interventions |
| Q69253432 | Usefulness of sustained-release diltiazem for stable angina pectoris |
| Q58433931 | Using biomarkers to prioritise patients with stable angina pectoris for bypass surgery |
| Q93094574 | Utility of mean platelet volume to predict the prevalence of coronary artery disease on coronary angiography in patients with stable angina |
| Q37004023 | Utility of ranolazine in chronic stable angina patients. |
| Q34423176 | Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients. |
| Q92907742 | Validation of European Society of Cardiology pre-test probabilities for obstructive coronary artery disease in suspected stable angina |
| Q73937444 | Value of C-reactive protein in patients with stable angina pectoris, coronary narrowing (30% to 70%), and normal fractional flow reserve |
| Q33611477 | Value of ambulatory ST segment monitoring in patients with chronic stable angina: does measurement of the "total ischaemic burden" assist with management? |
| Q69275052 | Value of sustonit in the treatment of patients with stable angina pectoris |
| Q44099087 | Value of transdermal nitroglycerin in the treatment of patients with stable angina pectoris and its effect on selected hemodynamic parameters |
| Q41630043 | Variability in lipid profile among patients presented with acute myocardial infarction, unstable angina and stable angina pectoris |
| Q50750747 | Variability of changes in Doppler transmitral filling pattern during stress echocardiography in patients with stable angina pectoris. |
| Q72695641 | Variability of episodic ST segment depression in chronic stable angina: implications for individual and group trials of therapeutic efficacy |
| Q69583041 | Variability of results during repeat exercise stress testing in patients with stable angina pectoris: role of dynamic coronary flow reserve |
| Q72784906 | Variable responses of highly stenotic coronary arteries and collateral circulation to intracoronary injection of nitroglycerin in patients with chronic effort angina |
| Q52592992 | Vascular Healing Response after Everolimus-Eluting Stent Implantation in Acute Coronary Syndrome Culprit Lesions: Comparison with Implantation in Stable Angina Pectoris. |
| Q54412063 | Vascular endothelial function and carotid intima-media thickness in patients with isolated coronary artery ectasia and exercise-induced angina pectoris. |
| Q41333888 | Vasoconstrictor peptides and cold intolerance in patients with stable angina pectoris |
| Q38867313 | Vasodilator Therapy: Nitrates and Nicorandil |
| Q82974125 | Vasodilatory effect of subsequent administration of fasudil, a rho-kinase inhibitor, surpasses that of nitroglycerin at the concentric coronary stenosis in patients with stable angina pectoris |
| Q77958150 | Vasomotor responses of coronary stenoses to acetylcholine and their relation to serum lipid levels in stable angina pectoris |
| Q40681913 | Ventricular Arrhythmia in Chronic Stable Angina Pectoris with Surgical or Medical Treatment |
| Q71612395 | Ventricular arrhythmias during exercise testing and daily activities in patients with stable angina pectoris before and during Aldisem and penbutolol treatment |
| Q70307299 | Verapamil Administered Twice Daily in Stable Angina Pectoris |
| Q72534260 | Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris |
| Q72557200 | Verapamil in Treatment of Chronic Stable Angina |
| Q72904823 | Verapamil in chronic stable angina: Amelioration of pacing-induced abnormalities of left ventricular ejection fraction, regional wall motion, lactate metabolism and hemodynamics |
| Q71537560 | Verapamil in chronic stable angina: a controlled study with computerized multistage treadmill exercise |
| Q58645895 | Verapamil in stable effort angina: Effects on left ventricular function evaluated with exercise radionuclide ventriculography |
| Q70482781 | Verapamil or propranolol in the treatment of stable angina pectoris of effort |
| Q70263937 | Verapamil versus placebo in relieving stable angina pectoris |
| Q40657112 | Veterans Administration Cooperative Study of surgical treatment of stable angina: preliminary results |
| Q44326547 | Virtual histology study of atherosclerotic plaque composition in patients with stable angina and acute phase of acute coronary syndromes without ST segment elevation |
| Q91183217 | Vitamin D and Ischaemic Heart Disease: A Casual or A Causal Association? : Commentary on: "Raslan E et al. Association of Vitamin D Deficiency with Chronic Stable Angina: A Case-Control Study" |
| Q53366567 | Volumetric evaluation of coronary plaque in patients presenting with acute myocardial infarction or stable angina pectoris-a multislice computerized tomography study. |
| Q30400121 | WITHDRAWN: Trimetazidine for stable angina |
| Q72166956 | Which drug to choose for stable angina pectoris: a comparative study between bisoprolol and nitrates |
| Q77682187 | Why we should attempt to eliminate (silent and symptomatic) ischemia in patients with chronic stable angina |
| Q91270807 | Will ORBITA change my practice? ORBITA trial: Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina |
| Q43714486 | With reference to article: "Impact of the first-generation drug-eluting stent implantation on periprocedural myocardial injury in patients with stable angina pectoris". Dewetting problem |
| Q72316508 | Withdrawal phenomenon after abrupt cessation of nifedipine in stable angina pectoris |
| Q61875211 | Women with Stable Angina Pectoris and No Obstructive Coronary Artery Disease: Closer to a Diagnosis |
| Q57300120 | Young adulthood obesity and risk of acute coronary syndromes, stable angina pectoris, and congestive heart failure: a 36-year cohort study |
| Q67301733 | [37 years of effort angina pectoris in a case of aortic stenosis. Major deficiency of lactate dehydrogenase 1 and 2 isoenzymes] |
| Q87184113 | [40-year-old athlete with exercise-induced angina pectoris] |
| Q87660142 | [67-year-old woman with exercise-induced angina pectoris] |
| Q70652155 | [A case of chronic recurrent pulmonary embolism complicated with effort angina pectoris] |
| Q77490364 | [A case of coronary artery bypass grafting for effort angina in a patient with post skin grafting for an extramammary Paget's disease] |
| Q72197713 | [A case of coronary artery bypass grafting for single coronary artery complicated by effort angina] |
| Q70591735 | [A case report with special reference to correlation between increased hematocrit and angina on effort] |
| Q93638352 | [A method of sanatorium treatment of patients with exertion-induced stable angina pectoris with graded physical exercises] |
| Q80060178 | [A new medicine for treatment of stable angina pectoris] |
| Q71095157 | [Accumulation of 99m Tc-Sn-pyrophosphate in the myocardium and the contractile function of the left ventricle in patients with stable angina] |
| Q83367779 | [Activity of angiotensin converting enzyme in blood serum of patients with stable effort angina] |
| Q70464680 | [Acute and long-term effects of gallopamil (D 600) in stable angina pectoris--a randomized double-blind study] |
| Q70251343 | [Acute effects of nisoldipine in patients with stable effort angina] |
| Q70181909 | [Acute effects of oral acebutolol on exercise tolerance in patients with stable angina pectoris (author's transl)] |
| Q54079840 | [Adherence of patients with stable angina to treatment with trimetazidine MR and frequency of emergency medical care: results of the EFFECT study]. |
| Q67941897 | [Age-related changes in clinical and prognostic significance of exercise-induced angina] |
| Q70682162 | [Ambulatory ECG monitoring in effort angina (author's transl)] |
| Q80549104 | [Amount of circulating endothelium precursors in patients with stable angina of effort and patients with acute non-ST-elevation coronary syndrome] |
| Q72559706 | [An ergometric cross-over evaluation of the anti-ischemic efficacy of amlodipine and gallopamil in stable angina of effort] |
| Q84462433 | [Analysis of factors influencing QT interval dispersion in patients with stable angina] |
| Q68968508 | [Angina of effort as an unfavorable prognostic factor] |
| Q83486877 | [Angioplasty in stable angina pectoris. Not cost effective compared to drug treatment] |
| Q95412765 | [Angioplasty not always the answer in stable angina] |
| Q69902748 | [Anti-angina effect of the calcium antagonist bepridil in stable angina pectoris] |
| Q70383844 | [Anti-ischemia effect of continuous 24-hour infusion of glyceryl trinitrate in patients with stable angina pectoris] |
| Q69378705 | [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris] |
| Q68162138 | [Anti-ischemic action of the transdermally-applied beta-receptor blocker, mepindolol, in patients with stable angina pectoris. Comparison with transdermal nitrate] |
| Q54502494 | [Are calcium inhibitors useful in the treatment of effort angina pectoris] |
| Q74580052 | [Assessment of exercise-induced silent myocardial ischemia by dipyridamole thallium imaging: (1). Its significance in stable angina pectoris] |
| Q83391142 | [Assessment of psychological status of patients with effort angina] |
| Q89492203 | [Assessment of the Impact of Nicorandil on the Quality of Life and Prognosis Indicators in Patients With Stable Angina] |
| Q95500405 | [Assessment of the Therapeutic Efficacy and Safety of the Original Bisoprolol and its Generic Biprol in Patients With Stable Angina] |
| Q85325365 | [Assessment of the therapeutic efficacy and safety of the original bisoprolol and its generic biprol in patients with stable angina] |
| Q79126059 | [Associated factors in subjects with cardiac ischemia (effort angina or infarct) in the 3d and 4th decades).] |
| Q92346446 | [Association between Lipoprotein(a) and the characteristics of left main coronary artery plaque in patients with stable angina pectoris] |
| Q53758100 | [Association between the ApoB/A1 ratio and the vulnerability of LMCA plaque in the patients with stable angina pectoris]. |
| Q95447660 | [Association between thyroid dysfunction and incidence of atrial fibrillation in patients with stable angina pectoris] |
| Q89504494 | [Association of Some Homozygous Genotypes of Genes Regulating Inflammation, Destruction and Angiogenesis With Laboratory Markers of Atherosclerosis Course in Men With Stable Effort Angina] |
| Q69457941 | [Atrial stimulation test and repeated left ventriculography in the evaluation of left ventricular function in stable angina pectoris] |
| Q73769001 | [Behavior of plasma levels of endothelin 1 and noradrenaline in patients with stable angina during the cold pressor test] |
| Q72635772 | [Beta blockers in stable angina pectoris] |
| Q53750246 | [Beta-adrenergic blockaders and coronary insufficiency. Practolol in the treatment of the effort angina] |
| Q73475417 | [Biofeedback-wave rehabilitation therapy in combined treatment of patients with stable angina pectoris] |
| Q77560224 | [Biological activity of neutrophils from the peripheral blood and coronary sinus in patients with stable angina pectoris] |
| Q68506543 | [Captopril in the therapy of stable angina pectoris] |
| Q71615373 | [Cardiac function during exercise in effort angina Part 2. Comparison of the effects of nitroglycerin and digitalis (author's transl)] |
| Q57152947 | [Cardiac stem cell therapy for the treatment of chronic stable angina refractory to conventional therapy. State of the art and current clinical experience of the San Raffaele Hospital of Milan, Italy] |
| Q70746023 | [Cardiohemodynamic variants in the development of coronary insufficiency in patients with exercise-induced angina pectoris] |
| Q71172669 | [Cardiorespiratory response during exercises in effort angina pectoris] |
| Q71001562 | [Case of effort angina with sick sinus syndrome] |
| Q73528170 | [Catheter therapy in patients with stable angina pectoris. Results of 662 coronary angioplasties] |
| Q78550348 | [Causes of effort angina pectoris; anatomoclinical study of 828 autopsies.] |
| Q67260117 | [Changes in exercise capacity and in induced ischemia with an oral dose of 5 isosorbide mononitrate in patients with stable angina pectoris] |
| Q91076891 | [Chaotic Features on Excess/Deficiency Syndrome of Chronic Stable Angina Pectoris Based on Analyzing Approximate Entropy of Heart Rate Variability] |
| Q84587609 | [Characterization of atherosclerotic plaque in patients with unstable angina pectoris and stable angina pectoris by optical coherence tomography] |
| Q93684029 | [Choice of a calcium antagonist in chronic stable angina] |
| Q70414957 | [Chronic coronary insufficiency (stable angina)] |
| Q79443327 | [Chronic stable angina pectoris. A comparison of diagnostic pathways] |
| Q89504530 | [Clinical Case Demonstrating Use of Trimetazidine In the Treatment of Stable Angina] |
| Q68770322 | [Clinical and angiographic expression of myocardial ischemia in stable angina as a function of its coronary reserve] |
| Q71146967 | [Clinical application of Holter electrocardiography in effort angina] |
| Q54484470 | [Clinical characteristics and treatment of patients with exercise-induced angina pectoris resistant to propranolol] |
| Q71847191 | [Clinical efficacy of long-acting propranolol in patients with stable effort angina] |
| Q74178929 | [Clinical practice guidelines of the Spanish Society of Cardiology on stable angina] |
| Q79763799 | [Clinical significance of exercise-induced ST-segment elevation in lead aVR and V1 in patients with chronic stable angina pectoris and strongly positive exercise test results] |
| Q70320607 | [Clinical study of a new nitroglycerin spray preparation in patients with exertion stable angina] |
| Q76348454 | [Clinical usefulness of high-dose oral nitroglycerin in patients with stable angina pectoris] |
| Q83587265 | [Clinical value of gastroesophageal reflux disease in patients with stable angina] |
| Q68941925 | [Clinico-ergometric evaluation of timolol maleate in stable angina: double-blind, randomized and crossed study] |
| Q70170832 | [Clinico-instrumental criteria of functional classes of patients with ischemic heart disease and stable angina pectoris] |
| Q79761268 | [Clinicofunctional characteristics of the heart in patients with stable angina pectoris in combination with chronic obstructive pulmonary disease] |
| Q95499894 | [Comparative Assessment of Antianginal Efficacy and Safety of Nicorandil at the Background of Therapy With -Adrenoblockers in Ischemic Heart Disease Patients With Stable Angina] |
| Q68239214 | [Comparative effects of diltiazem and nifedipine combined with propranolol, in patients with chronic stable angina pectoris] |
| Q84830874 | [Comparative efficiency of a course of multi-factor physiotherapeutic treatment and a complex of instrumental physiotherapy technics for medical rehabilitation of patients with stable angina pectoris] |
| Q73170576 | [Comparative evaluation of antianginal efficacy of isosorbide dinitrate in various doses in patients with stable angina] |
| Q71551963 | [Comparative evaluation of long-acting nitro preparations in patients with ischemic heart disease and stable angina pectoris of different functional classes] |
| Q78350074 | [Comparative evaluation of the clinical effectiveness and the adverse effects of three different forms of nitrates in high oral doses in patients with stable angina pectoris] |
| Q69397990 | [Comparative evaluation using an ergometric test of the efficacy of the 3 major calcium antagonists on exertion stable angina] |
| Q71603585 | [Comparative pharmacodynamics of 2 long-acting niroglycerin formulations, sustac and trinitrolong, in patients with effort angina pectoris] |
| Q77543907 | [Comparative study of composite danshen droplet pills and sordi in treatment of patients with chronic stable angina] |
| Q73123793 | [Comparative study of isosorbide dinitrates and mononitrates in patients with ischemic heart disease and stable angina pectoris caused by stenosing coronary atherosclerosis] |
| Q73572221 | [Comparative study of retard and non-retard forms of isosorbide-5-mononitrate in coronary patients with stable angina pectoris] |
| Q71903512 | [Comparative study of triombrast and omnipaque tolerance in coronary angiography of patients with ischemic heart disease and stable angina pectoris] |
| Q84437292 | [Comparison between initial medical therapy only and PCI to stable effort angina] |
| Q53621947 | [Comparison between unstable angina pectoris and stable effort angina pectoris by using 123I-BMIPP and 201Tl myocardial SPECT]. |
| Q84559766 | [Comparison of 64 MDCT coronary CTA and coronary angiography in the detection of coronary artery stenosis in low risk patients with stable angina and acute coronary syndrome] |
| Q57909685 | [Comparison of Atherosclerotic Lesions in Patients With Acute Myocardial Infarction and Stable Angina Pectoris Using Intravascular Ultrasound] |
| Q53638732 | [Comparison of Atherosclerotic Lesions in Patients With Acute Myocardial Infarction and Stable Angina Pectoris Using Intravascular Ultrasound]. |
| Q68671585 | [Comparison of calcium antagonist drugs on stable angina caused by exertion] |
| Q72115011 | [Comparison of continuous and intermittent treatment with glyceryl trinitrate by the transdermal route in stable effort angina] |
| Q73185296 | [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina] |
| Q72020691 | [Comparison of nisoldipine and diltiazem in the treatment of effort angina pectoris] |
| Q79812826 | [Comparison of the effect of nitroglycerine and pentaerithritol compositum on exercise time restricted by anginal pain or objective parameters of ischaemia in patients with stable angina] |
| Q69315017 | [Comparison of the effects of diltiazem and isradipine in patients with chronic stable angina pectoris] |
| Q72539039 | [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test] |
| Q79306329 | [Comparison of the morphology of atherosclerotic plaques in patients with stable angina pectoris and acute coronary syndrome using intravascular ultrasonography] |
| Q80507631 | [Complying with guidelines to improve the diagnosis and treatment of chronic stable angina (no abstract)] |
| Q52982570 | [Computed tomography in patients with chronic stable angina : Fractional flow reserve measurement]. |
| Q82104595 | [Connection of endothelial dysfunction and level of blood leukocytes with clinical course of stable angina pectoris in patients with ischemic heart disease] |
| Q71393925 | [Conservative treatment concepts for stable angina pectoris in coronary heart disease] |
| Q85271757 | [Control of myocardial ischemia in patients with effort angina and polyvascular atherosclerotic involvement] |
| Q79678937 | [Coronary angiography in stable angina: friends and foes] |
| Q73192449 | [Coronary artery bypass grafting for a patient with effort angina pectoris and apical hypertrophic cardiomyopathy: case report] |
| Q72253384 | [Coronary artery bypass grafting for the treatment with chronic stable angina] |
| Q72376595 | [Coronary atheromatosis with effort angina in a young patient. Balloon dilatation is better than bypass surgery] |
| Q71407057 | [Coronary flow and myocardial metabolism during ischemic attack. Effort angina vs vasospastic angina] |
| Q90423928 | [Coronary revascularization for stable angina pectoris] |
| Q89059029 | [Correlation Between Referred Pain Region and Sensitized Acupoints in Patients with Stable Angina Pectoris and Distribution of Sensitized Spots in Rats with Myocardial Ischemia] |
| Q81102571 | [Criteria for stable angina verification in cases of difficult diagnosis] |
| Q85391152 | [Current Treatment of Stable Angina] |
| Q53386474 | [Current status and influence factors of beta blocker prescription in Chinese patients with stable angina pectoris]. |
| Q69915837 | [Dazoxiben compared with verapamil in the treatment of stable angina pectoris evaluated by an exercise test] |
| Q90425201 | [Definition and classification in stable effort angina] |
| Q86715072 | [Determination of indications for coronary angiography in asymptomatic patients and patients with stable angina] |
| Q90425205 | [Diagnosis and treatment of stable angina pectoris] |
| Q84437290 | [Diagnosis and treatment of stable effort angina pectoris] |
| Q77545183 | [Diagnosis in patients with suspected stable angina pectoris--coronary scintigraphy/coronary arteriography] |
| Q78604020 | [Diagnosis of effort angina pectoris at rest by first derivative electrocardiography] |
| Q73533018 | [Diagnosis of stable effort angina pectoris] |
| Q71172659 | [Diagnostic reliabilities of exercise stress radionuclide angiocardiography and thallium-201 myocardial perfusion imaging in patients with effort angina] |
| Q86708449 | [Diagnostics and therapy of ischemia in chronic stable angina pectoris. Role of echocardiography] |
| Q79395116 | [Differentiation of acute coronary syndrome and ulcerative colitis as causes of elevated macro creatine kinase in a patient with effort angina pectoris: a case report] |
| Q70014500 | [Diltiazem in chronic stable angina] |
| Q54042124 | [Does captopril possess antianginal actions? An evaluation of its effects on myocardial ischemia by stress tests in patients with stable angina and normal ventricular function] |
| Q70170825 | [Does captopril produce an antianginal effect in patients with stable exercise-induced angina pectoris?] |
| Q69676081 | [Does coronary pathomorphology affect the anti-anginal and anti-ischemic effects of diltiazem in patients with chronic stable angina pectoris?] |
| Q72598362 | [Dose-response relationship of nisoldipine in patients with stable angina pectoris and stress-induced myocardial ischemia] |
| Q69912057 | [Drug therapy of stable angina pectoris] |
| Q70367166 | [Duration of action of sustained-release metoprolol in effort angina pectoris] |
| Q71570573 | [Echocardiography during ergometric tests in subjects with stable effort angina (author's transl)] |
| Q84247620 | [Echocardiography with physical exercise in patients with stable angina pectoris concurrent with chronic obstructive pulmonary disease: safety, informative value, and performance conditions] |
| Q73432497 | [Economic evaluation of different treatment strategies in patients with stable angina pectoris or asymptomatic myocardial ischemia on basis of results from the Asymptomatic-Cardiac-Ischemia Pilot study (ACIP)] |
| Q73042470 | [Effect of L-arginine on platelet aggregation, endothelial function adn exercise tolerance in patients with stable angina pectoris] |
| Q81379567 | [Effect of Long-Acting Nifedipine on Mortality and Cardiovascular Morbidity in Patients With Stable Angina Requiring Treatment. Results of the ACTION Study.]. |
| Q88418914 | [Effect of Xinling Wan in treatment of stable angina pectoris: a randomized, double-blinded, placebo parallel-controlled, multicenter trial] |
| Q69457623 | [Effect of a single episode of exertion on serum 6-keto-PGF1 alpha concentration in healthy individuals and patients with exercise-induced stable angina pectoris] |
| Q78956997 | [Effect of adjuvant magnesium therapy on the quality of life and emotional status of elderly patients with stable angina] |
| Q84765319 | [Effect of buxu huayu qutan decoction on anti-oxidative capacity in aged patients with stable angina pectoris of coronary heart disease] |
| Q81313495 | [Effect of carvedilol on antioxidative enzymatic defence in patients with stable angina] |
| Q81313491 | [Effect of carvedilol on lipid peroxidation in patients with stable angina] |
| Q68708391 | [Effect of fendiline on left-ventricular function evaluated by the echocardiographic method and on physical work capacity of patients with stable angina pectoris] |
| Q52545582 | [Effect of sinusoidal modulated currents on physical ability to work and disruption of cardiac rhythm in coronary heart disease with stable angina pectoris] |
| Q70461800 | [Effect of sorbonite on exercise tolerance in stable angina pectoris] |
| Q78479136 | [Effect of superhigh frequency electromagnetic fields and physical exercise on physical performance and extrasystole in myocardial ischemia patients with stable angina pectoris] |
| Q67968004 | [Effect of ticlopidine and dipyridamole on platelet aggregation and count in patients with chronic stable angina pectoris] |
| Q71476288 | [Effectiveness and duration of action of nifedipine in effort angina (author's transl)] |
| Q84648432 | [Effectiveness of aggressive lipid-lowering therapy in elderly patients with stable angina] |
| Q68885186 | [Effectiveness of amiodarone in patients with exercise-induced angina pectoris] |
| Q71430010 | [Effectiveness of depot diltiazem in stable effort angina: a double-blind study compared with placebo] |
| Q68547266 | [Effectiveness of nifedipine, diltiazem and their combination in the treatment of chronic stable angina pectoris] |
| Q70018308 | [Effectiveness of trimetazidine in stable effort angina due to chronic coronary insufficiency. A double-blind versus placebo study] |
| Q72183926 | [Effects of allopurinol on uric acid metabolism and lipid peroxidation in ischemic heart disease patients with stable angina] |
| Q46002667 | [Effects of beta 1-adrenoblocker bisoprolol on endothelial dysfunction in patients with stable angina pectoris in combination with chronic obstructive pulmonary disease] |
| Q71777869 | [Effects of coenzyme Q10 injections on exercise tolerance in patients with stable angina pectoris] |
| Q54103447 | [Effects of fenigidin treatment regimen on the state of peripheral hemodynamics of patients with stable effort angina pectoris and postinfarction cardiosclerosis] |
| Q69540392 | [Effects of slow-release isosorbide-5-mononitrate on ergometric parameters and cardiac output in stable effort angina pectoris: a double-blind randomized placebo study] |
| Q73158039 | [Effects of the K(+) channel blocker tedisamil on hemodynamics, myocardial ischemia and neurohumoral systems in patients with stable angina pectoris. A comparison with the beta blocker atenolol] |
| Q54547581 | [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate]. |
| Q69510401 | [Efficacy and length of action of a slow-release formulation of isosorbide-5-mononitrate in stable effort angina] |
| Q71256796 | [Efficacy and tolerability of felodipine and nifedipine in stable angina refractory to beta-blocker therapy] |
| Q51949354 | [Efficacy of an educational preventive technology in patients with stable angina in ambulatory conditions]. |
| Q69568517 | [Efficacy of diltiazem in elderly patients with stable effort angina] |
| Q70237563 | [Effort angina and calcium antagonists] |
| Q70235637 | [Effort angina in an adult patient with anomalous origin of the left coronary artery] |
| Q70223706 | [Erythrocyte filterability in patients with stable angina pectoris depending on meteorosensitivity] |
| Q72959654 | [Etiologic diagnosis of effort angina] |
| Q69733481 | [Evaluation by an ergometric test of the effects of diltiazem in patients with stable angina] |
| Q70253684 | [Evaluation by exercise test of effects of a single oral dose of atenolol in patients with stable angina (author's transl)] |
| Q70462676 | [Evaluation of a new percutaneous nitroglycerin preparation in effort angina] |
| Q72420111 | [Evaluation of amlodipine in stable effort angina in office cardiologic practice] |
| Q73491794 | [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris] |
| Q96771758 | [Evaluation of the efficiency of combined pharmacotherapy with the use of trimetazidine with prolonged release in patients with stable angina in outpatient practice] |
| Q69876524 | [Evaluation, by the bicycle ergometry test ECG, of the efficacy of a single dosage of nadolol, in patients with stable angina pectoris] |
| Q84625497 | [Exercise tolerance after coronary stenting in patients with stable angina] |
| Q93662507 | [Exercise-induced angina and coronary vasospasm] |
| Q70794468 | [Exertion without angina in angina of effort] |
| Q69899777 | [Experience with 5 years of drug therapy of ischemic heart disease patients with stable angina and stenosing atherosclerosis of the coronary arteries] |
| Q79982234 | [Factors influencing policy of examination of patients with stable angina pectoris] |
| Q71472772 | [Global left ventricular function in chronic stable angina: the role of myocardial infarction] |
| Q80507634 | [Guideline for diagnosis and treatment of patients with chronic stable angina (no abstract)] |
| Q75296952 | [Guidelines and methods for clinical investigation of drugs for treatment of stable angina pectoris] |
| Q80789477 | [Guidelines of chronic coronary disease: stable angina] |
| Q79335742 | [Guidelines on the management of stable angina pectoris: executive summary] |
| Q54661666 | [Hemodynamico-metabolic aspects of the post-atrial pacing recovery period in stable angina] |
| Q58911385 | [Histopathologic features in atherectomy samples obtained from patient with unstable angina, stable angina and restenosis. Directional Atherectomy Lombardi Group] |
| Q53380555 | [Impacts on neutrophil to lymphocyte ratio in patients of chronic stable angina pectoris treated with acupuncture at Neiguan (PC 6)]. |
| Q54000699 | [Indications for percutaneous angioplasty and coronary surgery in stable angina pectoris] |
| Q70541379 | [Influence of myocardial infarct on ventricular arrhythmias during the exercise test. Study in patients with stable angina of effort] |
| Q68067620 | [Influence of posture on exercise-induced electrocardiographic and hemodynamic changes in patients with stable effort angina pectoris] |
| Q89492267 | [Influence of the Potassium Channels Activator Nicorandil to the Quality of Life in Patients With Ishemic Heart Disease and Stable Angina Pectoris] |
| Q81061510 | [Interpretation of the appropriate guideline for elective coronary angioplasty for the cases with stable angina pectoris] |
| Q73971797 | [Is it worthwhile to treat stable angina pectoris with long-acting nitrates?] |
| Q64891502 | [Is the exercise test in stable angina reproducible? Personal experience and review of the literature] |
| Q72426963 | [Isradipine versus diltiazem in the treatment of stable effort angina pectoris: ergometric evaluation in a crossover double-blind study] |
| Q79381383 | [Ivabradine--a medical alternative for patients with chronic stable angina pectoris] |
| Q79261864 | [Ivabradine--the first selective and specific I(f) inhibitor, novel preparation for treatment of stable angina] |
| Q69457937 | [Kordaron treatment of effort angina pectoris] |
| Q81581872 | [Laws of syndrome element combination in stable angina pectoris: a study based on cluster analysis and corresponding-correlation analysis] |
| Q60730205 | [Life style intervention treatment as effective as PCI in stable angina] |
| Q71126487 | [Long duration of action of metoprolol in the prolonged treatment of angina of effort] |
| Q95576196 | [Long-Term Statin Adherence in Patients with Stable Angina after Coronary Stenting] |
| Q69521463 | [Long-term treatment of stable angina pectoris with penbutolol] |
| Q71349952 | [Management and treatment of stable angina] |
| Q80039662 | [Markers of inflammation--monocyte chemoattractant protein-1 (MCP-1) and C-reactive protein--in blood of patients with unstable angina pectoris and stable effort angina] |
| Q81153529 | [Matrix metalloproteinases, C-reactive protein, and markers of thrombinemia in patients with stable angina and restenoses after percutaneous coronary interventions.]. |
| Q70923696 | [Medical treatment of patients with stable angina pectoris] |
| Q72822487 | [Methodologic approaches to evaluation of interaction of anti-anginal agents in their combined use in patients with exercise-induced angina] |
| Q70383506 | [Methods of studying an anti-ischemia agent in chronic stable angina] |
| Q80958991 | [Moderate coronary lesion with severe vasospasm and the development of collateral circulation in a patient with effort angina and ST-segment depression] |
| Q74316420 | [Molsidomine and isosorbide dinitrate: a comparative trial of tolerance in long-term intake by IHD patients with stable angina of effort] |
| Q84686218 | [More patients with stable angina should be treated with PCI] |
| Q68590790 | [Myocardial adrenergic derangement due to myocardial ischemia: decreased myocardial uptake of I-123 metaiodobenzylguanidine after PTCA in a patient with effort angina] |
| Q84966125 | [Myocardial cytoprotectors, a reserve therapeutic modality for patients with stable angina of effort] |
| Q73813388 | [Myocardial perfusion scintigraphy for diagnosis and risk stratification in stable angina pectoris] |
| Q73729253 | [Myocardial scintigraphy and coronary arteriography in patients with known or suspected stable angina pectoris] |
| Q70549192 | [Myocardial scintigraphy with thallium 201 in exercise-induced angina pectoris] |
| Q31044303 | [New data in the diagnosis and treatment of stable angina pectoris]. |
| Q95384986 | [New guidelines for diagnosis and management of stable angina pectoris. Recommendations from the European Society of Cardiology] |
| Q73538047 | [New observation of pernicious anemia with syndrome of intermittent claudication and effort angina disappearing after treatment of the anemia] |
| Q98154069 | [New opportunities to improve the treatment effectiveness of patients with stable angina] |
| Q70230481 | [Nisoldipine in stable angina pectoris. Efficacy and tolerance in comparison with diltiazem] |
| Q72219996 | [Nitrates in the treatment of chronic stable angina] |
| Q69705909 | [Observation of the circadian distribution of attacks in chronic stable angina pectoris] |
| Q79451122 | [Observations on patients with effort angina pectoris.] |
| Q81423047 | [Optimal medical therapy in stable angina pectoris--CURAGE clinical trail] |
| Q84591085 | [Optimal prevention and pharmacotheraphy in stable angina pectoris] |
| Q71123209 | [Pacing-dependent changes in myocardial oxygen consumption and coronary flow in normal subjects and patients with stable angina] |
| Q77910945 | [Pain sensitivity threshold in patients with ischemic heart diseases with and without stable angina with episodes of "silent" myocardial ischemia] |
| Q80352912 | [Painless myocardial ischemia at various blood pressure levels in patients with effort angina (J-shaped relationship)] |
| Q73533014 | [Pathophysiology of stable effort angina] |
| Q85001737 | [Peculiarities of stable angina of effort in aged and elderly patients] |
| Q90729126 | [Percutaneous coronary intervention in stable angina pectoris : Objective randomised blinded investigation with optimal medical therapy of angioplasty in stable angina (ORBITA) trial] |
| Q85222673 | [Percutaneous coronary intervention vs coronary artery bypass grafting for patients with stable angina pectoris] |
| Q71750264 | [Plasma catecholamines during maximal exercise in patients with effort angina] |
| Q71373719 | [Prazosin in exercise-induced angina pectoris. An open study of work capacity after a single dose of prazosin, isosorbide dinitrate, atenolol and nifedipine] |
| Q83312070 | [Predictive value of an ischemia test in men and women with stable angina pectoris in clinical practice. Results of the heart catheter registry of the Working Society of Senior Hospital Cardiologists] |
| Q71519241 | [Preventive action on stable exercise-induced angina of a topical nitroglycerin gel and of an oral slow-release nitroglycerin compound (Lénitral) in low and high dosage (author's transl)] |
| Q84437269 | [Prognostic evidences of chronic stable angina pectoris, vasospastic angina and microvascular angina] |
| Q70225847 | [Prognostic significance of the electrocardiographic coronary reserve in stable angina] |
| Q31133983 | [Prospective assessment of changes in microcirculation and central hemodynamics in patients with stable angina pectoris according to the data of radionuclide study methods]. |
| Q83048412 | [Psychological stress status in patients with acute coronary syndrome and stable angina pectoris] |
| Q84957880 | [Ranolazine in the treatment of chronic stable angina] |
| Q71256577 | [Reflex constriction of resistance vessels in people with varying pathogenetic mechanisms of angina of effort] |
| Q71106530 | [Relationship between ischemic ST depression and oxygen uptake kinetics during ramp exercise test in patients with effort angina] |
| Q44882231 | [Relationship between lung-to-heart uptake ratio of technetium-99m-tetrofosmin during exercise myocardial single photon emission computed tomographic imaging and the number of diseased coronary arteries in patients with effort angina pectoris withou |
| Q73373228 | [Release of troponin T following PTCA in patients with unstable and stable angina pectoris] |
| Q71771816 | [Results of a 2-year prospective study of patients with ischemic heart disease with stable angina pectoris] |
| Q71404565 | [Results of ambulatory graded exercise therapy of exertion-induced stable angina pectoris] |
| Q51329473 | [Results of combined therapy of stable 2-3 FC angina of effort with metabolic syndrome including metformin]. |
| Q74466205 | [Rheological and hydrodynamic properties of blood from patients with stable angina pectoris: correction with high molecular polyethylene oxide] |
| Q95537305 | [Selection of antiplatelet therapy for patients with stable angina] |
| Q50748290 | [Sensitivity and related factors in iodine-123-beta-methyl-p-iodophenyl-pentadecanoic acid myocardial scintigraphy to detect stable effort angina pectoris]. |
| Q72112277 | [Serial evaluation by effort test of the effects of coronary artery bypass on effort angina (author's transl)] |
| Q71622239 | [Serum nitrate levels in patients with stable angina pectoris treated with sustained-action nitroglycerin preparations] |
| Q90648362 | [Shensong Yangxin Capsules in the adjuvant treatment of stable angina pectoris:a Meta-analysis and trial sequential analysis] |
| Q69127127 | [Silent ischemia in stable angina pectoris. Characteristics in frequency-modulated long-term ECG] |
| Q81327072 | [Stable angina pectoris can be treated successfully by drugs alone--contra] |
| Q84041721 | [Stable angina pectoris. Coronary angiography is not always necessary] |
| Q84535881 | [Stable angina pectoris. Effective symptom control and cardioprotection with ivabradine] |
| Q78491113 | [Stable angina pectoris. PTCA improves symptoms, but not prognosis] |
| Q68661335 | [Stable angina pectoris. Physiopathology, diagnosis, course and prognosis, treatment] |
| Q89276812 | [Stable angina pectoris: assessment] |
| Q73970194 | [Stable angina pectoris: what is the role of calcium antagonists?] |
| Q69918872 | [Stable angina pectoris; why has the prognosis changed so much?] |
| Q74084268 | [Stable angina pectoris] |
| Q73104478 | [Stable angina, effort angina, stable effort angina] |
| Q87976605 | [Stable angina: what the European guidelines say or do not say] |
| Q84437287 | [Stable effort angina pectoris: concept and classification] |
| Q73259658 | [Studies of arrhythmia incidence and heart rate variability in patients with stable angina pectoris] |
| Q77919666 | [Study of the general and topical tolerance of Trinipatch and its clinical efficacy in the therapy of chronic stable angina in 5078 coronary disease patients] |
| Q101463822 | [Study on drug properties and syndrome-symptom-formula-herb network of traditional Chinese medicine in treatment of effort angina pectoris based on data visualization] |
| Q71528721 | [Sustained effect of nitroglycerin ointment on exercise tolerance in patients with effort angina (author's transl)] |
| Q80333760 | [Systematic assessment on randomized controlled trials for treatment of stable angina pectoris by compound salvia pellet] |
| Q69871465 | [TTS-nitroglycerin and slow-release metoprolol: efficacy in patients with stable exercise-induced angina] |
| Q72591466 | [The acute and chronic effects of 10-mg nitroglycerin patches in stable angina of effort] |
| Q67904446 | [The antianginal effects of a new delayed-release formulation of diltiazem in patients with stable angina pectoris: its evaluation by the ergometry test and dynamic electrocardiogram] |
| Q72318573 | [The antianginal efficacy of verapamil and nitrosorbide used separately and jointly in patients with angina of effort] |
| Q95353799 | [The comparative effectiveness of beta-blockers and inhibitors of if-iodium using in patients with stable angina pectoris] |
| Q61822890 | [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina] |
| Q68008498 | [The effect of a single administration of diltiazem on exercise tolerance in patients with stable angina pectoris] |
| Q68928029 | [The effect of diltiazem and nifedipine, alone or in combination, on exercise performance, myocardial ischemia and left ventricular function in patients with chronic stable effort angina: a double-blind, randomized and placebo-controlled clinical st |
| Q72381400 | [The effect of diuretics on the magnitude of the effect of isosorbide dinitrate given as a single dose and after long-term administration. Ergometric study in patients with stable angina pectoris] |
| Q68207238 | [The effect of gallopamil on myocardial perfusion in angina of effort] |
| Q69461801 | [The effect of molsidomine on bicycle ergometry in patients with stable angina pectoris] |
| Q70154062 | [The effect of nifedipine and diltiazem on left ventricular function in patients with stable angina pectoris and severe left ventricular dysfunction] |
| Q77370824 | [The effect of pentoxifylline on oxidative metabolism in neutrophils primed with tumor necrosis factor alpha in patients with stable angina pectoris] |
| Q72318576 | [The effect of pyridinolcarbamate (parmidine) on the microcirculation and immunity of patients with stable angina] |
| Q71814121 | [The effectiveness of oxprenolol in depot form in stable angina pectoris] |
| Q60808510 | [The efficacy of slow-release diltiazem in the treatment of stable angina of effort: a comparison between diltiazem and placebo] |
| Q70787152 | [The ergometric test in the evaluation of the effects of nifedipine, verapamil and ethyl cinepazat maleate in angina of effort] |
| Q80656047 | [The evidence-based invasive therapy of stable angina pectoris] |
| Q72328102 | [The pharmacokinetic interaction of propranolol and nifedipine in patients with angina of effort] |
| Q80541782 | [The relationship between serum C-reactive protein levels and coronary artery disease in patients with stable angina pectoris and positive exercise stress test] |
| Q84546780 | [The role of duplex scanning of the carotid arteries in detection of correlations between carotid and coronary atherosclerosis by the results of coronaroangiography in patients with stable angina] |
| Q84085420 | [The role of dynamic perfusion scyntiography of myocardium at rest and during exercise in the assessment of the clinical course of chronic cardiac failure and angina of effort in patients with stable forms of coronary heart disease] |
| Q84309461 | [The scope and algorithm of instrumental physiotherapy programs at the hospital stage of rehabilitation of patients with stable angina pectoris] |
| Q72647857 | [The utility of body surface isochrone mapping of recovery time in diagnosing effort angina] |
| Q94589434 | [The value of cytochrome P4502C19 gene assay for anti-platelet therapy after PCI in stable angina patients with left main coronary artery lesions] |
| Q82655521 | [The value of myocardial perfusion scintigraphy as a "gatekeeper" for coronary angiography and revascularisation in patients with stable angina pectoris--a secondary publication] |
| Q71809611 | [Therapeutic association in chronic stable angina: verapamil plus beta-blockers] |
| Q72904499 | [Therapeutic effectiveness of molsidomine in patients with exercise-induced angina pectoris] |
| Q70253681 | [Therapeutical comparison between atenolol and nifedipine in effort angina (author's transl)] |
| Q79835110 | [Therapy in stable angina pectoris] |
| Q53402701 | [Thiotriazoline in the Treatment of Stable Angina IIIII Functional Class]. |
| Q53214503 | [Thiotriazoline in the Treatment of Stable Angina Pectoris of II-III Functional Class]. |
| Q86444607 | [Thyroid hypofunction as a predictor of the absence of clinically significant coronary stenosis in elderly patients with coronary heart disease and typical stable angina] |
| Q70349280 | [Transdermal therapy of stable angina pectoris. Comparison of 2 different transdermal systems] |
| Q73533022 | [Treatment and prognosis of stable effort angina] |
| Q73507610 | [Treatment of chronic stable angina: follow-up study with nifedipine gastrointestinal therapeutic system. SENIOR Study Group] |
| Q73085493 | [Treatment of effort angina pectoris] |
| Q81401262 | [Treatment of erectile dysfunction in patients with ischemic heart disease and angina of effort] |
| Q70383404 | [Treatment of patients with exercise-induced angina pectoris with korinfar and isoptin] |
| Q72758407 | [Treatment of patients with stable angina by combination of trinitrolong and propranolol] |
| Q70591231 | [Treatment of spontaneous and effort angina with nifedipine] |
| Q80002687 | [Treatment of stable angina pectoris with trimetazidine] |
| Q80656041 | [Treatment of stable angina pectoris. "Mother Courage and her children"] |
| Q84546782 | [Trimetazidine addition to antianginal therapy: effects on efficacy and quality of life in patients with stable angina treated outpatiently] |
| Q80002742 | [Trimetazidine in the treatment of stable angina pectoris TRIADA-(trimetazidine in stable angina twice daily)] |
| Q89895870 | [Triple antianginal combinations in the treatment of elderly and senile patients with stable angina] |
| Q70169510 | [Use of multicenter clinical trial of molsidomine by single-blind method in stable angina pectoris] |
| Q69239453 | [Use of nitroderm in effort angina pectoris] |
| Q73042767 | [Use of olicard retard in patients with stable angina of low effort in an outpatient setting] |
| Q68691551 | [Usefulness of the pharmacological dipyridamole test in the diagnosis of exercise-induced angina pectoris] |
| Q85306323 | [Using functional brain imaging technique to study central mechanism of acupuncture therapy for chronic stable angina pectoris in view of heart-brain correlation] |
| Q77546051 | [Validation of methods assessing the quality of life in patients with stable angina pectoris] |
| Q72963987 | [Value and significance of cardiodynamic changes in angina of effort] |
| Q68232070 | [Value of fendiline in the treatment of patients with stable angina pectoris] |
| Q70038412 | [Various indicators of hemostasis, plasminogen-plasmin and kinin systems of the blood and their inhibitors in patients with stable angina pectoris and post-infarction cardiosclerosis after graded physical load] |
| Q69915797 | [Various theories on the pharmacological treatment of stable exercise-induced angina pectoris] |
| Q71646613 | [Verapamil in effort angina: a multi-centre study] |
| Q57813031 | [Which elderly with stable angina should be referred for cardiac surgery?] |
| Q33561276 | rs5911 and rs3842788 Genetic Polymorphism, Blood Stasis Syndrome, and Plasma TXB2 and hs-CRP Levels Are Associated with Aspirin Resistance in Chinese Chronic Stable Angina Patients |
| Q61651374 | von Willebrand Factor Inhibition Improves Endothelial Function in Patients with Stable Angina |
| Q45160979 | Оptimization of stable angina standard therapy in patients with concomitant osteoarthritis and obesity |
| Q28137895 | Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular |
| Q28217880 | The initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey o |